Compounds > lithium chloride
Page last updated: 2024-09-27

lithium chloride

Description

Lithium Chloride: A salt of lithium that has been used experimentally as an immunomodulator. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

lithium chloride : A metal chloride salt with a Li(+) counterion. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID433294
CHEMBL ID69710
CHEBI ID48607
MeSH IDM0027208

Synonyms (102)

Synonym
licl
LOPAC0_000604
EU-0100604
lithium chloride, bioxtra, >=99.0% (titration)
MOLMAP_000071
NCGC00015607-01
lopac-l-4408
wln: li g
nsc-327172
7447-41-8
lithium chloride (licl)
lithium chloride
nsc327172
hsdb 4281
ccris 5924
nsc 327172
chlorku litu [polish]
chlorure de lithium [french]
einecs 231-212-3
luthium chloride
lithium chloride, for molecular biology, >=99%
lithium chloride, anhydrous, beads, -10 mesh, 99.998% trace metals basis
lithium chloride, anhydrous, beads, -10 mesh, >=99.9% trace metals basis
lithium chloride, powder, >=99.99% trace metals basis
NCGC00093980-01
NCGC00093980-02
chloride, lithium
cloruro de litio
lithiumchlorid
lithii chloridum
chlorure de lithium
CHEBI:48607 ,
chembl69710 ,
lithium chloride, puriss. p.a., acs reagent, anhydrous, >=99.0% (at)
lithium chloride, bioultra, for molecular biology, anhydrous, >=99.0% (at)
NCGC00015607-02
L 4408
L0204
L0222
NCGC00015607-04
chlorku litu
chlorolithium
lithium cholride
A838146
HMS3261J10
59217-69-5
lithium chloride, gamma irradiated, 8m
CCG-204693
AKOS015950647
NCGC00015607-03
g4962qa067 ,
unii-g4962qa067
ec 231-212-3
FT-0627896
LP00604
lithium chloride [mi]
lithium chloride [hsdb]
lithium chloride [inci]
lithium muriaticum [hpus]
lithium muriaticum
lithium chloride [who-dd]
AKOS015902822
clli
lithiumchloridegr(anhydrous)
NCGC00261289-01
tox21_500604
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
lithim chloride
lithiumchloride
AKOS024438070
mfcd00011078
DTXSID2025509 ,
lithium chloride, 3-5% in thf
lithium chloride, ultra dry
lithium chloride, puriss. p.a., anhydrous, >=99.0% (at)
lithium chloride, anhydrous, free-flowing, redi-dri(tm), acs reagent, >=99%
lithium chloride, anhydrous, free-flowing, redi-dri(tm), reagentplus(r), 99%
lithium chloride, anhydrous, chunks, 99.99% trace metals basis
lithium chloride, anhydrous
lithium chloride, acs reagent, >=99%
lithium chloride, saj special grade, >=99.0%
lithium chloride, saj first grade, >=98.0%
lithium chloride, reagentplus(r), 99%
lithium chloride, acs grade
lithium chloride, acs reagent
lithium chloride, vetec(tm) reagent grade
sr-01000076252
SR-01000076252-1
lithium chloride, trace metals grade 99.9%
lithium chloride battery grade
BP-13612
lithium chloride (2.3% in tetrahydrofuran, ca. 0.5mol/l)
Q422930
lithium;chloride
bdbm50494542
SDCCGSBI-0050586.P002
NCGC00015607-07
SY002997
lithium chloride (powder)
2m lithium chloride electrolyte, electrode filling solution
dtxcid105509
lithium monochloride

Research Excerpts

Overview

ExcerptReference
"Lithium chloride (LiCl) is an important mood-stabilizing therapeutic agent for bipolar disorders, which has also been shown to inhibit cancer cell metastasis. "( Jeon, SH; Kim, JY; Park, HH; Yong, TS, 2021)
"Lithium chloride (LiCl) is a widely used and extensively researched drug for the treatment of bipolar disorder (BD). "( Al-Gafari, M; Golshani, A; Hajikarimlou, M; Jagadeesan, SK; Moteshareie, H; Samanfar, B; Smith, M; Takallou, S; Tayabali, A, 2022)
"Lithium chloride (LiCl) is a compound that induces unpleasant sensations, including visceral discomfort, although its effects on behavior and physiological conditions have also not been investigated extensively in birds."( Cline, MA; Khan, S; Makino, R; Nakatani, A; Tachibana, T, 2022)
"Lithium chloride (LiCl) is a widely used drug for the treatment of bipolar disorders, but as a side effect, 40% of the patients develop diabetes insipidus. "( Edemir, B; Kaiser, M, 2020)
"Lithium chloride is a glycogen synthase kinase 3β (GSK-3β) inhibitor and exert its effects through modulation of nitric oxide pathway."( Dehpour, AR; Esmaeili, J; Mumtaz, F; Nezamoleslami, S; Shafaroodi, H; Sheibani, M, 2020)
"Lithium Chloride (LiCl) is a widely prescribed drug for the treatment of bipolar disorder, acute brain injuries, and chronic neurodegenerative diseases."( Kumar, S; Shokeen, K; Srivathsan, A, 2021)
"Lithium chloride (LiCl) is an emetic drug that has been used to create animal models of anticipatory nausea and conditioned place aversion. "( Cross-Mellor, SK; Doobay, M; Kavaliers, M; Ossenkopp, KP; Wah, DTO, 2021)
"Lithium chloride (LiCl) is a widely-used medication to treat neurological disorders that has undesirable side effects on the female reproductive system. "( Bai, L; Chang, HM; Cheng, JC; Chu, G; Leung, PCK; Yang, G, 2018)
"Lithium chloride (LiCl) is a drug used to treat bipolar disorder, but has side effects in the female reproductive system. "( Mirakhori, F; Shirmohammadian, A; Tafreshi, AP; Zeynali, B, 2013)
"Lithium chloride (LiCl) is an FDA-approved drug for bipolar disorder."( Goliaei, B; Khodagholi, F; Nikoofar, A; Rouhani, M, 2014)
"Lithium chloride (LiCl) is an activator of Wnt/β-catenin signaling through stabilizing β-catenin."( Dong, PY; Mai, Y; Yang, GS; Yang, H; Zhang, ZY; Zheng, XL, 2014)
"Lithium chloride is a GSK-3 family inhibitor that has been a mainstay of in vitro and in vivo studies for many years."( Abdul, AR; Gary, RK; Gorjala, P; Mudireddy, SR, 2014)
"Lithium chloride (LiCl), which is a specific inhibitor of glycogen synthase kinase-3β, is known to induce cell cycle arrest at the G2/M phase and to regulate apoptosis. "( Ha, TK; Kim, YG; Lee, GM, 2014)
"Lithium chloride is a potential antiviral drug for viruses."( Fang, B; Fu, C; Fu, X; Hong, M; Huang, S; Li, S; Yan, Z; Zhou, P, 2015)
"Lithium chloride (LiCl), is a drug used to treat bipolar disorder and has also shown activity against bacterial and viral infections."( Feng, ZX; Ishag, HZ; Liu, MJ; Shao, GQ; Wu, YZ; Xiong, QY; Yang, RS, 2016)
"Lithium chloride is a therapeutic agent for treatment of bipolar affective disorders. "( Ge, J; Ge, Y; Kaminski, JM; Li, F; Lin, J; Liu, X; Liu, Z; Summers, JB; Wang, Z; Yu, K; Zhuang, J, 2009)
"Lithium Chloride (LiCl), which is an inhibitor of GSK3β, markedly reduced the TNF-α-stimulated IL-6 release, similar to the results with Wnt3a."( Adachi, S; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Minamitani, C; Natsume, H; Otsuka, T; Tokuda, H, 2011)
"Lithium chloride (LiCl) is a selective inhibitor of glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase that regulates many cellular processes, in addition to its role in the regulation of glycogen synthase."( Gayathri, G; Ravi Sankar, B; Sangeetha, G; Suganthi, M, 2012)
"Lithium chloride (LiCl) is a potent inhibitor of the DNA virus herpes simplex virus but not RNA viruses."( Harrison, SM; Hiscox, JA; Kaiser, P; Rothwell, L; Tarpey, I, 2007)

Effects

ExcerptReference
"Lithium chloride (LiCl) has a significant neuroprotective effect in cerebral ischaemia. "( Dan, Y; Junde, Z; Lu, Z; Shan, C; Tingting, L; Yizhen, Z, 2023)
"Lithium chloride (LiCl) has a significant neuroprotective effect in cerebral ischaemia. "( Dan, Y; Junde, Z; Lu, Z; Shan, C; Tingting, L; Yizhen, Z, 2023)
"Lithium chloride (LiCl) has been widely researched and utilized as a therapeutic option for bipolar disorder (BD). "( Al-Gafari, M; Allard, D; Golshani, A; Hajikarimlou, M; Jagadeesan, SK; Kazmirchuk, TDD; Moteshareie, H; Nokhbeh, R; Said, KB; Samanfar, B; Smith, M; Takallou, S; Wang, J, 2023)
"Lithium chloride has previously been shown to enhance myogenesis and prevent certain forms of muscular dystrophy."( Jung, DW; Kim, HJ; Kim, JH; Kim, SW; Lee, JH; Um, J; Williams, DR, 2021)
"Lithium chloride has been widely used as a therapeutic mood stabilizer. "( Barrantes, FJ; Henríquez, JP; Zelada, D, 2021)
"Lithium chloride (LiCl) has been shown to improve the tightness of brain endothelial cell monolayers in vitro by inhibition of the GSK-3β enzyme, activation of the Wnt/beta-catenin pathway and regulation of tight junction (TJ) protein expression. "( Couraud, PO; Declèves, X; Ganeshamoorthy, K; Huilong, L; Scherrmann, JM; Shawahna, R, 2017)
"Lithium chloride (LiCl) has been reported to possess antiviral activity against several viruses. "( Cheng, X; Nair, V; Qian, K; Qin, A; Shao, H; Yao, Y; Zhang, D, 2018)
"Lithium chloride (LiCl) has been reported as a potential antiviral drug for certain viruses."( Gao, DS; Li, HJ; Li, YT; Liu, HY; Wang, YS; Zhao, J, 2018)
"Lithium chloride (LiCl) has shown neuroprotective effects through glycogen synthase kinase-3β (GSK-3β) inhibition in a variety of central nervous system diseases."( Li, R; Liu, Z; Tang, X; Wu, X; Yu, Z; Zhao, S, 2019)
"Lithium chloride has demonstrated neuroprotective qualities and therefore shows great potential therapeutic benefit for some neurodegenerative diseases."( Lin, YC; Marra, KG; Oh, SJ, 2013)
"Lithium chloride (LiCl) has been used as a mood stabilizer in the manic depressive disorders treatment. "( Fan, HJ; Hao, HP; Li, JR; Mao, X; Ni, B; Sun, MX; Wang, R; Wang, X; Wang, Y; Wen, LB, 2015)
"Lithium chloride (LiCl) has long been used as a mood stabilizer for bipolar mood depression patients. "( Chang, MY; Chen, HC; Chien, WC; Hsieh, MY; Lai, MD; Leu, TH; Maa, MC, 2015)
"Lithium chloride (LiCl) has long been used as a psychiatric medication; however, its role in the differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) remains largely unknown. "( Chen, Y; Pei, F; Tang, L; Zhang, H, 2015)
"Lithium Chloride (LiCl) has been used as a canonical Wnt pathway activator due to its ability to inhibit a glycogen synthase kinase-3. "( Osathanon, T; Pavasant, P; Rattanawarawipa, P; Sukarawan, W, 2016)
"Lithium chloride (LiCl) has been found to be effective against several DNA viruses, such as Herpes simplex virus and vaccinia virus."( Herrler, G; Li, G; Li, X; Meng, F; Ren, X; Wang, C; Yin, J, 2011)
"Lithium chloride (LiCl) has been considered to be a potent inhibitor of glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase that is involved in the control of cell proliferation, differentiation, and apoptosis."( Babu, SD; Benson, CS; Ramadoss, S; Ravi Sankar, B; Sangeetha, G; Sathyavathy, A; Suganthi, M, 2012)
"Lithium chloride (LiCl) has been shown to demonstrate anticancer properties at supratherapeutic doses. "( Goodfellow, PJ; Mutch, DG; Novetsky, AP; Powell, MA; Thaker, PH; Thompson, DM; Zighelboim, I, 2013)
"Lithium chloride (LiCl) has been shown to decrease gastric acid secretion and protect against ethanol-induced hemorrhagic gastritis in the rat. "( Boedeker, HB; Harmon, JW; Johnson, LF; Lillemoe, KD; Wong, RK, 1983)
"Lithium chloride has been used in many studies of conditioning to induce taste aversion behaviour, and in some experiments investigating conditioning effects on immunity it has been used on the assumption that it is immunologically neutral. "( Bull, DF; Gauci, M; Husband, AJ; King, MG; Schedlowski, M, 1992)
"Lithium chloride has been shown to cause granulocytosis both in vivo and in vitro."( Berne, RM; Gualtieri, RJ; Huster, WJ; McGrath, HE; Quesenberry, PJ, 1986)

Actions

ExcerptReference
"Lithium chloride can inhibit the proliferation of K562 cells and cause the apoptosis of K562 cells."( He, Q; Tang, HR, 2003)

Treatment

ExcerptReference
"Lithium chloride treatment reduces IRI in many organs including liver."( Boettcher, M; Dahmen, U; Dirsch, O; Fang, H; Kan, C; Liu, A, 2017)
"Lithium chloride, a classical treatment for bipolar disorder, has shown neuroprotective effects through glycogen synthase kinase-3β inhibition in a variety of central nervous system diseases, including stroke."( Jiang, C; Li, R; Li, W; Liu, Z; Tang, X; Zhao, S, 2018)
"Lithium chloride-treated birds had a 22% reduction in stiffness compared with control in the femora (P=0.02) without a corresponding reduction in elastic modulus."( Adams, DJ; Darre, M; Eschbach, M; Glynn, EA; Govoni, KE; Harvey, BM; Kotha, S; Mancini, R; Ramanathan, R, 2015)
"Lithium chloride treatment of human skin fibroblasts from control and Glut-1 DS patients produced a 45% increase in glucose uptake."( De Vivo, DC; Di Nardo, A; Engelstad, K; Goldman, JE; Sahin, M; Schobel, S; Ullner, PM; Wang, D; Yang, H, 2009)
"Lithium chloride treatment increased urine volume and decreased osmolality in both WT and AQP2-CNT-KO mice."( Fenton, RA; Kortenoeven, ML; Miller, RL; Pedersen, NB; Rojek, A, 2013)
"Lithium chloride (LiCl) treatment activated Wnt signaling in osteoblasts, inhibited myeloma bone disease, and decreased tumor burden in bone, but increased tumor growth when 5TGM1 cells were inoculated subcutaneously."( Edwards, CM; Edwards, JR; Esparza, J; Grubbs, B; Lwin, ST; McCluskey, B; Mundy, GR; Munoz, S; Oyajobi, BO, 2008)
"Both lithium chloride and quinine treatments gave rise to a slow rate of eating accompanied by a disordered temporal sequence of eating, grooming and resting."( Blundell, JE; Hill, AJ; Rogers, PJ, 1985)
"As treatment with lithium chloride (LiCl) can restore passaged chondrocytes in monolayer, in this study, we investigated whether this approach would be effective in 3D culture and restore chondrocyte mechanosensitivity."( Chiu, LLY; Momin, A; Soave, A; Waldman, SD, 2022)
"Treatment with lithium chloride induced autophagy and apoptosis in recombinant insect cells and led to increases in the yields of secreted antibodies."( Katsuda, T; Ohmuro-Matsuyama, Y; Yamaji, H, 2019)
"Treatment with lithium chloride caused a robust increase in interleukin-10, preserved ψ(m), and markedly decreased all other parameters with the effect being most prominent for hearts perfused at the high pressure."( Baban, B; Liu, JY; Mozaffari, MS, 2013)
"Rats treated with lithium chloride for 6 weeks have been reported to demonstrate reduced turnover of arachidonic acid (AA) in brain phospholipids, and decreases in mRNA and protein levels, and enzyme activity, of AA-selective cytosolic phospholipase A(2)(cPLA(2)). "( Bosetti, F; Chang, MC; Contreras, MA; Rapoport, SI; Rintala, J; Rosenberger, TA; Seemann, R, 2002)
"Pretreatment with lithium chloride at the threshold concentrations enhanced the inhibitory effects of verapamil on diaphragmatic contractions elicited either indirectly or directly."( Abdel-Zaher, AO, 2000)

Roles (2)

RoleDescription
antimanic drugAntimanic drugs are agents used to treat bipolar disorders or mania associated with other affective disorders.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
inorganic chloride
lithium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

lithium chloride is involved in 2 pathway(s), involving a total of 98 unique proteins and 19 unique compounds

PathwayProteinsCompounds
Integrated breast cancer pathway9818
OSX and miRNAs in tooth development01

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLS proteinHomo sapiens (human)Potency5.62340.35487.935539.8107AID624146
thyroid stimulating hormone receptorHomo sapiens (human)Potency31.62280.001318.074339.8107AID926
arylsulfatase AHomo sapiens (human)Potency0.47751.069113.955137.9330AID720538
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency0.02240.035520.977089.1251AID504332
D(1A) dopamine receptorHomo sapiens (human)Potency0.81990.02245.944922.3872AID488982
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency6.30960.01789.637444.6684AID588834
flap endonuclease 1Homo sapiens (human)Potency5.32330.133725.412989.1251AID588795
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency31.62280.031610.279239.8107AID884; AID885
inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency708.9730707.9460708.9730710.0000AID2301; AID2308
muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Potency0.02000.00106.000935.4813AID943
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Cholecystokinin receptor type ARattus norvegicus (Norway rat)Potency710.0000710.0000710.0000710.0000AID2301
Gastrin/cholecystokinin type B receptorRattus norvegicus (Norway rat)Potency710.0000710.0000710.0000710.0000AID2301
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency8.49210.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glycogen synthase kinase-3 betaHomo sapiens (human)IC50 (µMol)6.53000.00060.801310.0000AID1056787
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glycogen synthase kinase-3 betaHomo sapiens (human)EC50 (µMol)3,000.00000.20000.85001.5000AID82517
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (73)

Processvia Protein(s)Taxonomy
positive regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
ER overload responseGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-serine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
intracellular signal transductionGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of apoptotic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein export from nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
epithelial to mesenchymal transitionGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cell-matrix adhesionGlycogen synthase kinase-3 betaHomo sapiens (human)
glycogen metabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
protein phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
mitochondrion organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
dopamine receptor signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
circadian rhythmGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of autophagyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of gene expressionGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-serine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
peptidyl-threonine phosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
viral protein processingGlycogen synthase kinase-3 betaHomo sapiens (human)
hippocampus developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
establishment of cell polarityGlycogen synthase kinase-3 betaHomo sapiens (human)
maintenance of cell polarityGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of cell migrationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of axon extensionGlycogen synthase kinase-3 betaHomo sapiens (human)
neuron projection developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein-containing complex assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein-containing complex assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein ubiquitinationGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of proteasomal ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of phosphoprotein phosphatase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule-based processGlycogen synthase kinase-3 betaHomo sapiens (human)
intracellular signal transductionGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to interleukin-3Glycogen synthase kinase-3 betaHomo sapiens (human)
regulation of circadian rhythmGlycogen synthase kinase-3 betaHomo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of GTPase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of osteoblast differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of glycogen biosynthetic processGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of cilium assemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein catabolic processGlycogen synthase kinase-3 betaHomo sapiens (human)
protein autophosphorylationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of protein export from nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of dendrite morphogenesisGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of axonogenesisGlycogen synthase kinase-3 betaHomo sapiens (human)
canonical Wnt signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
excitatory postsynaptic potentialGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule cytoskeleton organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of calcineurin-NFAT signaling cascadeGlycogen synthase kinase-3 betaHomo sapiens (human)
superior temporal gyrus developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to retinoic acidGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of canonical Wnt signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
extrinsic apoptotic signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandGlycogen synthase kinase-3 betaHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlycogen synthase kinase-3 betaHomo sapiens (human)
neuron projection organizationGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of microtubule anchoring at centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of cellular response to heatGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein localization to nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of long-term synaptic potentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of protein acetylationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein localization to ciliumGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of dopaminergic neuron differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
cellular response to amyloid-betaGlycogen synthase kinase-3 betaHomo sapiens (human)
positive regulation of protein localization to centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin destruction complex disassemblyGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of type B pancreatic cell developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of glycogen (starch) synthase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of mesenchymal stem cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
negative regulation of TOR signalingGlycogen synthase kinase-3 betaHomo sapiens (human)
regulation of neuron projection developmentGlycogen synthase kinase-3 betaHomo sapiens (human)
cell differentiationGlycogen synthase kinase-3 betaHomo sapiens (human)
insulin receptor signaling pathwayGlycogen synthase kinase-3 betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
protease bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
p53 bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein serine/threonine kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
ATP bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
ubiquitin protein ligase bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein kinase A catalytic subunit bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
dynactin bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
tau protein bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
tau-protein kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
NF-kappaB bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingGlycogen synthase kinase-3 betaHomo sapiens (human)
protein serine kinase activityGlycogen synthase kinase-3 betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
glutamatergic synapseGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
mitochondrionGlycogen synthase kinase-3 betaHomo sapiens (human)
centrosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 betaHomo sapiens (human)
plasma membraneGlycogen synthase kinase-3 betaHomo sapiens (human)
axonGlycogen synthase kinase-3 betaHomo sapiens (human)
dendriteGlycogen synthase kinase-3 betaHomo sapiens (human)
beta-catenin destruction complexGlycogen synthase kinase-3 betaHomo sapiens (human)
presynapseGlycogen synthase kinase-3 betaHomo sapiens (human)
postsynapseGlycogen synthase kinase-3 betaHomo sapiens (human)
Wnt signalosomeGlycogen synthase kinase-3 betaHomo sapiens (human)
cytosolGlycogen synthase kinase-3 betaHomo sapiens (human)
axonGlycogen synthase kinase-3 betaHomo sapiens (human)
nucleusGlycogen synthase kinase-3 betaHomo sapiens (human)
cytoplasmGlycogen synthase kinase-3 betaHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (53)

Assay IDTitleYearJournalArticle
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID118788Compound was tested for cognitive activity by measuring retention for passive avoidance learning in mice at dose 10 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID243255Inhibitory activity (20 mM) against Glycogen synthase kinase-3 beta, expressed as percent control2004Bioorganic & medicinal chemistry letters, Nov-15, Volume: 14, Issue:22
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds.
AID111838Compound was evaluated for the ability to reverse electroconvulsive shock (ECS) induced amnesia in mice, after administering intraperitoneally, at a dose of 40 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID605822Inhibition of GSK3 in granule cerebellar neurons assessed as increase of tau phosphorylation at 25 uM after 16 hrs by Western blot analysis2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
AID111826Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 1.25 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID111834Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 20.0 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID1765308Improvement in learning and spatial memory in mouse harboring APP/PSI/Tau assessed as improvement in trajectory at 100 mg/kg, po for 30 consecutive days and studied for 5 days by Morris water maze test relative to control2021European journal of medicinal chemistry, Oct-15, Volume: 222Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
AID111828Ability to reverse electroconvulsive shock (ECS) induced amnesia in mice, after administering intraperitoneally, at a dose of 10.0 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID1563653Neuroprotective activity against amyloid beta (25 to 35 residues)-induced cell death in human SH-SY5Y cells assessed as increase in cell viability at 10 mM preincubated for 1 hr followed by amyloid beta (25 to 35 residues) addition and measured after 72 h2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
AID1056787Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors.
AID82517Effective concentration of compound against glycogen synthase kinase-3 in HEK293 cells2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
AID1477067Toxicity in Wistar rat assessed as induction of malaise at 0.4 M measured 30 mins for 2 days by conditioned taste aversion test2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
A Positive Allosteric Modulator of the Serotonin 5-HT
AID111830Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 2.5 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID118793Retention for passive avoidance learning in mice at dose 5 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID605823Inhibition of GSK3 in granule cerebellar neurons assessed as decrease of tau phosphorylation at Ser396 at 25 uM after 16 hrs by Western blot analysis2011Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
AID111841Ability to reverse electroconvulsive shock induced amnesia in mice, after administering intraperitoneally at a dose of 5 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID1261852Inhibition of amphetamine-induced hypermotility in C57BL/6J mouse at 50 to 100 mg/kg, ip measured for 90 mins2015Journal of medicinal chemistry, Nov-25, Volume: 58, Issue:22
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
AID118787Retention for passive avoidance learning in mice at dose 1.25 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID1633450Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in copper-induced tau hyperphosphorylation at 10 mM preincubated for 1 hr followed by copper addition and measured after 26 hrs by ELISA2019ACS medicinal chemistry letters, Apr-11, Volume: 10, Issue:4
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.
AID118789Retention for passive avoidance learning in mice at dose 2.5 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID118792Compound was tested for cognitive activity by measuring retention for passive avoidance learning in mice at dose 40 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID1814365Cytotoxicity against human NB-4 cells assessed as reduction in cell viability measured after 24 hrs by CCK-8 assay2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of Novel Benzothiazepinones as Irreversible Covalent Glycogen Synthase Kinase 3β Inhibitors for the Treatment of Acute Promyelocytic Leukemia.
AID111825Ability to reverse electroconvulsive shock (ECS) induced amnesia in mice, after administering intraperitoneally, at a dose of 0.63 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID111843Ability to reverse electroconvulsive shock (ECS) induced amnesia in mice, after administering intraperitoneally, at a dose of 80 mg/kg1984Journal of medicinal chemistry, May, Volume: 27, Issue:5
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
AID118795Retention for passive avoidance learning in mice at dose 80 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID1261876Toxicity in C57BL/6J mouse amphetamine-induced hypermotility model assessed as reduction of spontaneous locomotor activity at 100 mg/kg, ip2015Journal of medicinal chemistry, Nov-25, Volume: 58, Issue:22
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
AID1563656Effect on cell proliferation in human SH-SY5Y cells at 1 to 10 mM measured after 1 hr by MTT assay2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
AID1543581Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue at 20 mM preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs b2019European journal of medicinal chemistry, Apr-01, Volume: 167Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease.
AID1814387Antiproliferative activity against human NB4-DR1 cells assessed as reduction in cell viability incubated for 24 hrs by CCK-8 assay2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of Novel Benzothiazepinones as Irreversible Covalent Glycogen Synthase Kinase 3β Inhibitors for the Treatment of Acute Promyelocytic Leukemia.
AID243257Inhibitory activity (20 mM) against Glycogen synthase kinase-3 alpha, expressed as percent control2004Bioorganic & medicinal chemistry letters, Nov-15, Volume: 14, Issue:22
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID118785Compound was tested for cognitive activity by measuring retention for passive avoidance learning in mice at dose 0.63 mg/kg1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Cognition-activating properties of 3-(Aryloxy)pyridines.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3,741)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990697 (18.63)18.7374
1990's691 (18.47)18.2507
2000's1044 (27.91)29.6817
2010's1147 (30.66)24.3611
2020's162 (4.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials45 (1.16%)5.53%
Reviews73 (1.88%)6.00%
Case Studies46 (1.18%)4.05%
Observational1 (0.03%)0.25%
Other3,718 (95.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
caffeine[no description available]high150purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
chlorpromazine[no description available]medium170organochlorine compound;
phenothiazines;
tertiary amine		anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
ethosuximide[no description available]medium30dicarboximide;
pyrrolidinone		anticonvulsant;
geroprotector;
T-type calcium channel blocker
imipramine[no description available]medium180dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
imipramine[no description available]medium181dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
methylphenidate[no description available]medium60beta-amino acid ester;
methyl ester;
piperidines
methylphenidate[no description available]medium61beta-amino acid ester;
methyl ester;
piperidines
pemoline[no description available]medium201,3-oxazolescentral nervous system stimulant
piracetam[no description available]medium30organonitrogen compound;
organooxygen compound
dextroamphetamine[no description available]medium2901-phenylpropan-2-amineadrenergic agent;
adrenergic uptake inhibitor;
dopamine uptake inhibitor;
dopaminergic agent;
neurotoxin;
sympathomimetic agent
pentylenetetrazole[no description available]medium200organic heterobicyclic compound;
organonitrogen heterocyclic compound
pramiracetam[no description available]medium20organonitrogen compound;
organooxygen compound
nicotine[no description available]medium1903-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
4-phenylpiracetam[no description available]medium10
cocaine[no description available]medium300benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
amphetamine[no description available]medium440primary amine
diazepam[no description available]medium1601,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
physostigmine[no description available]medium70carbamate ester;
indole alkaloid		antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
tetrabenazine[no description available]medium10benzoquinolizine;
cyclic ketone;
tertiary amino compound
pimozide[no description available]medium40benzimidazoles;
heteroarylpiperidine;
organofluorine compound		antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
strychnine[no description available]medium20monoterpenoid indole alkaloid;
organic heteroheptacyclic compound		avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
scopolamine hydrobromide[no description available]medium130
phenytoin sodium[no description available]medium20
sb 216763[no description available]medium620indoles;
maleimides
valproic acid[no description available]high907branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
valproic acid[no description available]high900branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
dipropylacetamide[no description available]medium10fatty amidegeroprotector;
metabolite;
teratogenic agent
2-propyl-4-pentenoic acid[no description available]medium10methyl-branched fatty acid
sb 415286[no description available]medium180C-nitro compound;
maleimides;
monochlorobenzenes;
phenols;
secondary amino compound;
substituted aniline		antioxidant;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
trans-2-en-valproate[no description available]medium10methyl-branched fatty acid
gamma-aminobutyric acid[no description available]medium240amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid		human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
acetamide[no description available]medium10acetamides;
carboximidic acid;
monocarboxylic acid amide;
N-acylammonia
quinacrine[no description available]medium20acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound		antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
catechol[no description available]medium10catecholsallelochemical;
genotoxin;
plant metabolite
taxifolin[no description available]medium103'-hydroxyflavanones;
4'-hydroxyflavanones;
dihydroflavonols;
pentahydroxyflavanone;
secondary alpha-hydroxy ketone
phosphonoacetic acid[no description available]medium20monocarboxylic acid;
phosphonic acids		antiviral agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
3,4-dihydroxyphenylacetic acid[no description available]medium50catechols;
dihydroxyphenylacetic acid		human metabolite
aminocaproic acid[no description available]medium10amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite
diacetyl[no description available]medium10alpha-diketoneEscherichia coli metabolite;
Saccharomyces cerevisiae metabolite
hydroquinone[no description available]medium10benzenediol;
hydroquinones		antioxidant;
carcinogenic agent;
cofactor;
Escherichia coli metabolite;
human xenobiotic metabolite;
mouse metabolite;
skin lightening agent
melatonin[no description available]high100acetamides;
tryptamines		anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
n-acetylserotonin[no description available]medium10acetamides;
N-acylserotonin;
phenols		antioxidant;
human metabolite;
mouse metabolite;
tropomyosin-related kinase B receptor agonist
pyrazinamide[no description available]medium10monocarboxylic acid amide;
N-acylammonia;
pyrazines		antitubercular agent;
prodrug
quinolinic acid[no description available]medium20pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
taurine[no description available]medium20amino sulfonic acid;
zwitterion		antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
2-amino-5-phosphonovalerate[no description available]medium70non-proteinogenic alpha-amino acidNMDA receptor antagonist
alpha-methyl-4-carboxyphenylglycine[no description available]medium10
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid[no description available]medium10
1-hydroxy-3-amino-2-pyrrolidone[no description available]medium20
ibotenic acid[no description available]medium160non-proteinogenic alpha-amino acidneurotoxin
n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane[no description available]medium10
sk&f-38393[no description available]medium40benzazepine;
catechols;
secondary amino compound
vanilmandelic acid[no description available]medium102-hydroxy monocarboxylic acid;
aromatic ether;
phenols		human metabolite
1,10-diaminodecane[no description available]medium10
1,3-diethyl-8-phenylxanthine[no description available]medium10
1,3-dipropyl-8-cyclopentylxanthine[no description available]medium10oxopurineadenosine A1 receptor antagonist;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
1,3-dipropyl-8-(4-sulfophenyl)xanthine[no description available]medium10
1,5-dihydroxyisoquinoline[no description available]medium10isoquinolinolEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
pk 11195[no description available]medium10aromatic amide;
isoquinolines;
monocarboxylic acid amide;
monochlorobenzenes		antineoplastic agent
1-(2-trifluoromethylphenyl)imidazole[no description available]medium10imidazoles
1-aminobenzotriazole[no description available]medium10
1-methylimidazole[no description available]medium10imidazoles
edelfosine[no description available]medium10glycerophosphocholine
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one[no description available]medium20oxadiazoloquinoxalineEC 4.6.1.2 (guanylate cyclase) inhibitor
2,2'-dipyridyl[no description available]medium10bipyridinechelator;
ferroptosis inhibitor
2-hydroxysaclofen[no description available]medium10organochlorine compound
3,4-dichloroisocoumarin[no description available]medium10isocoumarins;
organochlorine compound		geroprotector;
serine protease inhibitor
phaclofen[no description available]medium10organophosphate oxoanion;
zwitterion
3-aminobenzamide[no description available]medium10benzamides;
substituted aniline		EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
3-bromo-7-nitroindazole[no description available]medium10
enprofylline[no description available]medium10oxopurineanti-arrhythmia drug;
anti-asthmatic drug;
bronchodilator agent;
non-steroidal anti-inflammatory drug
3-nitropropionic acid[no description available]medium40C-nitro compoundantimycobacterial drug;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor;
mycotoxin;
neurotoxin
4-amino-1,8-naphthalimide[no description available]medium10benzoisoquinoline;
dicarboximide
4-aminopyridine[no description available]medium20aminopyridine;
aromatic amine		avicide;
orphan drug;
potassium channel blocker
homovanillic acid[no description available]medium40guaiacols;
monocarboxylic acid		human metabolite;
mouse metabolite
4-hydroxybenzoic acid hydrazide[no description available]medium10carbohydrazide;
phenols
4-phenyl-3-furoxancarbonitrile[no description available]medium101,2,5-oxadiazole;
benzenes;
N-oxide;
nitrile		geroprotector;
nitric oxide donor;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
5,5-dimethyl-1-pyrroline-1-oxide[no description available]medium101-pyrroline nitronesneuroprotective agent;
spin trapping reagent
phenytoin[no description available]medium60imidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
5,7-dichlorokynurenic acid[no description available]medium10quinolines
5-(n,n-hexamethylene)amiloride[no description available]medium10aromatic amine;
azepanes;
guanidines;
monocarboxylic acid amide;
organochlorine compound;
pyrazines		antineoplastic agent;
apoptosis inducer;
odorant receptor antagonist;
sodium channel blocker
ethylisopropylamiloride[no description available]medium10aromatic amine;
guanidines;
monocarboxylic acid amide;
organochlorine compound;
pyrazines;
tertiary amino compound		anti-arrhythmia drug;
neuroprotective agent;
sodium channel blocker
5-fluoroindole-2-carboxylic acid[no description available]medium10indolyl carboxylic acid
hydroxyindoleacetic acid[no description available]medium50indole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite
phenanthridone[no description available]medium10lactam;
phenanthridines		EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
immunosuppressive agent;
mutagen
6-chloromelatonin[no description available]medium10acetamides
6-hydroxymelatonin[no description available]medium10acetamides;
tryptamines		metabolite;
mouse metabolite
6-methoxytryptoline[no description available]medium20
6-nitroso-1,2-benzopyrone[no description available]medium10
7-chlorokynurenic acid[no description available]medium10organochlorine compound;
quinolinemonocarboxylic acid		neuroprotective agent;
NMDA receptor antagonist
7-nitroindazole[no description available]medium60
8-(4-sulfophenyl)theophylline[no description available]medium10
8-cyclopentyl-1,3-dimethylxanthine[no description available]medium10oxopurine
8-phenyltheophylline[no description available]medium10
acetazolamide[no description available]medium60monocarboxylic acid amide;
sulfonamide;
thiadiazoles		anticonvulsant;
diuretic;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
acetohexamide[no description available]medium10acetophenones;
N-sulfonylurea		hypoglycemic agent;
insulin secretagogue
ag 127[no description available]medium10nitrophenol
rtki cpd[no description available]medium10aromatic ether;
monochlorobenzenes;
quinazolines		antineoplastic agent;
antiviral agent;
epidermal growth factor receptor antagonist;
geroprotector
tyrphostin a23[no description available]medium10catechols
tyrphostin 25[no description available]medium10benzenetriol
tyrphostin a1[no description available]medium10methoxybenzenesgeroprotector
1-aminoindan-1,5-dicarboxylic acid[no description available]medium20
albuterol[no description available]medium30phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
alpha-methyltyrosine methyl ester[no description available]medium10
altretamine[no description available]medium10triamino-1,3,5-triazine
amfonelic acid[no description available]medium20
amifostine anhydrous[no description available]medium10diamine;
organic thiophosphate		antioxidant;
prodrug;
radiation protective agent
theophylline[no description available]medium80dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
amoxapine[no description available]high20dibenzooxazepineadrenergic uptake inhibitor;
antidepressant;
dopaminergic antagonist;
geroprotector;
serotonin uptake inhibitor
aniracetam[no description available]medium10N-acylpyrrolidine;
pyrrolidin-2-ones
2-amino-4-phosphonobutyric acid[no description available]medium20
aspirin[no description available]high51benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
aspirin[no description available]high50benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
atenolol[no description available]medium30ethanolamines;
monocarboxylic acid amide;
propanolamine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate[no description available]medium10alpha-amino acid
aurintricarboxylic acid[no description available]medium10monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid		fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
azathioprine[no description available]medium10aryl sulfide;
C-nitro compound;
imidazoles;
thiopurine		antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
azelaic acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		antibacterial agent;
antineoplastic agent;
dermatologic drug;
plant metabolite
baclofen[no description available]medium40amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound		central nervous system depressant;
GABA agonist;
muscle relaxant
bay-k-8644[no description available]medium20(trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester
benzamide[no description available]medium10benzamides
bepridil[no description available]medium10pyrrolidines;
tertiary amine		anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
bml 190[no description available]medium10N-acylindole
brimonidine[no description available]medium10imidazoles;
quinoxaline derivative;
secondary amine		adrenergic agonist;
alpha-adrenergic agonist;
antihypertensive agent
bumetanide[no description available]medium30amino acid;
benzoic acids;
sulfonamide		diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
carbamazepine[no description available]high272dibenzoazepine;
ureas		analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
carbamazepine[no description available]high270dibenzoazepine;
ureas		analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
carbetapentane[no description available]medium10benzenes
carisoprodol[no description available]medium10carbamate estermuscle relaxant
carmustine[no description available]medium10N-nitrosoureas;
organochlorine compound		alkylating agent;
antineoplastic agent
cgs 12066[no description available]medium10N-arylpiperazine;
organofluorine compound;
pyrroloquinoxaline		serotonergic agonist
cgs 15943[no description available]medium10aromatic amine;
biaryl;
furans;
organochlorine compound;
primary amino compound;
quinazolines;
triazoloquinazoline		adenosine A1 receptor antagonist;
adenosine A2A receptor antagonist;
antineoplastic agent;
central nervous system stimulant
chlorambucil[no description available]medium10aromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
chlormezanone[no description available]medium101,3-thiazine;
lactam;
monochlorobenzenes;
sulfone		antipsychotic agent;
anxiolytic drug;
muscle relaxant
chlorothiazide[no description available]medium10benzothiadiazineantihypertensive agent;
diuretic
chlorpropamide[no description available]medium10monochlorobenzenes;
N-sulfonylurea		hypoglycemic agent;
insulin secretagogue
chlorzoxazone[no description available]medium101,3-benzoxazoles;
heteroaryl hydroxy compound;
organochlorine compound		muscle relaxant;
sedative
cilostamide[no description available]medium10quinolines
cilostazol[no description available]medium10lactam;
tetrazoles		anticoagulant;
bronchodilator agent;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
fibrin modulating drug;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
cimetidine[no description available]medium40aliphatic sulfide;
guanidines;
imidazoles;
nitrile		adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
cinoxacin[no description available]medium10cinnolines;
oxacycle;
oxo carboxylic acid		antibacterial drug;
antiinfective agent
ciprofibrate[no description available]medium10cyclopropanes;
monocarboxylic acid;
organochlorine compound		antilipemic drug
clofibrate[no description available]medium10aromatic ether;
ethyl ester;
monochlorobenzenes		anticholesteremic drug;
antilipemic drug;
geroprotector;
PPARalpha agonist
clotrimazole[no description available]medium10conazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes		antiinfective agent;
environmental contaminant;
xenobiotic
cx546[no description available]medium10
cyclothiazide[no description available]medium10benzothiadiazineantihypertensive agent;
diuretic
dephostatin[no description available]medium10
nonivamide[no description available]medium10capsaicinoid;
phenols		lachrymator
r 59022[no description available]medium40diarylmethane
diazoxide[no description available]medium50benzothiadiazine;
organochlorine compound;
sulfone		antihypertensive agent;
beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
diuretic;
K-ATP channel agonist;
sodium channel blocker;
sympathomimetic agent;
vasodilator agent
pentetic acid[no description available]medium10pentacarboxylic acidcopper chelator
diphenyleneiodonium[no description available]medium10organic cation
dipyridamole[no description available]medium20piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol		adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
disopyramide[no description available]medium10monocarboxylic acid amide;
pyridines;
tertiary amino compound		anti-arrhythmia drug
disulfiram[no description available]medium10organic disulfide;
organosulfur acaricide		angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
2-amino-7-phosphonoheptanoic acid[no description available]medium10
thiorphan[no description available]medium10N-acyl-amino acid
2,3-dimethoxy-1,4-naphthoquinone[no description available]medium101,4-naphthoquinones
domperidone[no description available]medium20benzimidazoles;
heteroarylpiperidine		antiemetic;
dopaminergic antagonist
droperidol[no description available]medium10aromatic ketone;
benzimidazoles;
organofluorine compound		anaesthesia adjuvant;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic
ebselen[no description available]medium20benzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
ellipticine[no description available]medium10indole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound;
polycyclic heteroarene		antineoplastic agent;
plant metabolite
emodin[no description available]medium10trihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
etodolac[no description available]medium10monocarboxylic acid;
organic heterotricyclic compound		antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
felbamate[no description available]medium10carbamate esteranticonvulsant;
neuroprotective agent
felodipine[no description available]medium10dichlorobenzene;
dihydropyridine;
ethyl ester;
methyl ester		anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
fenofibrate[no description available]high20aromatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
flumazenil[no description available]medium20ethyl ester;
imidazobenzodiazepine;
organofluorine compound		antidote to benzodiazepine poisoning;
GABA antagonist
fluorouracil[no description available]medium40nucleobase analogue;
organofluorine compound		antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
fluspirilene[no description available]medium10diarylmethane
flutamide[no description available]medium10(trifluoromethyl)benzenes;
monocarboxylic acid amide		androgen antagonist;
antineoplastic agent
formoterol fumarate[no description available]medium10formamides;
phenols;
phenylethanolamines;
secondary alcohol;
secondary amino compound
fpl 64176[no description available]medium10carboxylic ester;
pyrroles		calcium channel agonist
furafylline[no description available]medium10oxopurine
furosemide[no description available]medium50chlorobenzoic acid;
furans;
sulfonamide		environmental contaminant;
loop diuretic;
xenobiotic
fusaric acid[no description available]medium10aromatic carboxylic acid;
pyridines
gabapentin[no description available]medium20gamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
4-amino-5-hexynoic acid[no description available]medium10
glipizide[no description available]medium10aromatic amide;
monocarboxylic acid amide;
N-sulfonylurea;
pyrazines		EC 2.7.1.33 (pantothenate kinase) inhibitor;
hypoglycemic agent;
insulin secretagogue
glyburide[no description available]medium60monochlorobenzenes;
N-sulfonylurea		anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
1-(5-isoquinolinesulfonyl)piperazine[no description available]medium10isoquinolines
haloperidol[no description available]medium210aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
haloperidol[no description available]medium211aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
hemicholinium 3[no description available]medium10morpholines
4-fluorohexahydrosiladifenidol[no description available]medium10
hydrochlorothiazide[no description available]medium10benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
hydroxyurea[no description available]medium50one-carbon compound;
ureas		antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
ibudilast[no description available]medium10pyrazolopyridine
ibuprofen[no description available]high20monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
ic 261[no description available]medium10indoles
ifenprodil[no description available]medium30piperidines
indirubin-3'-monoxime[no description available]medium20
indomethacin[no description available]medium180aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
iodoacetamide[no description available]medium20
1-methyl-3-isobutylxanthine[no description available]medium703-isobutyl-1-methylxanthine
4-piperidinecarboxylic acid[no description available]medium10
4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline[no description available]medium10
jl 18[no description available]medium10
nsc 664704[no description available]medium40indolobenzazepine;
lactam;
organobromine compound		cardioprotective agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
geroprotector
ketoconazole[no description available]medium20dichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
ketoprofen[no description available]medium10benzophenones;
oxo monocarboxylic acid		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
kynurenic acid[no description available]medium20monohydroxyquinoline;
quinolinemonocarboxylic acid		G-protein-coupled receptor agonist;
human metabolite;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist;
Saccharomyces cerevisiae metabolite
2-amino-3-phosphonopropionic acid[no description available]medium50alanine derivative;
non-proteinogenic alpha-amino acid;
phosphonic acids		human metabolite;
metabotropic glutamate receptor antagonist
lamotrigine[no description available]high711,2,4-triazines;
dichlorobenzene;
primary arylamine		anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic
lamotrigine[no description available]high701,2,4-triazines;
dichlorobenzene;
primary arylamine		anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic
lansoprazole[no description available]medium10benzimidazoles;
pyridines;
sulfoxide		anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
beta-lapachone[no description available]medium10benzochromenone;
orthoquinones		anti-inflammatory agent;
antineoplastic agent;
plant metabolite
leflunomide[no description available]medium10(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide		antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
linopirdine[no description available]medium10indoles
loratadine[no description available]medium10benzocycloheptapyridine;
ethyl ester;
N-acylpiperidine;
organochlorine compound;
tertiary carboxamide		anti-allergic agent;
cholinergic antagonist;
geroprotector;
H1-receptor antagonist
loxoprofen[no description available]medium10cyclopentanones;
monocarboxylic acid		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one[no description available]medium240chromones;
morpholines;
organochlorine compound		autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
meclofenamate sodium anhydrous[no description available]medium10organic sodium salt
methiothepin[no description available]high20aryl sulfide;
dibenzothiepine;
N-alkylpiperazine;
tertiary amino compound		antipsychotic agent;
dopaminergic antagonist;
geroprotector;
serotonergic antagonist
methoctramine[no description available]medium10aromatic ether;
tetramine		muscarinic antagonist
nocodazole[no description available]medium30aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes		antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator
3-Hydroxy-alpha-methyl-DL-tyrosine[no description available]medium10benzenes;
monocarboxylic acid
metolazone[no description available]medium10organochlorine compound;
quinazolines;
sulfonamide		antihypertensive agent;
diuretic;
ion transport inhibitor
milrinone[no description available]medium10bipyridines;
nitrile;
pyridone		cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
minoxidil[no description available]medium10dialkylarylamine;
tertiary amino compound
mitotane[no description available]medium20diarylmethane
mitoxantrone[no description available]medium10dihydroxyanthraquinoneanalgesic;
antineoplastic agent
ml 7[no description available]medium10N-sulfonyldiazepane;
organoiodine compound		EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide[no description available]medium20naphthalenes;
organochlorine compound;
primary amino compound;
sulfonamide
n-bromoacetamide[no description available]medium10
ethylmaleimide[no description available]medium10maleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
fg 7142[no description available]medium10beta-carbolines
fenamic acid[no description available]medium10aminobenzoic acid;
secondary amino compound		membrane transport modulator
n 0840[no description available]medium10
nialamide[no description available]medium10organonitrogen compound;
organooxygen compound
niclosamide[no description available]medium20benzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide		anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
nifedipine[no description available]medium30C-nitro compound;
dihydropyridine;
methyl ester		calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
niflumic acid[no description available]medium10aromatic carboxylic acid;
pyridines
nilutamide[no description available]medium10(trifluoromethyl)benzenes;
C-nitro compound;
imidazolidinone		androgen antagonist;
antineoplastic agent
nimesulide[no description available]medium10aromatic ether;
C-nitro compound;
sulfonamide		cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
nimodipine[no description available]medium202-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester		antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
nipecotic acid[no description available]medium20beta-amino acid;
piperidinemonocarboxylic acid
nitrendipine[no description available]medium10C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester		antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
masoprocol[no description available]medium10catechols;
lignan;
tetrol		antioxidant;
ferroptosis inhibitor;
geroprotector;
plant metabolite
5-nitro-2-(3-phenylpropylamino)benzoic acid[no description available]medium10nitrobenzoic acid
ns 2028[no description available]medium10
ns 1619[no description available]medium10(trifluoromethyl)benzenes;
benzimidazoles;
phenols		potassium channel opener
o(6)-benzylguanine[no description available]medium10
ofloxacin[no description available]medium203-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
olomoucine[no description available]medium202,6-diaminopurines;
ethanolamines		EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
oxaprozin[no description available]medium101,3-oxazoles;
monocarboxylic acid		analgesic;
non-steroidal anti-inflammatory drug
oxatomide[no description available]medium10benzimidazoles;
diarylmethane;
N-alkylpiperazine		anti-allergic agent;
anti-inflammatory agent;
geroprotector;
H1-receptor antagonist;
serotonergic antagonist
oxiracetam[no description available]medium10organonitrogen compound;
organooxygen compound
oxolinic acid[no description available]medium10aromatic carboxylic acid;
organic heterotricyclic compound;
oxacycle;
quinolinemonocarboxylic acid;
quinolone antibiotic		antibacterial drug;
antifungal agent;
antiinfective agent;
antimicrobial agent;
enzyme inhibitor
quinone[no description available]medium101,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
fenclonine[no description available]medium10phenylalanine derivative
palmidrol[no description available]medium10endocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-(saturated fatty acyl)ethanolamine		anti-inflammatory drug;
anticonvulsant;
antihypertensive agent;
neuroprotective agent
1,7-dimethylxanthine[no description available]medium10dimethylxanthinecentral nervous system stimulant;
human blood serum metabolite;
human xenobiotic metabolite;
mouse metabolite
pd 98059[no description available]medium90aromatic amine;
monomethoxyflavone		EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
pentamidine[no description available]medium10aromatic ether;
carboxamidine;
diether		anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
pentoxifylline[no description available]medium10oxopurine
perphenazine[no description available]medium10N-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines		antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
phenyl biguanide[no description available]medium10guanidinescentral nervous system drug
phenylbutazone[no description available]medium10pyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
phloretin[no description available]medium20dihydrochalconesantineoplastic agent;
plant metabolite
picotamide[no description available]medium10benzamides
pinacidil[no description available]medium10pyridines
pindolol[no description available]medium20indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
piperidine-4-sulfonic acid[no description available]medium10
pirenperone[no description available]medium10aromatic ketone
praziquantel[no description available]medium10isoquinolines
primidone[no description available]medium10pyrimidoneanticonvulsant;
environmental contaminant;
xenobiotic
proglumide[no description available]medium10benzamides;
dicarboxylic acid monoamide;
glutamine derivative;
racemate		anti-ulcer drug;
cholecystokinin antagonist;
cholinergic antagonist;
delta-opioid receptor agonist;
drug metabolite;
gastrointestinal drug;
opioid analgesic;
xenobiotic metabolite
propentofylline[no description available]medium10oxopurine
propofol[no description available]medium20phenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
pf 5901[no description available]medium10quinolines
riluzole[no description available]medium10benzothiazoles
risperidone[no description available]medium401,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
risperidone[no description available]medium411,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
ritanserin[no description available]medium10organofluorine compound;
piperidines;
thiazolopyrimidine		antidepressant;
antipsychotic agent;
anxiolytic drug;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone[no description available]medium10methoxybenzenes
rolipram[no description available]medium20pyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
salmeterol xinafoate[no description available]medium10ether;
phenols;
primary alcohol;
secondary alcohol;
secondary amino compound
sb 202190[no description available]medium10imidazoles;
organofluorine compound;
phenols;
pyridines		apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
sobuzoxane[no description available]medium10organic molecular entity
spiroxatrine[no description available]medium10imidazolidines
sq 22536[no description available]medium10nucleoside analogue;
oxolanes		EC 4.6.1.1 (adenylate cyclase) inhibitor
sulfaphenazole[no description available]medium10primary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor
sulpiride[no description available]medium80benzamides;
N-alkylpyrrolidine;
sulfonamide		antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
t0156[no description available]medium10naphthyridine derivative
1,4-bis(2-(3,5-dichloropyridyloxy))benzene[no description available]medium10
terfenadine[no description available]medium10diarylmethane
tetraisopropylpyrophosphamide[no description available]medium10phosphoramide
thalidomide[no description available]medium20phthalimides;
piperidones
theobromine[no description available]medium10dimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate[no description available]medium40trihydroxybenzoic acid
tolazamide[no description available]medium10N-sulfonylureahypoglycemic agent;
potassium channel blocker
tolbutamide[no description available]medium10N-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid[no description available]medium10
ici 136,753[no description available]medium10pyrazolopyridine
triamterene[no description available]medium10pteridinesdiuretic;
sodium channel blocker
trimethoprim[no description available]medium20aminopyrimidine;
methoxybenzenes		antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
tropicamide[no description available]medium10acetamides
tyrphostin a9[no description available]medium10alkylbenzenegeroprotector
vigabatrin[no description available]medium30gamma-amino acidanticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine[no description available]medium10
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole[no description available]medium10aromatic primary alcohol;
furans;
indazoles		antineoplastic agent;
apoptosis inducer;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
zardaverine[no description available]medium10organofluorine compound;
pyridazinone		anti-asthmatic drug;
bronchodilator agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
peripheral nervous system drug
cortisone acetate[no description available]medium10corticosteroid hormone
corticosterone[no description available]medium29011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
reserpine[no description available]medium40alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
procaine hydrochloride[no description available]medium10organic molecular entity
isoproterenol hydrochloride[no description available]medium10catechols
histamine dihydrochloride[no description available]medium10
carbachol[no description available]medium480ammonium salt;
carbamate ester		cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
spironolactone[no description available]medium303-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester		aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
estrone[no description available]medium1017-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols		antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
androsterone[no description available]medium1017-oxo steroid;
3alpha-hydroxy steroid;
androstanoid;
C19-steroid		androgen;
anticonvulsant;
human blood serum metabolite;
human metabolite;
human urinary metabolite;
mouse metabolite;
pheromone
promazine hydrochloride[no description available]medium10hydrochloride
pilocarpine hydrochloride[no description available]medium10hydrochloride
dimethylphenylpiperazinium iodide[no description available]medium10N-arylpiperazine;
organic iodide salt;
piperazinium salt;
quaternary ammonium salt		nicotinic acetylcholine receptor agonist
racepinephrine hydrochloride[no description available]medium10
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride[no description available]medium20
hexamethonium bromide[no description available]medium10
cystamine dihydrochloride[no description available]medium10
cantharidin[no description available]medium20cyclic dicarboxylic anhydride;
monoterpenoid		EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
herbicide
tetraethylammonium chloride[no description available]medium10organic chloride salt;
quaternary ammonium salt		potassium channel blocker
aspartic acid[no description available]medium90aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
glutamine[no description available]medium40amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
vincristine[no description available]medium10acetate ester;
formamides;
methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid		antineoplastic agent;
drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
apomorphine[no description available]medium260aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
promethazine hydrochloride[no description available]medium10hydrochlorideanti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
geroprotector;
H1-receptor antagonist;
local anaesthetic;
sedative
bromodeoxyuridine[no description available]medium130pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
levodopa[no description available]medium30amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
methoxamine hydrochloride[no description available]medium10dimethoxybenzene
papaverine hydrochloride[no description available]medium10
bretylium tosylate[no description available]medium10organosulfonate salt;
quaternary ammonium salt		adrenergic antagonist;
anti-arrhythmia drug;
antihypertensive agent
berlition[no description available]medium10dithiolanes;
heterocyclic fatty acid;
lipoic acid;
thia fatty acid		cofactor;
nutraceutical;
prosthetic group
methacholine chloride[no description available]medium30quaternary ammonium salt
androstenedione[no description available]medium1017-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
colchicine[no description available]medium40alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
yohimbine hydrochloride[no description available]medium10
gallamine triethiodide[no description available]medium20
cycloheximide[no description available]medium130antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol		anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
egtazic acid[no description available]medium140diether;
tertiary amino compound;
tetracarboxylic acid		chelator
cycloserine[no description available]medium604-amino-1,2-oxazolidin-3-one;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic;
zwitterion		antiinfective agent;
antimetabolite;
antitubercular agent;
metabolite;
NMDA receptor agonist
17-alpha-hydroxyprogesterone[no description available]medium1017alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone		human metabolite;
metabolite;
mouse metabolite;
progestin
quinacrine monohydrochloride[no description available]medium10
chlorpromazine hydrochloride[no description available]medium10hydrochloride;
phenothiazines		anticoronaviral agent;
phenothiazine antipsychotic drug
cytarabine hydrochloride[no description available]medium10
tryptophan[no description available]medium80erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan		antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
lidocaine hydrochloride[no description available]medium10hydrochlorideanti-arrhythmia drug;
local anaesthetic
arginine[no description available]medium170arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
rotenone[no description available]medium30organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
synephrine[no description available]medium10ethanolamines;
phenethylamine alkaloid;
phenols		alpha-adrenergic agonist;
plant metabolite
pyridostigmine bromide[no description available]medium10pyridinium salt
imipramine hydrochloride[no description available]medium10hydrochlorideantidepressant
neostigmine bromide[no description available]medium10bromide salt
edrophonium chloride[no description available]medium10chloride salt;
quaternary ammonium salt		antidote;
diagnostic agent;
EC 3.1.1.8 (cholinesterase) inhibitor
suramin sodium[no description available]medium10organic sodium saltangiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
pyrazolanthrone[no description available]medium40anthrapyrazole;
aromatic ketone;
cyclic ketone		antineoplastic agent;
c-Jun N-terminal kinase inhibitor;
geroprotector
methapyrilene hydrochloride[no description available]medium10hydrochlorideanti-allergic agent;
carcinogenic agent;
H1-receptor antagonist;
sedative
tetrracaine hydrochloride[no description available]medium10benzoate ester
chelidamic acid[no description available]medium10
2-chloroadenosine[no description available]medium10purine nucleoside
diphenhydramine hydrochloride[no description available]medium10hydrochloride;
organoammonium salt		anti-allergic agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
sedative
cysteamine hydrochloride[no description available]medium10
propantheline bromide[no description available]medium10xanthenes
hydralazine hydrochloride[no description available]medium10hydrochlorideantihypertensive agent;
vasodilator agent
ethamivan[no description available]medium10methoxybenzenes;
phenols
pargyline hydrochloride[no description available]medium10
aminophylline[no description available]medium20mixturebronchodilator agent;
cardiotonic drug
azacitidine[no description available]medium30N-glycosyl-1,3,5-triazine;
nucleoside analogue		antineoplastic agent
orphenadrine hydrochloride[no description available]medium10hydrochlorideantiparkinson drug;
H1-receptor antagonist;
muscarinic antagonist;
muscle relaxant;
NMDA receptor antagonist;
parasympatholytic
betamethasone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide[no description available]medium10
cyproterone acetate[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
chlorinated steroid;
steroid ester		androgen antagonist;
geroprotector;
progestin
bicuculline[no description available]medium20benzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines		agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin
kainic acid[no description available]medium170dicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid		antinematodal drug;
excitatory amino acid agonist
podophyllotoxin[no description available]medium20furonaphthodioxole;
lignan;
organic heterotetracyclic compound		antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
tetrahydrozoline hydrochloride[no description available]medium10hydrochloridenasal decongestant;
sympathomimetic agent;
vasoconstrictor agent
dequalinium chloride[no description available]medium10organic chloride saltantifungal agent;
antineoplastic agent;
antiseptic drug;
mitochondrial NADH:ubiquinone reductase inhibitor
decamethonium dibromide[no description available]medium10
amitriptyline hydrochloride[no description available]medium10organic tricyclic compound
naphazoline hydrochloride[no description available]medium10organic molecular entity
doxylamine succinate[no description available]medium10organic molecular entity
carbamylhydrazine monohydrochloride[no description available]medium10organic molecular entity
formestane[no description available]medium1017-oxo steroid;
3-oxo-Delta(4) steroid;
enol;
hydroxy steroid		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
debrisoquin sulfate[no description available]medium10organic sulfate salt
betaine hydrochloride[no description available]medium10
bethanechol chloride[no description available]medium10carbamate ester;
chloride salt;
quaternary ammonium salt		muscarinic agonist
acetylcysteine[no description available]high30acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
Mecamylamine hydrochloride[no description available]medium10monoterpenoid
vinblastine[no description available]medium10
cyproheptadine hydrochloride (anhydrous)[no description available]medium10hydrochloride
5 alpha-androstane-3 alpha,17 beta-diol[no description available]medium10androstane-3alpha,17beta-diolDaphnia magna metabolite;
human metabolite
azetidyl-2-carboxylic acid[no description available]medium10azetidine-2-carboxylic acid
muscarine[no description available]medium10
antazoline hydrochloride[no description available]medium10
doxifluridine[no description available]medium10organofluorine compound;
pyrimidine 5'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
prodrug
meclofenoxate hydrochloride[no description available]medium10
clonidine hydrochloride[no description available]medium10dichlorobenzene
beclomethasone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
corticosteroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic drug;
anti-inflammatory drug
buthionine sulfoximine[no description available]medium10diastereoisomeric mixture;
homocysteines;
non-proteinogenic alpha-amino acid;
sulfoximide		EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
mexiletine hydrochloride[no description available]medium10hydrochlorideanti-arrhythmia drug
cyclophosphamide[no description available]medium10hydratealkylating agent;
antineoplastic agent;
carcinogenic agent;
immunosuppressive agent
suxamethonium chloride[no description available]medium10chloride saltmuscle relaxant
cyclobenzaprine hydrochloride[no description available]medium10hydrochlorideantidepressant;
muscle relaxant
n-methylaspartate[no description available]medium160amino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound		neurotransmitter agent
3-deazaadenosine[no description available]medium10
metoclopramide hydrochloride[no description available]medium10
isoetharine mesylate[no description available]medium10
zalcitabine[no description available]medium10pyrimidine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
propionylpromazine hydrochloride[no description available]medium10
camptothecin[no description available]medium20delta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol		antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
nsc-145,668[no description available]medium10hydrochlorideantimetabolite;
antineoplastic agent
clodronic acid[no description available]medium101,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound		antineoplastic agent;
bone density conservation agent
benserazide hydrochloride[no description available]medium10hydrochlorideantiparkinson drug;
dopaminergic agent;
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
pancuronium bromide[no description available]medium10bromide saltcholinergic antagonist;
muscle relaxant;
nicotinic antagonist
tetradecanoylphorbol acetate[no description available]medium260acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
danazol[no description available]medium1017beta-hydroxy steroid;
terminal acetylenic compound		anti-estrogen;
estrogen antagonist;
geroprotector
metergoline[no description available]high20carbamate ester;
ergoline alkaloid		dopamine agonist;
geroprotector;
serotonergic antagonist
lisuride[no description available]medium20monocarboxylic acid amideantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
serotonergic agonist
disopyramide phosphate[no description available]medium10organoammonium phosphate
bromocriptine[no description available]medium10indole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist
ergocristine[no description available]medium10ergot alkaloid
triamcinolone[no description available]medium1011beta-hydroxy steroid;
16alpha-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-allergic agent;
anti-inflammatory drug
zidovudine[no description available]medium20azide;
pyrimidine 2',3'-dideoxyribonucleoside		antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
paclitaxel[no description available]medium110taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
buspirone hydrochloride[no description available]medium10hydrochlorideanxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
etoposide[no description available]medium40beta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound		antineoplastic agent;
DNA synthesis inhibitor
propafenone hydrochloride[no description available]medium10hydrochlorideanti-arrhythmia drug
etazolate hydrochloride[no description available]medium10
butaclamol[no description available]medium10amino alcohol;
organic heteropentacyclic compound;
tertiary alcohol;
tertiary amino compound		dopaminergic antagonist
ribavirin[no description available]medium101-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide		anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
carbidopa[no description available]medium10catechols;
hydrate;
hydrazines;
monocarboxylic acid		antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
cephradine[no description available]medium10beta-lactam antibiotic allergen;
cephalosporin		antibacterial drug
methyldopa[no description available]medium10L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent
lonidamine[no description available]medium10dichlorobenzene;
indazoles;
monocarboxylic acid		antineoplastic agent;
antispermatogenic agent;
EC 2.7.1.1 (hexokinase) inhibitor;
geroprotector
dexibuprofen[no description available]medium10ibuprofennon-narcotic analgesic;
non-steroidal anti-inflammatory drug
quisqualic acid[no description available]medium80non-proteinogenic alpha-amino acid
pirfenidone[no description available]medium10pyridoneantipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
flecainide acetate[no description available]medium10acetate saltanti-arrhythmia drug
nicardipine hydrochloride[no description available]medium10dihydropyridinegeroprotector
idarubicin[no description available]medium10anthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
captopril[no description available]medium30alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
terazosin hydrochloride anhydrous[no description available]medium10
pergolide mesylate[no description available]medium10methanesulfonate saltantiparkinson drug;
dopamine agonist;
geroprotector
ranitidine hydrochloride[no description available]medium10
colforsin[no description available]medium260acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol		adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
cefaclor anhydrous[no description available]medium10cephalosporinantibacterial drug;
drug allergen
alo 2145[no description available]medium10hydrochloridealpha-adrenergic agonist;
antiglaucoma drug
enoximone[no description available]medium10aromatic ketone
atomoxetine[no description available]medium10aromatic ether;
secondary amino compound;
toluenes		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
xenobiotic
raloxifene hydrochloride[no description available]medium10hydrochloridebone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
mifepristone[no description available]medium303-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound		abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
quinpirole hydrochloride[no description available]medium10
imazodan[no description available]medium10
mibefradil dihydrochloride[no description available]medium10
aptiganel hydrochloride[no description available]medium10
adenosine[no description available]medium50adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
phenelzine sulfate[no description available]medium10organic molecular entity
fluoxetine hydrochloride[no description available]medium10hydrochloride;
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
propranolol hydrochloride[no description available]medium10hydrochloride
bupropion hydrochloride[no description available]medium10aromatic ketone
diltiazem hydrochloride[no description available]medium10hydrochlorideantihypertensive agent;
calcium channel blocker;
vasodilator agent
trazodone hydrochloride[no description available]medium100hydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
verapamil hydrochloride[no description available]medium10
doxazosin mesylate[no description available]medium10methanesulfonate saltgeroprotector
amantadine hydrochloride[no description available]medium10hydrochlorideantiviral agent;
dopamine agonist;
NMDA receptor antagonist
mevastatin[no description available]medium102-pyranones;
carboxylic ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		antifungal agent;
apoptosis inducer;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
fungal metabolite;
Penicillium metabolite
chloroquine diphosphate[no description available]medium10
dobutamine hydrochloride[no description available]medium10hydrochloridebeta-adrenergic agonist;
cardiotonic drug;
sympathomimetic agent
desipramine hydrochloride[no description available]medium10hydrochloridedrug allergen
dopamine hydrochloride[no description available]medium10catecholamine
proadifen hydrochloride[no description available]medium10
4-nitrobenzylthioinosine[no description available]medium10purine nucleoside
metrifudil[no description available]medium10
rutecarpine[no description available]medium10beta-carbolines
trihexyphenidyl hydrochloride[no description available]medium10aralkylamine
thioridazine hydrochloride[no description available]medium10hydrochloridefirst generation antipsychotic;
geroprotector
procainamide hydrochloride[no description available]medium10hydrochlorideanti-arrhythmia drug
siquil[no description available]medium10hydrochlorideanticoronaviral agent
sotalol hydrochloride[no description available]medium10hydrochlorideanti-arrhythmia drug;
beta-adrenergic antagonist
oxymetazoline hydrochloride[no description available]medium10hydrochloridealpha-adrenergic agonist;
nasal decongestant;
sympathomimetic agent;
vasoconstrictor agent
alprenolol hydrochloride[no description available]medium10hydrochloride
2-methoxyestradiol[no description available]medium1017beta-hydroxy steroid;
3-hydroxy steroid		angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite
fluphenazine hydrochloride[no description available]medium10phenothiazinesanticoronaviral agent
tryptamine monohydrochloride[no description available]medium10
clomipramine hydrochloride[no description available]medium10hydrochlorideanticoronaviral agent;
antidepressant;
serotonergic antagonist;
serotonergic drug
amiloride hydrochloride[no description available]medium10hydratediuretic;
sodium channel blocker
prazosin hydrochloride[no description available]medium10hydrochloride
mianserin hydrochloride[no description available]medium10hydrochloridegeroprotector
lomefloxacin hydrochloride[no description available]medium10hydrochlorideantimicrobial agent;
antitubercular agent;
photosensitizing agent
fenspiride hydrochloride[no description available]medium10
nilverm[no description available]medium10organic molecular entity
sanguinarine chloride[no description available]medium10
ropinirole hydrochloride[no description available]medium10indoles
plasmenylserine[no description available]medium10O-phosphoserineEC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor;
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
5-aminovaleric acid hydrochloride[no description available]medium10
n-acetyltryptamine[no description available]medium10acetamides;
indoles
D-serine[no description available]medium10D-alpha-amino acid;
serine zwitterion;
serine		Escherichia coli metabolite;
human metabolite;
NMDA receptor agonist
dihydroergotamine mesylate[no description available]medium10methanesulfonate saltnon-narcotic analgesic;
serotonergic agonist;
vasoconstrictor agent
ranolazine hydrochloride[no description available]medium10
loxapine succinate[no description available]medium10succinate saltgeroprotector
guanfacine hydrochloride[no description available]medium10acetamidesgeroprotector
pirenzepine dihydrochloride[no description available]medium10hydrochloride
labetalol hydrochloride[no description available]medium10salicylamides
acecainide hydrochloride[no description available]medium10
loperamide hydrochloride[no description available]medium10hydrochlorideanticoronaviral agent;
antidiarrhoeal drug;
mu-opioid receptor agonist
maprotiline hydrochloride[no description available]medium10anthracenes
protoporphyrin ix, disodium salt[no description available]medium10
siguazodan[no description available]medium10pyridazinone
3-octadecanamido-2-ethoxypropylphosphocholine[no description available]medium10
chelerythrine chloride[no description available]medium10
tosyllysine chloromethyl ketone[no description available]medium10
5-(n-methyl-n-isobutyl)amiloride[no description available]medium20
1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride[no description available]medium10hydrochlorideEC 2.7.11.13 (protein kinase C) inhibitor
amperozide hydrochloride[no description available]medium10hydrochlorideanxiolytic drug;
dopamine uptake inhibitor;
geroprotector;
second generation antipsychotic;
serotonergic antagonist
pyrrolidine dithiocarbamic acid[no description available]medium10
agroclavine[no description available]medium10ergot alkaloid
s-methylisothiourea sulfate[no description available]medium10
p-Aminobenzamidine dihydrochloride[no description available]medium10organic molecular entity
benzamidine hydrochloride[no description available]medium10
ketorolac tromethamine[no description available]medium10organoammonium saltanalgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor
methionine sulfoximine[no description available]medium10L-alpha-amino acid zwitterion;
L-methionine derivative;
methionine sulfoximine;
non-proteinogenic L-alpha-amino acid		EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor;
geroprotector
tretazicar[no description available]medium10
carbetapentane citrate[no description available]medium10carbonyl compound
phentolamine mesylate[no description available]medium10
mephentermine[no description available]medium102-aminooctadecane-1,3-diolEC 2.7.11.13 (protein kinase C) inhibitor;
human metabolite;
mouse metabolite
oxybutynin hydrochloride[no description available]medium10hydrochloride
nimustine[no description available]medium10hydrochlorideantineoplastic agent
cordium[no description available]medium10hydrate;
hydrochloride
L-2-aminoadipic acid[no description available]medium102-aminoadipic acidEscherichia coli metabolite;
human metabolite
prilocaine hydrochloride[no description available]medium10hydrochloridelocal anaesthetic
mor-14[no description available]medium10hydroxypiperidine;
piperidine alkaloid;
tertiary amino compound		anti-HIV agent;
cardioprotective agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
plant metabolite
brexanolone[no description available]medium103-hydroxy-5alpha-pregnan-20-oneantidepressant;
GABA modulator;
human metabolite;
intravenous anaesthetic;
sedative
phenylisopropyladenosine[no description available]medium10aromatic amine;
benzenes;
hydrocarbyladenosine;
purine nucleoside;
secondary amino compound		adenosine A1 receptor agonist;
neuroprotective agent
hexamethonium chloride[no description available]medium10
6-(4-nitrobenzylthio)guanosine[no description available]medium10
3-aminopropylphosphonic acid[no description available]medium10phosphonic acids;
primary amino compound;
zwitterion		GABAB receptor agonist
5'-n-methylcarboxamideadenosine[no description available]medium10
3,7-dimethyl-1-propargylxanthine[no description available]medium10
zpck[no description available]medium10
n(6)-phenyladenosine[no description available]medium10purine nucleoside
tetrahydrodeoxycorticosterone[no description available]medium1021-hydroxy steroid
n-methyladenosine[no description available]medium10methyladenosine
mizoribine[no description available]medium10imidazolesanticoronaviral agent
1-amino-1,3-dicarboxycyclopentane[no description available]medium30
u 73122[no description available]medium70aromatic ether;
aza-steroid;
maleimides		EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
alphaxalone[no description available]medium10corticosteroid hormone
s-nitrosoglutathione[no description available]medium10glutathione derivative;
nitrosothio compound		bronchodilator agent;
nitric oxide donor;
platelet aggregation inhibitor;
signalling molecule
cp-55,940[no description available]medium10
vanoxerine[no description available]medium10hydrochloridedopamine uptake inhibitor
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate[no description available]medium10beta-carbolines
u 69593[no description available]medium30monocarboxylic acid amide;
N-alkylpyrrolidine;
organic heterobicyclic compound;
oxaspiro compound		anti-inflammatory agent;
diuretic;
kappa-opioid receptor agonist
cv 3988[no description available]medium10
beta-carboline-3-carboxylic acid methyl ester[no description available]medium10beta-carbolines
methoctramine[no description available]medium30hydrochloridemuscarinic antagonist
hypotaurine[no description available]medium10aminosulfinic acid;
zwitterion		human metabolite;
metabolite;
mouse metabolite
dihydrokainate[no description available]medium10dicarboxylic acid
gabazine[no description available]medium10
cl 218872[no description available]medium10pyridazines;
ring assembly
betaxolol hydrochloride[no description available]medium10hydrochlorideantihypertensive agent;
beta-adrenergic antagonist
catechin[no description available]medium10hydrategeroprotector
1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine[no description available]medium10hydrobromideserotonergic antagonist
s-methylthiocitrulline[no description available]medium10imidothiocarbamic ester;
L-arginine derivative;
L-ornithine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
neuroprotective agent
dihydrocapsaicin[no description available]medium10capsaicinoid
ml 9[no description available]medium10
parthenolide[no description available]medium10germacranolide
3',4'-dichlorobenzamil[no description available]medium20guanidines;
pyrazines
1-(carboxymethylthio)tetradecane[no description available]medium10straight-chain fatty acid
2-iodomelatonin[no description available]medium10acetamides
arcaine, sulfate[no description available]medium10
gr 113808[no description available]medium10indolyl carboxylate ester;
piperidines;
sulfonamide		serotonergic antagonist
gallopamil hydrochloride[no description available]medium10
gamma-glutamylaminomethylsulfonic acid[no description available]medium10
buthionine sulfoximine[no description available]medium102-amino-4-(S-butylsulfonimidoyl)butanoic acidEC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
sb 204070a[no description available]medium10
1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine[no description available]medium10(trifluoromethyl)benzenes;
N-alkylpiperazine;
N-arylpiperazine;
primary arylamine;
substituted aniline		geroprotector;
serotonergic agonist
l 655240[no description available]medium10methylindole
san 58035[no description available]medium10
nnc 711[no description available]medium10
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide[no description available]medium10diarylmethane
e 64[no description available]medium10dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion		antimalarial;
antiparasitic agent;
protease inhibitor
azetidine-2,4-dicarboxylic acid[no description available]medium10
pre 084[no description available]medium10morpholines
methotrexate[no description available]medium10dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
1-(2-allylphenoxy)-3-((8-bromoacetylamino-4-menthane-1-yl)amino)-1-propanol[no description available]medium10
sr 2640[no description available]medium10quinolines
ici 204448[no description available]medium10
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride[no description available]medium10
n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide[no description available]medium10phenylindole
3,5-bis(trifluoromethyl)benzyl n-acetyltryptophan[no description available]medium10
8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine[no description available]medium10
l 741626[no description available]medium10piperidines
nisoxetine hydrochloride[no description available]medium10
ng-nitroarginine methyl ester[no description available]medium10hydrochlorideEC 1.14.13.39 (nitric oxide synthase) inhibitor
tilarginine acetate[no description available]medium10
alpha-guanidinoglutaric acid[no description available]medium10L-glutamic acid derivative
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-isomer[no description available]medium10
imidazole-4-acetic acid hydrochloride[no description available]medium10
nsc-141549[no description available]medium10
2-chloro-2-deoxyglucose[no description available]medium10
idazoxan hydrochloride[no description available]medium10
isoguvacine hydrochloride[no description available]medium10
8-methoxymethyl-3-isobutyl-1-methylxanthine[no description available]medium10oxopurine
cyc 202[no description available]medium202,6-diaminopurinesantiviral drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
Serotonin hydrochloride[no description available]medium10tryptamines
n-phthaloylglutamic acid[no description available]medium10L-glutamic acid derivative;
phthalimides
1,3-dipropyl-7-methylxanthine[no description available]medium10
ag 3-5[no description available]medium10C-nitro compound
n-n-propylnorapomorphine[no description available]medium10aporphine alkaloid
urapidil monohydrochloride[no description available]medium10
aminopterin[no description available]medium10dicarboxylic acidEC 1.5.1.3 (dihydrofolate reductase) inhibitor;
mutagen
azepexole, dihydrochloride[no description available]medium10
2,5-dimethoxy-4-iodoamphetamine hydrochloride[no description available]medium10
abt 980[no description available]medium10
sk&f 75670[no description available]medium10
esatenolol[no description available]medium10atenololbeta-adrenergic antagonist
nbi 27914[no description available]medium10dialkylarylamine;
tertiary amino compound
(R)-atenolol[no description available]medium10atenolol
memantine hydrochloride[no description available]medium10hydrochlorideantidepressant;
antiparkinson drug;
dopaminergic agent;
neuroprotective agent;
NMDA receptor antagonist
pefabloc[no description available]medium10
pongidae[no description available]medium10
succinylproline[no description available]medium10N-acyl-amino acid
sb 205384[no description available]medium10thienopyridine
hydrastine[no description available]medium10isoquinolinesmetabolite
gabaculine hydrochloride[no description available]medium10
etiron monohydrobromide[no description available]medium10
bmy 7378[no description available]medium10
vesamicol[no description available]medium10
cortisone[no description available]medium2011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
vincristine sulfate[no description available]medium10organic sulfate saltantineoplastic agent;
geroprotector
n-methylserotonin oxalate salt[no description available]medium10
nsc 95397[no description available]medium101,4-naphthoquinones
wortmannin[no description available]high140acetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound		anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
canavanine[no description available]medium10amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		phytogenic insecticide;
plant metabolite
5-hydroxytryptophan[no description available]medium105-hydroxytryptophan;
amino acid zwitterion;
hydroxy-L-tryptophan;
non-proteinogenic L-alpha-amino acid		human metabolite;
mouse metabolite;
plant metabolite
ouabain[no description available]medium26011alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone		anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
tosylphenylalanyl chloromethyl ketone[no description available]medium10alpha-chloroketone;
sulfonamide		alkylating agent;
serine proteinase inhibitor
monoiodotyrosine[no description available]medium10amino acid zwitterion;
L-tyrosine derivative;
monoiodotyrosine;
non-proteinogenic L-alpha-amino acid		EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor;
human metabolite;
mouse metabolite
nitroarginine[no description available]medium20guanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
willardiine[no description available]medium10amino acid zwitterion;
L-alanine derivative;
non-proteinogenic L-alpha-amino acid
cortodoxone[no description available]medium10deoxycortisol;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
amiodarone hydrochloride[no description available]medium10aromatic ketone
dicyclomine hydrochloride[no description available]medium10hydrochlorideantispasmodic drug;
muscarinic antagonist
metyrosine[no description available]medium10L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		antihypertensive agent;
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
nortriptyline hydrochloride[no description available]medium10organic tricyclic compoundgeroprotector
paromomycin sulfate[no description available]medium10
Dubinidine[no description available]medium10organic heterotricyclic compound;
organonitrogen heterocyclic compound;
oxacycle
cyclopamine[no description available]medium20piperidinesglioma-associated oncogene inhibitor
s-(4-azidophenacyl)glutathione[no description available]medium10peptide
hydroxylamine hydrochloride[no description available]medium10organic molecular entity
sb 228357[no description available]medium10indolyl carboxylic acid
3,5-dihydroxyphenylglycine[no description available]medium10amino acid zwitterion;
non-proteinogenic L-alpha-amino acid;
resorcinols
actinonin[no description available]medium10
vinpocetine[no description available]medium10alkaloidgeroprotector
dihydroergocristine monomesylate[no description available]medium10methanesulfonate saltalpha-adrenergic antagonist;
geroprotector;
vasodilator agent
tretinoin[no description available]medium280retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
resveratrol[no description available]medium20resveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
oleic acid[no description available]medium40octadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
thapsigargin[no description available]medium100butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone		calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
brivudine[no description available]medium10
5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol[no description available]medium10carbotetracyclic compound;
polyphenol		estrogen receptor agonist;
estrogen receptor antagonist;
geroprotector;
neuroprotective agent
2-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid[no description available]medium10
adenosine-5'-(n-ethylcarboxamide)[no description available]medium10adenosines;
monocarboxylic acid amide		adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
L-cycloserine[no description available]medium104-amino-1,2-oxazolidin-3-oneanti-HIV agent;
anticonvulsant;
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor
1,4-dideoxy-1,4-imino-d-arabinitol[no description available]medium10
purvalanol a[no description available]medium10purvalanol
melphalan[no description available]medium10L-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
isoliquiritigenin[no description available]medium10chalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist
rauwolscine[no description available]medium10methyl 17-hydroxy-20xi-yohimban-16-carboxylate
gw9662[no description available]medium30benzamides
calmidazolium[no description available]medium10organic chloride saltapoptosis inducer;
calmodulin antagonist
tropisetron hydrochloride[no description available]medium10
Reactive blue 2[no description available]medium10anthraquinone
5,6-dichloro-1-ethyl-1,3-dihydro-2h-benzimidazol-2-one[no description available]medium10dichlorobenzene
quinidine sulfate[no description available]medium10
ipratropium bromide anhydrous[no description available]medium10
methamilane methiodide[no description available]medium10
pilocarpine nitrate[no description available]medium10
r 59949[no description available]medium10diarylmethane
n(6)-cyclopentyladenosine[no description available]medium10
methylatropine nitrate[no description available]medium10
sb 366791[no description available]medium10
ag-213[no description available]medium10
3,3',4,5'-tetrahydroxystilbene[no description available]medium10catechols;
polyphenol;
resorcinols;
stilbenol		antineoplastic agent;
apoptosis inducer;
geroprotector;
hypoglycemic agent;
plant metabolite;
protein kinase inhibitor;
tyrosine kinase inhibitor
bemesetron[no description available]medium10
(S)-(-)-pindolol[no description available]medium10pindolol
levosulpiride[no description available]medium10sulpirideantidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
caffeic acid[no description available]medium10caffeic acidgeroprotector;
mouse metabolite
4-fluorophenyl-L-alanine[no description available]medium104-fluorophenylalanine;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid
urocanic acid[no description available]medium10urocanic acidhuman metabolite
cotinine[no description available]medium10N-alkylpyrrolidine;
pyridines;
pyrrolidin-2-ones;
pyrrolidine alkaloid		antidepressant;
biomarker;
human xenobiotic metabolite;
plant metabolite
cinnarizine[no description available]medium10diarylmethane;
N-alkylpiperazine;
olefinic compound		anti-allergic agent;
antiemetic;
calcium channel blocker;
geroprotector;
H1-receptor antagonist;
histamine antagonist;
muscarinic antagonist
sulindac[no description available]medium10monocarboxylic acid;
organofluorine compound;
sulfoxide		analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
cysteine sulfinic acid[no description available]medium10organosulfinic acid;
S-substituted L-cysteine		Escherichia coli metabolite;
human metabolite;
metabotropic glutamate receptor agonist;
mouse metabolite
d-ap7[no description available]medium10
(1R,2S)-tranylcypromine hydrochloride[no description available]medium10hydrochloride
tacrine hydrochloride[no description available]medium10
4-bromotetramisole, oxalate (1:1), salt(s)-isomer[no description available]medium10
3-hydroxybenzylhydrazine hydrochloride[no description available]medium10
1-(3-chlorophenyl)biguanide hydrochloride[no description available]medium10
4-chlorophenylalanine methyl ester, hydrochloride, (dl)-isomer[no description available]medium10
capsazepine[no description available]medium20benzazepine;
catechols;
monochlorobenzenes;
thioureas		capsaicin receptor antagonist
diphenyleneiodium chloride[no description available]medium10organic chloride saltEC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor;
G-protein-coupled receptor agonist
azetidine-2,4-dicarboxylic acid, (cis)-isomer[no description available]medium10
tamoxifen citrate[no description available]medium10citrate saltangiogenesis inhibitor;
anticoronaviral agent
pimagedine hydrochloride[no description available]medium10
Betaine Aldehyde Chloride[no description available]medium10quaternary ammonium salt
eskazine[no description available]medium10
monastrol[no description available]medium10enoate ester;
ethyl ester;
phenols;
racemate;
thioureas		antileishmanial agent;
antimitotic;
antineoplastic agent;
EC 3.5.1.5 (urease) inhibitor
u 0126[no description available]medium70aryl sulfide;
dinitrile;
enamine;
substituted aniline		antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
4-diphenylacetoxy-n-methylpiperidine methiodide[no description available]medium10iodide salt;
quaternary ammonium salt		cholinergic antagonist;
muscarinic antagonist
1-(4-hydroxybenzyl)imidazole-2-thiol[no description available]medium10
2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide[no description available]medium10
bp 897[no description available]medium10naphthalenecarboxamide
trequinsin hydrochloride[no description available]medium10
neboglamine[no description available]medium10
benzatropine methanesulfonate[no description available]medium10
sb 203186[no description available]medium10indolyl carboxylic acid
n-(1-methyl-5-indolyl)-n'-(3-methyl-5-isothiazolyl)urea[no description available]medium101,2-thiazoles;
indoles;
ureas		receptor modulator;
serotonergic antagonist
gw 7647[no description available]medium20aryl sulfide;
monocarboxylic acid;
ureas		PPARalpha agonist
ro 41-0960[no description available]medium10
cgp 13501[no description available]medium10alkylbenzene
n-(2-(4-(4-chlorophenyl)piperazin-1-yl)ethyl)-3-methoxybenzamide[no description available]medium10
brl 15572[no description available]medium10monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
secondary alcohol		geroprotector;
serotonergic antagonist
mrs 1523[no description available]medium10
or486[no description available]medium10
fg 9041[no description available]medium10quinoxaline derivative
iik7[no description available]medium10
dm 235[no description available]medium10
jhw 015[no description available]medium10indolecarboxamide
bw 723c86[no description available]medium10tryptamines
sc 560[no description available]medium10aromatic ether;
monochlorobenzenes;
organofluorine compound;
pyrazoles		angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 1 inhibitor;
non-steroidal anti-inflammatory drug
sc-19220[no description available]medium10aromatic ether
le 300[no description available]medium10indoles
ly 367265[no description available]medium10dihydropyridine;
fluoroindole;
tertiary amino compound;
thiadiazoloquinoline		antidepressant;
geroprotector;
serotonergic antagonist;
serotonin uptake inhibitor
diclofenac sodium[no description available]medium10organic sodium salt
cgp 7930[no description available]medium10alkylbenzene
1,3,5-tris(4-hydroxyphenyl)-4-propyl-1h-pyrazole[no description available]medium10phenols;
pyrazoles		estrogen receptor agonist
sib 1757[no description available]medium10
sphingosine[no description available]medium30sphing-4-eninehuman metabolite;
mouse metabolite
apigenin[no description available]medium10trihydroxyflavoneantineoplastic agent;
metabolite
luteolin[no description available]medium103'-hydroxyflavonoid;
tetrahydroxyflavone		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
daphnetin[no description available]medium10hydroxycoumarin
genistein[no description available]high407-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
pulmicort[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone		anti-inflammatory drug;
bronchodilator agent;
drug allergen
timolol maleate[no description available]medium10maleate saltanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
brompheniramine maleate[no description available]medium10maleate saltanti-allergic agent
chlorpheniramine maleate[no description available]medium10organic molecular entity
clemastine fumarate[no description available]medium10fumarate saltanti-allergic agent;
antipruritic drug;
H1-receptor antagonist;
muscarinic antagonist
methylergonovine maleate[no description available]medium10ergoline alkaloidgeroprotector
astaxanthine[no description available]medium20carotenol;
carotenone		animal metabolite;
anticoagulant;
antioxidant;
food colouring;
plant metabolite
harman[no description available]medium10harmala alkaloid;
indole alkaloid fundamental parent;
indole alkaloid		anti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
morin[no description available]medium107-hydroxyflavonol;
pentahydroxyflavone		angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
myricetin[no description available]medium107-hydroxyflavonol;
hexahydroxyflavone		antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
daidzein[no description available]medium107-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
caffeic acid phenethyl ester[no description available]medium10alkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent
rottlerin[no description available]medium10aromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone		anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
flupenthixol[no description available]medium10flupenthixoldopaminergic antagonist
n-oleoyldopamine[no description available]medium10catechols;
fatty amide;
N-(fatty acyl)-dopamine;
secondary carboxamide		TRPV1 agonist
pheniramine maleate[no description available]medium10organic molecular entity
tranilast[no description available]medium10amidobenzoic acid;
cinnamamides;
dimethoxybenzene;
secondary carboxamide		anti-allergic agent;
anti-asthmatic drug;
antineoplastic agent;
aryl hydrocarbon receptor agonist;
calcium channel blocker;
hepatoprotective agent;
nephroprotective agent
trimipramine maleate[no description available]medium10maleate saltantidepressant
isotretinoin[no description available]medium10retinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
xylometazoline hydrochloride[no description available]medium10
flunarizine hydrochloride[no description available]medium10diarylmethane
ketotifen fumarate[no description available]medium10organoammonium saltanti-asthmatic drug;
H1-receptor antagonist
cis-flupenthixol dihydrochloride[no description available]medium10hydrochloridegeroprotector
n-arachidonylglycine[no description available]medium10fatty amide;
N-acylglycine
n-oleoylethanolamine[no description available]medium20endocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-acylethanolamine 18:1		EC 3.5.1.23 (ceramidase) inhibitor;
geroprotector;
PPARalpha agonist
cyclosporine[no description available]medium10homodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite
phenoxybenzamine hydrochloride[no description available]medium10organic molecular entity
phenylephrine hydrochloride[no description available]medium10hydrochloride
mepyramine maleate[no description available]medium10
brefeldin a[no description available]medium30macrolide antibioticPenicillium metabolite
fenretinide[no description available]medium10monocarboxylic acid amide;
retinoid		antineoplastic agent;
antioxidant
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid[no description available]medium10benzoic acids;
naphthalenes;
retinoid		antineoplastic agent;
retinoic acid receptor agonist;
teratogenic agent
l-2-(carboxypropyl)glycine[no description available]medium10
4-aminocrotonic acid[no description available]medium10
denopamine[no description available]medium10dimethoxybenzene
l 655,708[no description available]medium10
ro 41-1049[no description available]medium10
sb 200646a[no description available]medium10
seglitide[no description available]medium10
sib 1893[no description available]medium10
su 6656[no description available]medium10
tyrphostin ag 555[no description available]medium10
tyrphostin ag-494[no description available]medium10
tyrphostin b44[no description available]medium10
ag-490[no description available]medium10catechols;
enamide;
monocarboxylic acid amide;
nitrile;
secondary carboxamide		anti-inflammatory agent;
antioxidant;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector;
STAT3 inhibitor
ag 112[no description available]medium10
ag 183[no description available]medium10
semaxinib[no description available]medium10olefinic compound;
oxindoles;
pyrroles		angiogenesis modulating agent;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
8-(3-chlorostyryl)caffeine[no description available]medium10monochlorobenzenes;
trimethylxanthine		adenosine A2A receptor antagonist;
EC 1.4.3.4 (monoamine oxidase) inhibitor
bay 11-7085[no description available]medium10benzenes;
nitrile;
sulfone		anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
molsidomine[no description available]medium10ethyl ester;
morpholines;
oxadiazole;
zwitterion		antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
diamide[no description available]medium201,1'-azobis(N,N-dimethylformamide)
nomifensine maleate[no description available]medium10
nalbuphine hydrochloride[no description available]medium10hydrochloride
isoalloxazine[no description available]medium10benzo[g]pteridine-2,4-dione
vinblastine sulfate[no description available]medium10
n-methylscopolamine bromide[no description available]medium10
dextromethorphan hydrobromide[no description available]medium10hydrate;
hydrobromide
naloxone hydrochloride[no description available]medium10hydrochlorideantidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
s-trans,trans-farnesylthiosalicylic acid[no description available]medium10sesquiterpenoid
sulindac sulfone[no description available]medium10monocarboxylic acid;
organofluorine compound;
sulfone		apoptosis inducer;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
naltrexone hydrochloride[no description available]medium10hydrochlorideantidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
guanabenz acetate[no description available]medium10dichlorobenzenegeroprotector
nylidrin hydrochloride[no description available]medium10alkylbenzene
triprolidine hydrochloride anhydrous[no description available]medium10hydrochlorideH1-receptor antagonist
famotidine[no description available]medium101,3-thiazoles;
guanidines;
sulfonamide		anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
fenoterol[no description available]medium10hydrobromidebeta-adrenergic agonist;
bronchodilator agent;
sympathomimetic agent
tiapridex[no description available]medium10benzamides
quipazine maleate[no description available]medium10
n-(2-aminoethyl)-4-chlorobenzamide hydrochloride[no description available]medium10
tulobuterol hydrochloride[no description available]medium10organic molecular entity
hp 029[no description available]medium10
n,n,n-trimethyl-1-(4-stilbenoxy)-2-propylammonium iodide[no description available]medium10
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one[no description available]medium10naphthalenes
nf023[no description available]medium10
nf 449[no description available]medium10
7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine[no description available]medium10
gr 46611[no description available]medium10
diacetylmonoxime[no description available]medium10
homatropine hydrobromide, (endo-(+-)-isomer)[no description available]medium10
vancomycin hydrochloride[no description available]medium10
moxisylyte hydrochloride[no description available]medium10monoterpenoid
dizocilpine maleate[no description available]medium180maleate salt;
tetracyclic antidepressant		anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
beta-aminopropionitrile fumarate[no description available]medium10
flupirtine[no description available]medium10
zimelidine hydrochloride[no description available]medium10
pregna-4,17-diene-3,16-dione, (17z)-isomer[no description available]medium10
su 4312[no description available]medium10
gw 1929[no description available]medium10benzophenones
protriptyline hydrochloride[no description available]medium10hydrochlorideantidepressant
n(4)-chloroacetylcytosine arabinoside[no description available]medium10
n-(3-(cyclohexylidene-(1h-imidazol-4-ylmethyl))phenyl)ethanesulfonamide[no description available]medium10
n-(4-amino-2-chlorophenyl)phthalimide[no description available]medium10
cb 34[no description available]medium10
b 43[no description available]medium10aromatic amine;
aromatic ether;
cyclopentanes;
primary amino compound;
pyrrolopyrimidine		EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
(8R)-7-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol[no description available]medium10aporphine alkaloid
(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,13,14-triol[no description available]medium10aporphine alkaloid
3-(6-chloro-3-pyridazinyl)-3,8-diazabicyclo(3.2.1)octane[no description available]medium10
2-(3,3-diphenylpropylamino)acetamide[no description available]medium10diarylmethane
4-(2-(phenylsulfonylamino)ethylthio)-2,6-difluorophenoxyacetamide[no description available]medium10
gw2974[no description available]medium10pyridopyrimidine
l 162313[no description available]medium10
l-165041[no description available]medium10aromatic ketone
mrs 1754[no description available]medium10oxopurine
s-nitroso-n-acetylpenicillamine[no description available]medium10nitroso compound;
nitrosothio compound		nitric oxide donor;
vasodilator agent
pd 404182[no description available]medium10
sb 222200[no description available]medium10quinolines
dantrolene sodium[no description available]medium10
cr 2945[no description available]medium10
sb 218795[no description available]medium10quinolines
dihydroceramide[no description available]medium10N-acylsphinganine
epinephrine bitartrate[no description available]medium10
bicuculline methobromide[no description available]medium10
butylscopolammonium bromide[no description available]medium10
butaclamol hydrochloride[no description available]medium10
a 38503[no description available]medium10
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide[no description available]medium10
sk&f 89976-a[no description available]medium10
cv 1808[no description available]medium10purine nucleoside
fluvoxamine maleate[no description available]medium10(trifluoromethyl)benzenes
naloxone benzoylhydrazone[no description available]medium10
2-methyl-6-(phenylethynyl)pyridine hydrochloride[no description available]medium10hydrochlorideanxiolytic drug;
metabotropic glutamate receptor antagonist
amiprilose[no description available]medium10
(R)-fluoxetine hydrochloride[no description available]medium10hydrochlorideantidepressant;
serotonin uptake inhibitor
desmethylselegiline hydrochloride[no description available]medium10
3-morpholino-sydnonimine monohydrochloride[no description available]medium10
t 1032[no description available]medium10
qx-314 bromide[no description available]medium10
(S)-fluoxetine hydrochloride[no description available]medium10hydrochlorideantidepressant;
serotonin uptake inhibitor
sr 59230a[no description available]medium10
u 74389g[no description available]medium10
1-(2-methoxyphenyl)piperazine hydrochloride[no description available]medium10
y 27632, dihydrochloride, (4(r)-trans)-isomer[no description available]medium10
noscapine hydrochloride[no description available]medium10
a 77636[no description available]medium10hydrochlorideantiparkinson drug;
dopamine agonist
cgp 20712a[no description available]medium10
levodopa methyl ester hydrochloride[no description available]medium10
benalfocin hydrochloride[no description available]medium10
lu 19005[no description available]medium10
benoxathian hydrochloride[no description available]medium10
((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid, (+)-isomer[no description available]medium10
n-cyclopropyl adenosine-5'-carboxamide[no description available]medium10
cefotaxime sodium[no description available]medium10organic sodium salt
calpain inhibitor iii[no description available]medium10
GR 127935 hydrochloride[no description available]medium10hydrochlorideserotonergic antagonist
mrs 1845[no description available]medium10
1-aminocyclopropane-1-carboxylic acid hydrochloride[no description available]medium10
alaproclate hydrochloride[no description available]medium10
ubenimex[no description available]medium10peptide
3-chloroalanine hydrochloride, (l-ala)-isomer[no description available]medium10
dsp 4 hydrochloride[no description available]medium10
calcimycin[no description available]medium170benzoxazole
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzodioxan hydrochloride[no description available]medium10hydrochloridealpha-adrenergic antagonist
2-cyclooctyl-2-hydroxyethylamine hydrochloride[no description available]medium10
cirazoline monohydrochloride[no description available]medium10
adtn[no description available]medium10
apocodeine hydrochloride, (r)-isomer[no description available]medium10
Dihydro-beta-erythroidine hydrobromide[no description available]medium10indoles
lilly 78335[no description available]medium10
efaroxan hydrochloride[no description available]medium10
fenoldopam hydrobromide[no description available]medium10
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride[no description available]medium10hydrochloridedopamine uptake inhibitor
guvacine hydrochloride[no description available]medium10
7-hydroxy-2-n,n-dipropylaminotetralin hydrobromide[no description available]medium10
8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide, (r)-isomer,[no description available]medium10organic molecular entity
1-(2-(4-(4-fluoro-benzoyl)-piperidin-1-yl)-ethyl)-3,3-dimethyl-1,2-dihydro-indol-2-one[no description available]medium10hydrochloridereceptor modulator;
serotonergic antagonist
4-iodoclonidine[no description available]medium10
4-methylpyrazole monohydrochloride[no description available]medium10
tele-methylhistamine[no description available]medium10
alpha-methyltyrosine methyl ester, monohydrochloride[no description available]medium10
octoclothepine maleate[no description available]medium10
2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin hydrochloride[no description available]medium10
du 24565[no description available]medium10
2-methoxyidazoxan hydrochloride[no description available]medium10
ro 25-6981[no description available]medium10
sk&f 77434[no description available]medium10hydrobromidedopamine agonist;
prodrug
3-[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-yl]-1,1-diethylurea[no description available]medium10organic heterotetracyclic compound;
organonitrogen heterocyclic compound
demethylcantharidin[no description available]medium10
atropine sulfate[no description available]medium10
1-deoxynojirimycin hydrochloride[no description available]medium10
win 62577[no description available]medium10
quinine sulfate[no description available]medium10hydrate
quercetin[no description available]medium10
rv 538, (r-(r*,r*))-isomer[no description available]medium10
3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1s-cis)-isomer[no description available]medium10
valproate sodium[no description available]medium10organic sodium saltgeroprotector
u 63557a[no description available]medium10
taurocholic acid, monosodium salt[no description available]medium10bile salt
cefmetazole sodium[no description available]medium10organic sodium saltantimicrobial agent
fusidate sodium[no description available]medium10
cephapirin sodium[no description available]medium10cephalosporin;
organic sodium salt		antibacterial drug
sodium cephalothin[no description available]medium10organic sodium salt
cefazolin sodium[no description available]medium10organic sodium salt
5-hydroxydecanoic acid, monosodium salt[no description available]medium10
ro13-9904[no description available]medium10
cr 1409[no description available]medium10
cortisol succinate, sodium salt[no description available]medium10organic molecular entity
piroxicam[no description available]medium20benzothiazine;
monocarboxylic acid amide;
pyridines		analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
lfm a13[no description available]medium10aromatic amide;
dibromobenzene;
enamide;
enol;
nitrile;
secondary carboxamide		antineoplastic agent;
apoptosis inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 2.7.11.21 (polo kinase) inhibitor;
geroprotector;
platelet aggregation inhibitor
l 701324[no description available]medium10quinolines
hispidin[no description available]medium102-pyranones;
catechols		antioxidant;
EC 2.7.11.13 (protein kinase C) inhibitor;
fungal metabolite
minocycline hydrochloride[no description available]medium10
demeclocycline hydrochloride[no description available]medium10
acyclovir[no description available]medium102-aminopurines;
oxopurine		antimetabolite;
antiviral drug
sepiapterin[no description available]medium10sepiapterin
isoxanthopterin[no description available]medium10dihydroxypteridine
clozapine[no description available]medium60benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound		adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
clozapine[no description available]medium61benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound		adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
ganciclovir[no description available]medium102-aminopurines;
oxopurine		antiinfective agent;
antiviral drug
zaprinast[no description available]medium10triazolopyrimidines
allopurinol[no description available]medium20nucleobase analogue;
organic heterobicyclic compound		antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
thiolactomycin[no description available]medium10
2,4-diaminohypoxanthine[no description available]medium10hydroxypyrimidine
quazinone[no description available]medium10
8-bromocyclic gmp, sodium salt[no description available]medium10organic sodium saltmuscle relaxant;
protein kinase G agonist
ag-879[no description available]medium10
phenacyl bromide[no description available]medium10acetophenones;
alpha-bromoketone		metabolite
4-bromophenacyl bromide[no description available]medium20
2-bromo-4'-nitroacetophenone[no description available]medium10
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione[no description available]medium100benzenes;
thiadiazolidine		anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
np 031112[no description available]medium30benzenes;
naphthalenes;
thiadiazolidine		anti-inflammatory agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
clioquinol[no description available]medium10monohydroxyquinoline;
organochlorine compound;
organoiodine compound		antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antiprotozoal drug;
chelator;
copper chelator
edetic acid[no description available]high90ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid		anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid[no description available]medium10chromanol;
monocarboxylic acid;
phenols		antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
staurosporine[no description available]medium20indolocarbazole alkaloid;
organic heterooctacyclic compound		apoptosis inducer;
bacterial metabolite;
EC 2.7.11.13 (protein kinase C) inhibitor;
geroprotector
curcumin[no description available]medium10aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
vorinostat[no description available]medium10dicarboxylic acid diamide;
hydroxamic acid		antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
phthalimide[no description available]medium10phthalimides
dasatinib[no description available]medium101,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
su 11248[no description available]medium10monocarboxylic acid amide;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
bibw 2992[no description available]medium10aromatic ether;
enamide;
furans;
monochlorobenzenes;
organofluorine compound;
quinazolines;
secondary carboxamide;
tertiary amino compound		antineoplastic agent;
tyrosine kinase inhibitor
ponatinib[no description available]medium10(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine		antineoplastic agent;
tyrosine kinase inhibitor
verapamil[no description available]medium50aromatic ether;
nitrile;
polyether;
tertiary amino compound
clonidine[no description available]medium70clonidine;
imidazoline
enoxacin[no description available]medium101,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor
harmine[no description available]medium10harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
malondialdehyde[no description available]medium80dialdehydebiomarker
trichostatin a[no description available]medium40antibiotic antifungal agent;
hydroxamic acid;
trichostatin		bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
epidermal growth factor[no description available]medium130
glycine[no description available]medium140alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
alanine[no description available]medium120alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
lithium[no description available]medium1,0592alkali metal atom
isoflurane[no description available]medium30organofluorine compoundinhalation anaesthetic
cyclin d1[no description available]medium320
pilocarpine[no description available]medium1740pilocarpineantiglaucoma drug
amiodarone[no description available]medium101-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound		cardiovascular drug
cesium[no description available]medium300alkali metal atom
permanganate[no description available]medium10manganese oxoacid
cesium sulfate[no description available]medium10
baicalin[no description available]medium10dihydroxyflavone;
glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative		antiatherosclerotic agent;
antibacterial agent;
anticoronaviral agent;
antineoplastic agent;
antioxidant;
cardioprotective agent;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
ferroptosis inhibitor;
neuroprotective agent;
non-steroidal anti-inflammatory drug;
plant metabolite;
prodrug
sodium dodecyl sulfate[no description available]medium50organic sodium saltdetergent;
protein denaturant
galactose[no description available]medium90D-galactose;
galactopyranose		Escherichia coli metabolite;
mouse metabolite
sucrose[no description available]medium940glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
phenol[no description available]medium60phenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
glucose, (beta-d)-isomer[no description available]medium50D-glucopyranoseepitope;
mouse metabolite
fluoxetine[no description available]medium141(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
saccharin[no description available]medium16301,2-benzisothiazole;
N-sulfonylcarboxamide		environmental contaminant;
sweetening agent;
xenobiotic
phosphorus[no description available]medium40monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
alizarin[no description available]medium10dihydroxyanthraquinonechromophore;
dye;
plant metabolite
gentiopicroside[no description available]medium10glycoside
tolonium chloride[no description available]medium10
calcium sulfate[no description available]medium10calcium salt;
inorganic calcium salt
kaolinite[no description available]medium60aluminosilicate mineral;
mixture		antidiarrhoeal drug;
excipient
lithium carbonate[no description available]high190carbonate salt;
lithium salt		antimanic drug
ketamine[no description available]medium230cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
dimethyl fumarate[no description available]medium10diester;
enoate ester;
methyl ester		antipsoriatic;
immunomodulator
emetine[no description available]medium20isoquinoline alkaloid;
pyridoisoquinoline		antiamoebic agent;
anticoronaviral agent;
antiinfective agent;
antimalarial;
antineoplastic agent;
antiprotozoal drug;
antiviral agent;
autophagy inhibitor;
emetic;
expectorant;
plant metabolite;
protein synthesis inhibitor
acrylamide[no description available]medium30acrylamides;
N-acylammonia;
primary carboxamide		alkylating agent;
carcinogenic agent;
Maillard reaction product;
mutagen;
neurotoxin
dinoprostone[no description available]medium250prostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
muscone[no description available]medium10
titanium[no description available]medium80titanium group element atom
pyrroles[no description available]medium50pyrrole;
secondary amine
chir 99021[no description available]medium80aminopyridine;
aminopyrimidine;
cyanopyridine;
diamine;
dichlorobenzene;
imidazoles;
secondary amino compound		EC 2.7.11.26 (tau-protein kinase) inhibitor
wnt-c59[no description available]medium10
urea[no description available]medium400isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
ng-nitroarginine methyl ester[no description available]medium200alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
morphine[no description available]medium640morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
indazoles[no description available]medium70indazole
h 89[no description available]medium40N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
pioglitazone[no description available]medium10aromatic ether;
pyridines;
thiazolidinediones		antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
sevoflurane[no description available]medium50ether;
organofluorine compound		central nervous system depressant;
inhalation anaesthetic;
platelet aggregation inhibitor
oxazoles[no description available]medium501,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
mobic[no description available]medium101,3-thiazoles;
benzothiazine;
monocarboxylic acid amide		analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
1-methyltryptophan[no description available]medium20indolyl carboxylic acid
methylene blue[no description available]medium30organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
isoflurophate[no description available]medium40dialkyl phosphate
thyroxine[no description available]medium802-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine		antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
triiodothyronine[no description available]medium502-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine		human metabolite;
mouse metabolite;
thyroid hormone
farrerol[no description available]medium10organic molecular entitymetabolite
zeolites[no description available]medium30
daunorubicin[no description available]medium10aminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones		antineoplastic agent;
bacterial metabolite
tamoxifen[no description available]medium50stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
chloroquine[no description available]medium30aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
leupeptins[no description available]medium130
benzyloxycarbonylleucyl-leucyl-leucine aldehyde[no description available]medium100amino aldehyde;
carbamate ester;
tripeptide		proteasome inhibitor
bafilomycin a[no description available]medium10
tws 119[no description available]medium20
dimethylacetamide[no description available]medium330acetamides;
monocarboxylic acid amide		human metabolite
sirolimus[no description available]medium120antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol		antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
lithium bromide[no description available]medium60bromide salt;
lithium salt
iodine[no description available]medium80halide anion;
monoatomic iodine		human metabolite
bromide[no description available]medium150halide anion;
monoatomic bromine
cannabidiol[no description available]medium50olefinic compound;
phytocannabinoid;
resorcinols		antimicrobial agent;
plant metabolite
cannabidiolic acid[no description available]medium70dihydroxybenzoic acid;
phytocannabinoid;
polyketide;
resorcinols
foscarnet[no description available]medium30carboxylic acid;
one-carbon compound;
phosphonic acids		antiviral drug;
geroprotector;
HIV-1 reverse transcriptase inhibitor;
sodium-dependent Pi-transporter inhibitor
4,5,6,7-tetrabromo-2-azabenzimidazole[no description available]medium10
cyclosporine[no description available]medium60
okadaic acid[no description available]medium80ketal
triazoles[no description available]medium701,2,3-triazole
dronabinol[no description available]medium130benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea[no description available]medium80
thiazoles[no description available]medium2211,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
fpl 15896ar[no description available]medium10
8-prenylnaringenin[no description available]medium10(2S)-flavan-4-one;
4'-hydroxyflavanones;
trihydroxyflavanone		plant metabolite;
platelet aggregation inhibitor
xanthohumol[no description available]medium10aromatic ether;
chalcones;
polyphenol		anti-HIV-1 agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor;
metabolite
paclitaxel[no description available]medium10(2S)-flavan-4-one;
4'-hydroxyflavanones;
trihydroxyflavanone		T-type calcium channel blocker
methadone[no description available]medium10benzenes;
diarylmethane;
ketone;
tertiary amino compound
gant 61[no description available]medium10aminal;
dialkylarylamine;
pyridines;
substituted aniline;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
glioma-associated oncogene inhibitor;
Hedgehog signaling pathway inhibitor
carvedilol[no description available]medium10carbazoles;
secondary alcohol;
secondary amino compound		alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
D-fructopyranose[no description available]medium100cyclic hemiketal;
D-fructose;
fructopyranose		sweetening agent
quercetin[no description available]medium307-hydroxyflavonol;
pentahydroxyflavone		antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
transforming growth factor beta[no description available]medium151
oxalic acid[no description available]medium20alpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
2-aminoethoxydiphenyl borate[no description available]medium10organoboron compound;
primary amino compound		calcium channel blocker;
IP3 receptor antagonist;
potassium channel opener
glucagon-like peptide 1[no description available]medium130
mdl 100907[no description available]medium20
ammonium sulfate[no description available]medium10ammonium salt;
inorganic sulfate salt		fertilizer
sodium thiocyanate[no description available]medium40organic sodium salt
sodium sulfate[no description available]medium20inorganic sodium salt
magnesium sulfate[no description available]medium70magnesium salt;
metal sulfate;
organic magnesium salt		anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent
thiocyanic acid[no description available]medium10hydracid;
one-carbon compound;
organosulfur compound		Escherichia coli metabolite
methylparaben[no description available]medium10parabenantifungal agent;
antimicrobial food preservative;
neuroprotective agent;
plant metabolite
formic acid[no description available]medium30monocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
tetramethylammonium[no description available]medium10quaternary ammonium ion
propylparaben[no description available]medium10benzoate ester;
paraben;
phenols		antifungal agent;
antimicrobial agent
1,1-diphenyl-2-picrylhydrazyl[no description available]medium10
lignin[no description available]medium70
dimethyl sulfoxide[no description available]medium190sulfoxide;
volatile organic compound		alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
glutamic acid[no description available]medium250glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
thiazolyl blue[no description available]medium50organic bromide saltcolorimetric reagent;
dye
maleic acid[no description available]medium20butenedioic acidalgal metabolite;
mouse metabolite;
plant metabolite
anisomycin[no description available]medium70monohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
fucose[no description available]medium10fucopyranose;
L-fucose		Escherichia coli metabolite;
mouse metabolite
d-alpha tocopherol[no description available]medium20alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
quinazolines[no description available]medium10azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
2,4-diaminoquinazoline[no description available]medium10
oleanolic acid[no description available]medium30hydroxy monocarboxylic acid;
pentacyclic triterpenoid		plant metabolite
dimethoate[no description available]medium10monocarboxylic acid amide;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
dimethoxon[no description available]medium10organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
fh535[no description available]medium50sulfonamide
thymoquinone[no description available]medium201,4-benzoquinonesadjuvant;
anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
cardioprotective agent;
plant metabolite
isoxazoles[no description available]medium30isoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
wp1066[no description available]medium10
arsenic[no description available]medium20metalloid atom;
pnictogen		micronutrient
arsenic trioxide[no description available]medium10
activins[no description available]medium60
15-deoxy-delta(12,14)-prostaglandin j2[no description available]medium10prostaglandins Jelectrophilic reagent;
insulin-sensitizing drug;
metabolite
rosiglitazone[no description available]medium40aminopyridine;
thiazolidinediones		EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
troglitazone[no description available]medium10chromanes;
thiazolidinone		anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
pyrvinium[no description available]medium20quinolinium ionanthelminthic drug;
antineoplastic agent
prostaglandin d2[no description available]medium10prostaglandins Dhuman metabolite;
mouse metabolite
perampanel[no description available]medium10bipyridines;
nitrile;
pyridone		AMPA receptor antagonist;
anticonvulsant
pregnenolone[no description available]medium2020-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid		human metabolite;
mouse metabolite
isoquercitrin[no description available]medium20
aminoimidazole carboxamide[no description available]medium20aminoimidazole;
monocarboxylic acid amide		mouse metabolite
aica ribonucleotide[no description available]medium201-(phosphoribosyl)imidazolecarboxamide;
aminoimidazole		cardiovascular drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
bisindolylmaleimide i[no description available]medium40
brine[no description available]medium30
glycogen[no description available]medium110
davunetide[no description available]medium10oligopeptide
lactose[no description available]medium80lactose
methylnitrosourea[no description available]medium10N-nitrosoureasalkylating agent;
carcinogenic agent;
mutagen;
teratogenic agent
cellulose[no description available]medium370glycoside
deoxyglucose[no description available]medium110
lactic acid[no description available]medium402-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
aluminum[no description available]medium60boron group element atom;
elemental aluminium;
metal atom
fibrin[no description available]medium10peptide
cesium chloride[no description available]medium250inorganic caesium salt;
inorganic chloride		phase-transfer catalyst;
vasoconstrictor agent
potassium chloride[no description available]medium1102inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer
chlorine[no description available]medium9822halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
triptolide[no description available]medium10diterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound		antispermatogenic agent;
plant metabolite
adenine[no description available]medium706-aminopurines;
purine nucleobase		Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
3-methyladenine[no description available]medium40
phenanthrenes[no description available]medium10
piperidines[no description available]medium260
phorbolol myristate acetate[no description available]medium20
kn 93[no description available]medium10monochlorobenzenes;
monomethoxybenzene;
primary alcohol;
sulfonamide;
tertiary amino compound		EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor;
geroprotector
sb 203580[no description available]medium40imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide		EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
u-50488[no description available]medium50dichlorobenzene;
monocarboxylic acid amide;
N-alkylpyrrolidine		analgesic;
antitussive;
calcium channel blocker;
diuretic;
kappa-opioid receptor agonist
memantine[no description available]medium40adamantanes;
primary aliphatic amine		antidepressant;
antiparkinson drug;
dopaminergic agent;
neuroprotective agent;
NMDA receptor antagonist
mefloquine[no description available]medium10
n-vinyl-2-pyrrolidinone[no description available]medium10pyrrolidin-2-ones
mitomycin[no description available]medium10mitomycinalkylating agent;
antineoplastic agent
adenosine 5'-o-(3-thiotriphosphate)[no description available]medium30nucleoside triphosphate analogue
uridine triphosphate[no description available]medium40pyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
indium[no description available]medium30boron group element atom
palladium[no description available]medium70metal allergen;
nickel group element atom;
platinum group metal atom
benzaldehyde[no description available]medium10benzaldehydesEC 3.1.1.3 (triacylglycerol lipase) inhibitor;
EC 3.5.5.1 (nitrilase) inhibitor;
flavouring agent;
fragrance;
odorant receptor agonist;
plant metabolite
1-butyl-3-methylimidazolium[no description available]medium101-alkyl-3-methylimidazolium
quinine[no description available]medium190cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
rifampin[no description available]medium10cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion		angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
isoprothiolane[no description available]medium10dithiolanes;
isopropyl ester;
malonate ester		antifungal agrochemical;
environmental contaminant;
insecticide;
phospholipid biosynthesis inhibitor
thiophenes[no description available]medium20mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
pf 573228[no description available]medium10quinolines
carbostyril[no description available]medium30monohydroxyquinoline;
quinolone		bacterial xenobiotic metabolite
silicon nitride[no description available]medium10
methamphetamine[no description available]medium90amphetamines;
secondary amine		central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
abt-199[no description available]medium10aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine		antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
arq 197[no description available]medium10indoles
chitosan[no description available]medium20
beta-naphthoflavone[no description available]medium10extended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound		aryl hydrocarbon receptor agonist
methylprednisolone[no description available]medium206-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
serine[no description available]medium260L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
diisopropylamine[no description available]medium60
ondansetron[no description available]medium120carbazoles
exendin (9-39)[no description available]medium10
arecoline[no description available]medium40enoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine		metabolite;
muscarinic agonist
glyceryl 2-arachidonate[no description available]medium602-acylglycerol 20:4;
endocannabinoid		human metabolite
am 251[no description available]medium60amidopiperidine;
carbohydrazide;
dichlorobenzene;
organoiodine compound;
pyrazoles		antidepressant;
antineoplastic agent;
apoptosis inducer;
CB1 receptor antagonist
am 404[no description available]medium10anilide
jzl 184[no description available]medium20benzodioxoles
cytosine[no description available]medium10aminopyrimidine;
pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pf 3845[no description available]medium10piperidines
caprolactone[no description available]medium20epsilon-lactone
ascorbic acid[no description available]medium90ascorbic acid;
vitamin C		coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
hydroxychloroquine[no description available]medium10aminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene[no description available]medium10BODIPY compound
rubidium[no description available]medium240alkali metal atom
rubidium chloride[no description available]medium190inorganic chloride;
rubidium molecular entity		antidepressant;
biomarker
trifluoromethanesulfonic acid[no description available]medium20one-carbon compound;
perfluoroalkanesulfonic acid
nickel[no description available]medium60metal allergen;
nickel group element atom		epitope;
micronutrient
angiotensin ii[no description available]medium90amino acid zwitterion;
angiotensin II		human metabolite
cyclic gmp[no description available]medium1203',5'-cyclic purine nucleotide;
guanyl ribonucleotide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
exenatide[no description available]medium40
bay 11-7082[no description available]medium20nitrile;
sulfone		apoptosis inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
juglone[no description available]medium10hydroxy-1,4-naphthoquinonegeroprotector;
herbicide;
reactive oxygen species generator
naphthoquinones[no description available]medium10
retrorsine[no description available]medium10macrolide
acid fuchsin[no description available]medium10
guanosine diphosphate[no description available]medium30guanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
icodextrin[no description available]medium10
1,3-dimethyl-2-imidazolidinone[no description available]medium20imidazolidinone
cupric chloride[no description available]medium20copper molecular entity;
inorganic chloride		EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
celecoxib[no description available]medium10organofluorine compound;
pyrazoles;
sulfonamide;
toluenes		cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
bromochloroacetic acid[no description available]medium102-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound
fura-2[no description available]medium50
hes1 protein, human[no description available]medium10
dorsomorphin[no description available]medium10aromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines		bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
aldosterone[no description available]medium4011beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde		human metabolite;
mouse metabolite
deoxycytidine[no description available]medium20pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
gemcitabine[no description available]medium10organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
lenalidomide[no description available]medium10aromatic amine;
dicarboximide;
isoindoles;
piperidones		angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
longdaysin[no description available]medium10
alkenes[no description available]medium30
hydrogen sulfide[no description available]medium10gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride		Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
gyy 4137[no description available]medium10organic molecular entity
methanol[no description available]medium90alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
ethylene glycol[no description available]medium40ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin
n-methyl-3,4-methylenedioxyamphetamine[no description available]medium20amphetamines;
benzodioxoles		neurotoxin
2,5-di-tert-butylhydroquinone[no description available]medium10hydroquinones
isoproterenol[no description available]medium120catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
threonine[no description available]medium80amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
oxidopamine[no description available]medium70benzenetriol;
catecholamine;
primary amino compound		drug metabolite;
human metabolite;
neurotoxin
erythrosine[no description available]medium60
delta(9)-tetrahydrocannabinolic acid[no description available]medium10benzochromene;
diterpenoid;
hydroxy monocarboxylic acid;
phytocannabinoid;
polyketide		anti-inflammatory agent;
biomarker;
metabolite;
neuroprotective agent
thioctic acid[no description available]medium20dithiolanes;
heterocyclic fatty acid;
thia fatty acid		fundamental metabolite;
geroprotector
cannabidivarin[no description available]medium10monoterpenoid
sr141716[no description available]medium60amidopiperidine;
carbohydrazide;
dichlorobenzene;
monochlorobenzenes;
pyrazoles		anti-obesity agent;
appetite depressant;
CB1 receptor antagonist
tetrahydrocannabivarin 9[no description available]medium10
pyrophosphate[no description available]medium20diphosphate ion
sodium pyrophosphate[no description available]medium20inorganic sodium saltchelator;
food emulsifier;
food thickening agent
1-aminocyclopropane-1-carboxylic acid[no description available]medium10amino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid		ethylene releasers;
plant metabolite
ethylene[no description available]medium40alkene;
gas molecular entity		plant hormone;
refrigerant
ro 25-6981[no description available]medium10benzenes;
phenols;
piperidines;
secondary alcohol;
tertiary amino compound		anticonvulsant;
antidepressant;
neuroprotective agent;
NMDA receptor antagonist
anandamide[no description available]medium50endocannabinoid;
N-acylethanolamine 20:4		human blood serum metabolite;
neurotransmitter;
vasodilator agent
xylazine[no description available]medium301,3-thiazine;
methylbenzene;
secondary amino compound		alpha-adrenergic agonist;
analgesic;
emetic;
muscle relaxant;
sedative
metoclopramide[no description available]medium50benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound		antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
ammonium chloride[no description available]medium120ammonium salt;
inorganic chloride		ferroptosis inhibitor
phenyl acetate[no description available]medium90benzenes;
phenyl acetates
sodium acetate, anhydrous[no description available]medium40organic sodium saltNMR chemical shift reference compound
ammonium acetate[no description available]medium10acetate salt;
ammonium salt		buffer;
food acidity regulator
metaperiodate[no description available]medium10iodine oxoacid
metaperiodate[no description available]medium10iodine oxoanion;
monovalent inorganic anion
am 630[no description available]medium30N-acylindole
carbamates[no description available]medium80amino-acid anion
jzl195[no description available]medium10
oxytocin[no description available]medium290heterodetic cyclic peptide;
peptide hormone		oxytocic;
vasodilator agent
l 368899[no description available]medium20
atorvastatin[no description available]medium10aromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)		environmental contaminant;
xenobiotic
mocetinostat[no description available]medium30aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
levetiracetam[no description available]medium10pyrrolidin-2-onesanticonvulsant;
environmental contaminant;
xenobiotic
framycetin[no description available]medium120aminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
hydrochloric acid[no description available]medium70chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride		mouse metabolite
acetone[no description available]medium40ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
sodium hydroxide[no description available]medium20alkali metal hydroxide
6-bromoindirubin-3'-oxime[no description available]medium50
osteoprotegerin[no description available]medium20long-chain fatty acid
azobenzene[no description available]medium10azobenzenes
aripiprazole[no description available]medium30aromatic ether;
delta-lactam;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
quinolone		drug metabolite;
H1-receptor antagonist;
second generation antipsychotic;
serotonergic agonist
6-bromoindirubin-3'-acetoxime[no description available]medium10
cellulose sulfate[no description available]medium10ether;
flavonoids
sulfur trioxide[no description available]medium10sulfur oxide
pyridine[no description available]medium30azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
hydrogen[no description available]medium40elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
butyric acid[no description available]medium30fatty acid 4:0;
straight-chain saturated fatty acid		human urinary metabolite;
Mycoplasma genitalium metabolite
valine[no description available]medium40L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
valsartan[no description available]medium20biphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
xav939[no description available]medium40(trifluoromethyl)benzenes;
thiopyranopyrimidine		tankyrase inhibitor
8-hydroxy-2-(di-n-propylamino)tetralin[no description available]medium30phenols;
tertiary amino compound;
tetralins		serotonergic antagonist
sorafenib[no description available]medium10(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide		angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
niacinamide[no description available]medium10pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
acrolein[no description available]medium10enalherbicide;
human xenobiotic metabolite;
toxin
alpha-hydroxyglutarate[no description available]medium102-hydroxydicarboxylic acid;
dicarboxylic fatty acid		metabolite;
mouse metabolite
leptomycin b[no description available]medium10
acetylcellulose[no description available]medium10
calpain[no description available]medium80
minocycline[no description available]medium10
chlordiazepoxide[no description available]medium130benzodiazepine
bendroflumethiazide[no description available]medium20benzothiadiazine;
sulfonamide		antihypertensive agent;
diuretic
glycine amide[no description available]medium10amino acid amide;
glycine derivative
lithium bis(trimethylsilyl)amide[no description available]medium10
nephrin[no description available]medium30
zinc chloride[no description available]medium40inorganic chloride;
zinc molecular entity		astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid
amantadine[no description available]medium20adamantanes;
primary aliphatic amine		analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
manganese[no description available]medium50elemental manganese;
manganese group element atom		Escherichia coli metabolite;
micronutrient
4-toluenesulfonyl chloride[no description available]medium20
triethylamine[no description available]medium10tertiary amine
1-butyl-3-methylimidazolium chloride[no description available]medium10
1-allyl-3-methylimidazolium[no description available]medium10
cyclopropanecarboxamide[no description available]medium10cyclopropylcarboxamide
benzene[no description available]medium40aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
abscisic acid[no description available]medium802-trans-abscisic acid
gold[no description available]medium30copper group element atom;
elemental gold
ovalbumin[no description available]medium40
methionine[no description available]medium40aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
phlorhizin[no description available]medium30aryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative		antioxidant;
plant metabolite
cellobiose[no description available]medium40cellobioseepitope
carbene[no description available]medium30carbene;
methanediyl
methane[no description available]medium50alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
glycerol[no description available]medium90alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
phosphoserine[no description available]medium80non-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative		human metabolite
beryllium[no description available]medium30alkaline earth metal atom;
elemental beryllium;
metal allergen		adjuvant;
carcinogenic agent;
epitope
beryllium sulfate[no description available]medium20metal sulfateallergen
tomatine[no description available]medium10
tomatidine[no description available]medium103beta-hydroxy steroid;
azaspiro compound;
oxaspiro compound
amygdalin[no description available]medium10
clay[no description available]medium20
benzoxazoles[no description available]medium201,3-benzoxazoles;
mancude organic heterobicyclic parent
sb 334867-a[no description available]medium20naphthyridine derivative
trigonelline[no description available]medium10alkaloid;
iminium betaine		food component;
human urinary metabolite;
plant metabolite
teriflunomide[no description available]medium10(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide		drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
cytochrome c-t[no description available]medium40
myelin basic protein[no description available]medium30
nitrites[no description available]medium60monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species		human metabolite
nitrates[no description available]medium60monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
phenobarbital[no description available]medium60barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
trifluoroacetic anhydride[no description available]medium10
myristic acid[no description available]medium10long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite
chelerythrine[no description available]medium20benzophenanthridine alkaloid;
organic cation		antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
acriflavine[no description available]medium10
nalidixic acid[no description available]medium301,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic		antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
ferrous chloride[no description available]medium10iron coordination entity
sodium borohydride[no description available]medium30inorganic sodium salt;
metal tetrahydridoborate
fulvestrant[no description available]medium1017beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide		antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
go 6976[no description available]medium10indolocarbazole;
organic heterohexacyclic compound		EC 2.7.11.13 (protein kinase C) inhibitor
adenosine monophosphate[no description available]medium30adenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
deoxynivalenol[no description available]medium10cyclic ketone;
enone;
primary alcohol;
secondary alpha-hydroxy ketone;
trichothecene;
triol		mycotoxin
brimonidine tartrate[no description available]medium10
yohimbine[no description available]medium30methyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
benzofurans[no description available]medium30
1,2-dipalmitoylphosphatidylcholine[no description available]medium20
ag 1879[no description available]medium10aromatic amine;
monochlorobenzenes;
pyrazolopyrimidine		beta-adrenergic antagonist;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
geroprotector
benzotrifluoride[no description available]medium10(trifluoromethyl)benzenes;
fluorohydrocarbon		environmental contaminant;
NMR chemical shift reference compound;
solvent
fluorobenzenes[no description available]medium20monofluorobenzenesNMR chemical shift reference compound
wogonin[no description available]medium10dihydroxyflavone;
monomethoxyflavone		angiogenesis inhibitor;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
plant metabolite
sepharose[no description available]medium10
muramidase[no description available]medium90
enkephalin-leu, ala(2)-arg(6)-[no description available]medium10
enkephalin, leucine-2-alanine[no description available]medium10
gentamicin[no description available]medium40
arginine vasopressin[no description available]medium150vasopressincardiovascular drug;
hematologic agent;
mitogen
decitabine[no description available]medium102'-deoxyribonucleoside
carbidopa[no description available]medium10
alpha-aminopyridine[no description available]medium10
staurosporine[no description available]medium120ammonium ion derivative
glycidyl nitrate[no description available]medium20
salvinorin a[no description available]medium10organic heterotricyclic compound;
organooxygen compound		metabolite;
oneirogen
estradiol 3-benzoate[no description available]medium1017beta-hydroxy steroid;
benzoate ester		estrogen receptor agonist;
xenoestrogen
estradiol benzoate, progesterone drug combination[no description available]medium10
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one[no description available]medium10
sq-23377[no description available]medium50cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid		calcium ionophore;
metabolite
phenolsulfonphthalein[no description available]medium102,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone		acid-base indicator;
diagnostic agent;
two-colour indicator
triolein[no description available]medium30triglycerideCaenorhabditis elegans metabolite;
plant metabolite
ethylene dichloride[no description available]medium10chloroethaneshepatotoxic agent;
mutagen;
non-polar solvent
tetrapentylammonium[no description available]medium10quaternary ammonium ion
tetraphenylborate[no description available]medium10
nsc 23766[no description available]medium10hydrochlorideantiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
cellulose triacetate[no description available]medium10
methionine sulfoximine[no description available]medium10methionine derivative;
non-proteinogenic alpha-amino acid;
sulfoximide
2-aminoadipic acid[no description available]medium10amino dicarboxylic acid;
dicarboxylic fatty acid;
non-proteinogenic alpha-amino acid		Caenorhabditis elegans metabolite;
mammalian metabolite
chloroform[no description available]medium60chloromethanes;
one-carbon compound		carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant
bisphenol a[no description available]medium10bisphenolendocrine disruptor;
environmental contaminant;
xenobiotic;
xenoestrogen
phenylephrine[no description available]medium120phenols;
phenylethanolamines;
secondary amino compound		alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
xestospongin d[no description available]medium10
ex 527[no description available]medium10carbazoles;
monocarboxylic acid amide;
organochlorine compound
palmatine[no description available]medium10berberine alkaloid;
organic heterotetracyclic compound		plant metabolite
homocysteine[no description available]medium20amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
folic acid[no description available]medium20folic acids;
N-acyl-amino acid		human metabolite;
mouse metabolite;
nutrient
acetic acid[no description available]medium80monocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
1-butanol[no description available]medium20alkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol		human metabolite;
mouse metabolite;
protic solvent
lead nitrate[no description available]medium10inorganic nitrate salt;
lead coordination entity
lead[no description available]medium50carbon group element atom;
elemental lead;
metal atom		neurotoxin
hu 308[no description available]medium10aromatic ether;
bridged compound;
carbobicyclic compound;
primary allylic alcohol;
synthetic cannabinoid		anti-inflammatory agent;
antihypertensive agent;
apoptosis inhibitor;
bone density conservation agent;
CB2 receptor agonist
imatinib mesylate[no description available]medium30methanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
sch 23390[no description available]medium20benzazepine
norharman[no description available]medium10beta-carbolines;
mancude organic heterotricyclic parent		fungal metabolite;
marine metabolite
naloxone[no description available]medium200morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol		antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
midazolam[no description available]medium20imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound		anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
n-methylscopolamine[no description available]medium70
cellulase[no description available]medium40cellotriose
interleukin-8[no description available]medium50
antipyrine[no description available]medium10pyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
edaravone[no description available]medium10pyrazoloneantioxidant;
radical scavenger
succinic anhydride[no description available]medium10cyclic dicarboxylic anhydride;
tetrahydrofurandione
calcium aluminate[no description available]medium10
enkephalin, ala(2)-mephe(4)-gly(5)-[no description available]medium40
inositol 1,4,5-trisphosphate[no description available]medium530myo-inositol trisphosphatemouse metabolite
inositol[no description available]medium810cyclitol;
hexol
fenoldopam[no description available]medium10benzazepinealpha-adrenergic agonist;
antihypertensive agent;
dopamine agonist;
dopaminergic antagonist;
vasodilator agent
guanosine 5'-o-(3-thiotriphosphate)[no description available]medium90nucleoside triphosphate analogue
alpha-synuclein[no description available]medium10
m40[no description available]medium10
neuropeptide y[no description available]medium70
sodium chlorate[no description available]medium20chlorate salt;
inorganic sodium salt		herbicide
rhodamine 123[no description available]medium10organic cation;
xanthene dye		fluorochrome
chlorates[no description available]medium20chlorine oxoanion;
monovalent inorganic anion
dimethylformamide[no description available]medium30formamides;
volatile organic compound		geroprotector;
hepatotoxic agent;
polar aprotic solvent
ammonium hydroxide[no description available]medium30azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
flurbiprofen[no description available]medium10fluorobiphenyl;
monocarboxylic acid		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
paraldehyde[no description available]medium20trioxanesedative
bardoxolone methyl[no description available]medium10cyclohexenones
cucurbitacins[no description available]medium1011-oxo steroid
shu 9119[no description available]medium10
quinpirole[no description available]medium40pyrazoloquinolinedopamine agonist
iodine[no description available]medium20diatomic iodinenutrient
flag peptide[no description available]medium10peptide
plastoquinone[no description available]medium10plastoquinone
muromonab-cd3[no description available]medium10alkaloid;
macrocycle;
organic heteropentacyclic compound;
organonitrogen heterocyclic compound;
oxacycle;
tertiary amino compound		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
IP3 receptor antagonist;
marine metabolite
atropine[no description available]medium270
guanine[no description available]medium202-aminopurines;
oxopurine;
purine nucleobase		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
ecopipam[no description available]medium40benzazepine
raclopride[no description available]medium50salicylamides
oxadiazoles[no description available]medium40
quinoxalines[no description available]medium40mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
alprostadil[no description available]medium10prostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
endothelin-1[no description available]medium50
tanespimycin[no description available]medium101,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound		antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
cytidine[no description available]medium10cytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pyrimidin-2-one beta-ribofuranoside[no description available]medium10pyrimidine ribonucleosides
tacrolimus[no description available]medium40macrolide lactambacterial metabolite;
immunosuppressive agent
lithium hydroxide[no description available]medium20alkali metal hydroxide
topiramate[no description available]medium50cyclic ketal;
ketohexose derivative;
sulfamate ester		anticonvulsant;
sodium channel blocker
lithium citrate[no description available]medium10lithium salt
6-methyl-2-(phenylethynyl)pyridine[no description available]medium40acetylenic compound;
methylpyridines		anxiolytic drug;
metabotropic glutamate receptor antagonist
oxyntomodulin[no description available]medium60
sesquiterpenes[no description available]medium40
suberoyl bis-hydroxamic acid[no description available]medium20hydroxamic acid
3-hydroxybutyric acid[no description available]medium20(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid		human metabolite
palonosetron[no description available]medium10azabicycloalkane;
delta-lactam;
organic heterotricyclic compound		antiemetic;
serotonergic antagonist
quinuclidines[no description available]medium20quinuclidines;
saturated organic heterobicyclic parent
acepromazine[no description available]medium50aromatic ketone;
methyl ketone;
phenothiazines;
tertiary amino compound		phenothiazine antipsychotic drug
2,5-dimethylfuran[no description available]medium10furansantifungal agent;
bacterial metabolite;
fuel;
fumigant;
human urinary metabolite;
Maillard reaction product;
plant metabolite
furaldehyde[no description available]medium10aldehyde;
furans		Maillard reaction product;
metabolite
5-hydroxymethylfurfural[no description available]medium10arenecarbaldehyde;
furans;
primary alcohol		indicator;
Maillard reaction product
aconitic acid[no description available]medium10tricarboxylic acid
olanzapine[no description available]medium81benzodiazepine;
N-arylpiperazine;
N-methylpiperazine		antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor
metallothionein[no description available]medium10
quinic acid[no description available]medium10
chlorogenic acid[no description available]medium10cinnamate ester;
tannin		food component;
plant metabolite
fluorodeoxyglucose f18[no description available]medium302-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose
thiazolidines[no description available]medium10thiazolidine
(2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole[no description available]medium10
potassium fluoride[no description available]medium30fluoride salt;
potassium salt		NMR chemical shift reference compound;
poison
fluorides[no description available]medium120halide anion;
monoatomic fluorine
sodium iodide[no description available]medium40inorganic sodium salt;
iodide salt
cystine[no description available]medium20
n-(4,4-diphenyl-3-butenyl)nipecotic acid[no description available]medium10diarylmethane
calyculin a[no description available]medium10
kaempferol 3-o-neohesperidoside[no description available]medium10flavonoids;
glycoside
cyanidin-3-o-beta-glucopyranoside[no description available]medium10
brassinolide[no description available]medium1022-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
brassinosteroid		plant growth stimulator;
plant hormone
leptin[no description available]medium30
glycyrrhizic acid[no description available]medium20enone;
glucosiduronic acid;
pentacyclic triterpenoid;
tricarboxylic acid;
triterpenoid saponin		EC 3.4.21.5 (thrombin) inhibitor;
plant metabolite
sk&f 82958[no description available]medium20benzazepine
sodium oxybate[no description available]medium10
muscimol[no description available]medium30alkaloid;
isoxazoles;
primary amino compound		fungal metabolite;
GABA agonist;
oneirogen;
psychotropic drug
propranolol[no description available]medium180naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
harmaline[no description available]medium20harmala alkaloidoneirogen
vanoxerine[no description available]medium10ether;
N-alkylpiperazine;
organofluorine compound;
tertiary amino compound		dopamine uptake inhibitor
ozone[no description available]medium20elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
nitrobenzene[no description available]medium10nitroarene;
nitrobenzenes
tautomycin[no description available]medium10
vanadates[no description available]medium60trivalent inorganic anion;
vanadium oxoanion		EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
iofetamine[no description available]medium10
methylethyl ketone[no description available]medium30butanone;
dialkyl ketone;
methyl ketone;
volatile organic compound		bacterial metabolite;
polar aprotic solvent
diethyl ketone[no description available]medium10pentanoneanimal metabolite
fluconazole[no description available]medium10conazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug		environmental contaminant;
P450 inhibitor;
xenobiotic
adenosine diphosphate[no description available]medium80adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		fundamental metabolite;
human metabolite
dodecylphosphocholine[no description available]medium10phosphocholinesdetergent
phosphorylcholine[no description available]medium10phosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
1-anilino-8-naphthalenesulfonate[no description available]medium50aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
ezogabine[no description available]medium20carbamate ester;
organofluorine compound;
secondary amino compound;
substituted aniline		anticonvulsant;
potassium channel modulator
malic acid[no description available]medium202-hydroxydicarboxylic acid;
C4-dicarboxylic acid		food acidity regulator;
fundamental metabolite
aconitine[no description available]medium10
eicosapentaenoic acid[no description available]medium10icosapentaenoic acid;
omega-3 fatty acid		anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
toluene[no description available]medium20methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
pifithrin[no description available]medium10aromatic ketone
tacrine[no description available]medium70acridines;
aromatic amine		EC 3.1.1.7 (acetylcholinesterase) inhibitor
zm 336372[no description available]medium10benzamides
desipramine[no description available]medium81dibenzoazepine;
secondary amino compound		adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine[no description available]medium20methylpyridines;
phenylpyridine;
tetrahydropyridine		neurotoxin
maltodextrin[no description available]medium40
tetraethoxysilane[no description available]medium10
citric acid, anhydrous[no description available]medium20tricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
artenimol[no description available]medium10
agar[no description available]medium30
sildenafil citrate[no description available]medium30citrate saltEC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
methyl chloride[no description available]medium10chloromethanes;
methyl halides		marine metabolite;
mutagen;
refrigerant
methyl iodide[no description available]medium10iodomethanes;
methyl halides		fumigant insecticide
lithium fluoride[no description available]medium20
fluoromethane[no description available]medium10fluorohydrocarbon;
fluoromethanes;
methyl halides		refrigerant
methyl bromide[no description available]medium10bromohydrocarbon;
bromomethanes;
methyl halides		algal metabolite;
fumigant insecticide;
marine metabolite
ubiquinone[no description available]medium10
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide[no description available]medium10
feldspar[no description available]medium10
ibogaine[no description available]medium10
18-methoxycoronaridine[no description available]medium10
clomipramine[no description available]medium30dibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
perylene[no description available]medium10ortho- and peri-fused polycyclic arene;
perylenes
cl 316243[no description available]medium10
granisetron[no description available]medium10aromatic amide;
indazoles
sibutramine[no description available]medium10organochlorine compound;
tertiary amino compound		anti-obesity agent;
serotonin uptake inhibitor
agmatine[no description available]medium20guanidines;
primary amino compound		Escherichia coli metabolite;
mouse metabolite
aniline[no description available]medium10anilines;
primary arylamine
lutetium[no description available]medium10d-block element atom;
lanthanoid atom
lanthanum[no description available]medium30f-block element atom;
lanthanoid atom;
scandium group element atom
holmium[no description available]medium10f-block element atom;
lanthanoid atom
europium[no description available]medium20f-block element atom;
lanthanoid atom
neodymium[no description available]medium20f-block element atom;
lanthanoid atom
gadolinium[no description available]medium30f-block element atom;
lanthanoid atom
mercury[no description available]medium40elemental mercury;
zinc group element atom		neurotoxin
atrial natriuretic factor[no description available]medium50polypeptide
cardiovascular agents[no description available]medium20
methyllithium[no description available]medium20
tetrahydrofuran[no description available]medium40cyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound		polar aprotic solvent
substance p[no description available]medium40peptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
diphenylamine[no description available]medium10aromatic amine;
bridged diphenyl fungicide;
secondary amino compound		antifungal agrochemical;
antioxidant;
carotogenesis inhibitor;
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor;
ferroptosis inhibitor;
radical scavenger
betadex[no description available]medium20cyclodextrin
aluminum oxide[no description available]medium10
lactacystin[no description available]medium20lactam;
S-substituted L-cysteine
bafilomycin a1[no description available]medium20cyclic hemiketal;
macrolide antibiotic;
oxanes		apoptosis inducer;
autophagy inhibitor;
bacterial metabolite;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
ferroptosis inhibitor;
fungicide;
potassium ionophore;
toxin
am6545[no description available]medium10
yttrium[no description available]medium20d-block element atom;
rare earth metal atom;
scandium group element atom
lithium sulfate[no description available]medium20metal sulfateantidepressant
alsterpaullone[no description available]medium20C-nitro compound;
caprolactams;
organic heterotetracyclic compound		anti-HIV-1 agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor
mannitol[no description available]medium40mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
methiocarb[no description available]medium20aryl sulfide;
carbamate ester;
methyl sulfide		acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
molluscicide;
xenobiotic
boldenone undecylenate[no description available]medium10
cadmium chloride[no description available]medium30cadmium coordination entity
paraquat[no description available]medium30organic cationgeroprotector;
herbicide
dithiothreitol[no description available]medium301,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol		chelator;
human metabolite;
reducing agent
butoxamine[no description available]medium10
eedq[no description available]medium10
titanium dioxide[no description available]medium20titanium oxidesfood colouring
mercaptoethanol[no description available]medium40alkanethiol;
primary alcohol		geroprotector
aminoacetonitrile[no description available]medium20
sl 327[no description available]medium20
donepezil[no description available]medium10aromatic ether;
indanones;
piperidines;
racemate		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nootropic agent
n-acetylneuraminic acid[no description available]medium10N-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
tetrodotoxin[no description available]medium180azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid		animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
abt 869[no description available]medium10aromatic amine;
indazoles;
phenylureas		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
vidarabine[no description available]medium10beta-D-arabinoside;
purine nucleoside		antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
metformin[no description available]medium10guanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
rwj-333369[no description available]medium10organochlorine compound
pyrrolidine dithiocarbamate[no description available]medium10dithiocarbamic acids;
pyrrolidines		anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
congo red[no description available]medium10bis(azo) compound
trioctylmethylammonium[no description available]medium10quaternary ammonium ion
cobalt[no description available]medium40cobalt group element atom;
metal allergen		micronutrient
betaxolol[no description available]medium10propanolamineantihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
ziprasidone[no description available]medium111,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines		antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
cesium iodide[no description available]medium10
glutathione disulfide[no description available]medium10glutathione derivative;
organic disulfide		Escherichia coli metabolite;
mouse metabolite
t 0070907[no description available]medium10carbonyl compound;
organohalogen compound
fullerene c60[no description available]medium10fullerenegeroprotector
ethylenediamine[no description available]medium10alkane-alpha,omega-diamineGABA agonist
imidazolidines[no description available]medium10azacycloalkane;
imidazolidines;
saturated organic heteromonocyclic parent
tyrosine[no description available]medium50amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
acetonitrile[no description available]medium20aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
sc 45647[no description available]medium10
amyl acetate[no description available]medium30acetate estermetabolite
n-pentanol[no description available]medium60pentanol;
short-chain primary fatty alcohol		human metabolite;
plant metabolite
technetium tc 99m sestamibi[no description available]medium10
adenosine 3'-phosphate-5'-phosphate[no description available]medium30adenosine bisphosphateEscherichia coli metabolite;
mouse metabolite
strontium[no description available]medium40alkaline earth metal atom
gallium[no description available]medium10boron group element atom
deuterium oxide[no description available]medium70deuterated compound;
water		NMR solvent
proline[no description available]medium60amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
n-acetylproline[no description available]medium10L-proline derivative;
N-acetyl-L-amino acid;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
sodium bromide[no description available]medium50bromide salt;
inorganic sodium salt
propionic acid[no description available]medium40saturated fatty acid;
short-chain fatty acid		antifungal drug
carbon tetrachloride[no description available]medium10chlorocarbon;
chloromethanes		hepatotoxic agent;
refrigerant
n-methylpyrrolidone[no description available]medium10lactam;
N-alkylpyrrolidine;
pyrrolidin-2-ones		polar aprotic solvent
maleimide[no description available]medium10dicarboximide;
maleimides		EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
fluorosulfonic acid[no description available]medium10sulfur oxoacidNMR solvent
bupivacaine[no description available]medium10aromatic amide;
piperidinecarboxamide;
tertiary amino compound
phorbol-12-myristate[no description available]medium10
dihydrotestosterone[no description available]medium4017beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
thymosin beta(4)[no description available]medium10
thymosin[no description available]medium30
ryanodine[no description available]medium40
telmisartan[no description available]medium10benzimidazoles;
biphenyls;
carboxybiphenyl		angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
asparagine[no description available]medium10amino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
trimethyltin[no description available]medium10
mitotracker green fm[no description available]medium10
cerium[no description available]medium20f-block element atom;
lanthanoid atom
argon[no description available]medium20monoatomic argon;
noble gas atom;
p-block element atom		food packaging gas;
neuroprotective agent
n-acetylaspartic acid[no description available]medium30N-acetyl-L-amino acid;
N-acyl-L-aspartic acid		antioxidant;
human metabolite;
mouse metabolite;
nutraceutical;
rat metabolite
creatine[no description available]medium20glycine derivative;
guanidines;
zwitterion		geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
choline[no description available]medium282cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
lovastatin[no description available]medium10delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
cystothiazole a[no description available]medium101,3-thiazoles;
biaryl;
enoate ester;
enol ether;
methyl ester;
organonitrogen heterocyclic antibiotic		antifungal agent;
antineoplastic agent;
bacterial metabolite
3-hydroxybutanal[no description available]medium10
2-naphthol[no description available]medium10naphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol[no description available]medium10
CB-13[no description available]medium10benzophenones
sulforaphane[no description available]medium10isothiocyanate;
sulfoxide		antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
arachidonic acid[no description available]medium110icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
cetyltrimethylammonium ion[no description available]medium10quaternary ammonium ion
lentinan[no description available]medium10
thiourea[no description available]medium70one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
sulfuric acid[no description available]medium10sulfur oxoacidcatalyst
dobutamine[no description available]medium50catecholamine;
secondary amine		beta-adrenergic agonist;
cardiotonic drug;
sympathomimetic agent
paroxetine[no description available]medium62aromatic ether;
benzodioxoles;
organofluorine compound;
piperidines		antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
pentobarbital[no description available]medium200barbituratesGABAA receptor agonist
5,6-dihydroxytryptamine[no description available]medium10
1-(3-chlorophenyl)biguanide[no description available]medium20biguanides;
monochlorobenzenes
biguanides[no description available]medium20guanidines
venlafaxine hydrochloride[no description available]medium20hydrochloride
cyclohexanol[no description available]medium20cyclohexanols;
secondary alcohol		solvent
vanadium pentoxide[no description available]medium20vanadium oxide
amiloride[no description available]medium192aromatic amine;
guanidines;
organochlorine compound;
pyrazines		diuretic;
sodium channel blocker
guanfacine[no description available]medium10acetamides
medroxyprogesterone acetate[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester		adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
pimaric acid[no description available]medium10diterpenoid
norketamine[no description available]medium10organochlorine compound
quetiapine fumarate[no description available]medium21fumarate salt
cardamonin[no description available]medium10chalcones
2-fluoropyridine[no description available]medium10
3-hydroxychromone[no description available]medium10
tricalcium phosphate[no description available]medium20calcium phosphate
imidazole[no description available]medium20imidazole
cholecystokinin[no description available]medium210
3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde[no description available]medium10benzoic acids;
quinolines		fluorochrome
amitriptyline[no description available]medium32carbotricyclic compound;
tertiary amine		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
diuron[no description available]medium103-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene		environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic
sorbitol[no description available]medium70glucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
pirenzepine[no description available]medium70pyridobenzodiazepineanti-ulcer drug;
antispasmodic drug;
muscarinic antagonist
citalopram[no description available]medium302-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
dexfenfluramine[no description available]medium10fenfluramineappetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
triphenylmethane[no description available]medium10triarylmethaneenvironmental contaminant;
xenobiotic
pyrrolidonecarboxylic acid[no description available]medium105-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid		algal metabolite
guanosine triphosphate[no description available]medium140guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
fusidic acid[no description available]medium1011alpha-hydroxy steroid;
3alpha-hydroxy steroid;
alpha,beta-unsaturated monocarboxylic acid;
steroid acid;
steroid antibiotic;
sterol ester		EC 2.7.1.33 (pantothenate kinase) inhibitor;
Escherichia coli metabolite;
protein synthesis inhibitor
thiostrepton[no description available]medium10
glucagon-like peptide 1 (7-36)amide[no description available]medium40
glucagon[no description available]medium90peptide hormone
potassium hydroxide[no description available]medium10alkali metal hydroxide
1-(3-chloro-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone[no description available]medium10
acetylleucyl-leucyl-norleucinal[no description available]medium30aldehyde;
tripeptide		cysteine protease inhibitor
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone[no description available]medium50dichlorobenzene;
differentiation-inducing factor;
monomethoxybenzene;
resorcinols		eukaryotic metabolite;
signalling molecule
yttrium silicate[no description available]medium10
yttrium radioisotopes[no description available]medium10
caseins[no description available]medium30
alpha-chymotrypsin[no description available]medium20
nitrogenase[no description available]medium10
nefazodone[no description available]medium10aromatic ether;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazoles		alpha-adrenergic antagonist;
analgesic;
antidepressant;
serotonergic antagonist;
serotonin uptake inhibitor
ly 278584[no description available]medium10aromatic amide;
indazoles
1-(3-chlorophenyl)piperazine[no description available]medium50monochlorobenzenes;
N-arylpiperazine		drug metabolite;
environmental contaminant;
serotonergic agonist;
xenobiotic
paromomycin[no description available]medium10amino cyclitol glycoside;
aminoglycoside antibiotic		anthelminthic drug;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
fencamfamine[no description available]medium10monoterpenoid
amyloid beta-peptides[no description available]medium30
sarcosine[no description available]medium20N-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines		Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
org 24598[no description available]medium10
3,6-diamino-10-methylacridinium[no description available]medium10acridinium ion
urethane[no description available]medium20carbamate esterfungal metabolite;
mutagen
acridines[no description available]medium10acridines;
mancude organic heterotricyclic parent;
polycyclic heteroarene		genotoxin
digitalin[no description available]medium10cardenolide glycoside
papaverine[no description available]medium20benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent
n-methylacetamide[no description available]medium10acetamides;
monocarboxylic acid amide		metabolite
penicillin g[no description available]medium10penicillin allergen;
penicillin		antibacterial drug;
drug allergen;
epitope
boranes[no description available]medium10boranes;
mononuclear parent hydride
propadiene[no description available]medium10allenes
ximenynic acid[no description available]medium10long-chain fatty acid
boron trifluoride etherate[no description available]medium10
pectins[no description available]medium20D-galactopyranuronic acid
phencyclidine[no description available]medium10benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
nystatin a1[no description available]medium20nystatins
cytochalasin d[no description available]medium40
probenecid[no description available]medium20benzoic acids;
sulfonamide		uricosuric drug
taurocholic acid[no description available]medium10amino sulfonic acid;
bile acid taurine conjugate		human metabolite
[2-(2,6-dimethylanilino)-2-oxoethyl]-diethyl-(phenylmethyl)ammonium[no description available]medium10amino acid amide
sucrose octaacetate[no description available]medium20glycoside
3,4-dihydroxyphenylglycol[no description available]medium40catechols;
tetrol		metabolite;
mouse metabolite
methoxyhydroxyphenylglycol[no description available]medium40methoxybenzenes;
phenols
cyanine dye 3[no description available]medium10
guanidine[no description available]medium110carboxamidine;
guanidines;
one-carbon compound
carbocyanines[no description available]medium30cyanine dye;
organic iodide salt		fluorochrome
ephedrine[no description available]medium20phenethylamine alkaloid;
phenylethanolamines		bacterial metabolite;
environmental contaminant;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
pilocarpic acid[no description available]medium10
zolpidem[no description available]medium10imidazopyridinecentral nervous system depressant;
GABA agonist;
sedative
cuprous chloride[no description available]medium10copper molecular entity;
inorganic chloride		agrochemical;
molluscicide
lyngbyatoxin a[no description available]medium10indoles
molybdenum[no description available]medium10chromium group element atommicronutrient
ethyl magnesium bromide[no description available]medium10
isobutyric acid[no description available]medium10branched-chain saturated fatty acid;
fatty acid 4:0;
methyl-branched fatty acid		Daphnia magna metabolite;
plant metabolite;
volatile oil component
acetylcarnitine[no description available]medium10O-acylcarnitinehuman metabolite
cyanates[no description available]medium10
sodium fluoride[no description available]medium190fluoride saltmutagen
gallic acid[no description available]medium30trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
nekal[no description available]medium10
clonazepam[no description available]medium201,4-benzodiazepinone;
monochlorobenzenes		anticonvulsant;
anxiolytic drug;
GABA modulator
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid[no description available]medium20polyamino carboxylic acid;
tetracarboxylic acid		chelator
kb r7943[no description available]medium50
cgp 37157[no description available]medium10benzothiazepine
methylcellulose[no description available]medium10
beta-escin[no description available]medium30
glycosides[no description available]medium10
aluminum fluoride[no description available]medium30aluminium coordination entity
4-toluenesulfonyl fluoride[no description available]medium10
thymidine[no description available]medium100pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
lysophosphatidic acid[no description available]medium101-acyl-sn-glycerol 3-phosphate
sphingosine 1-phosphate[no description available]medium10sphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
propidium[no description available]medium10phenanthridines;
quaternary ammonium ion		fluorochrome;
intercalator
3-aminobenzeneboronic acid[no description available]medium10
xestospongin a[no description available]medium10
hydrogen carbonate[no description available]medium40carbon oxoanioncofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
bucladesine[no description available]medium1603',5'-cyclic purine nucleotide
guanosine[no description available]medium10guanosines;
purines D-ribonucleoside		fundamental metabolite
4-iodo-2,5-dimethoxyphenylisopropylamine[no description available]medium20amphetamines;
dimethoxybenzene;
organoiodine compound
pituitrin[no description available]medium200
chlorpyrifos[no description available]medium10chloropyridine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
oligonucleotides[no description available]medium30
fenfluramine[no description available]medium40(trifluoromethyl)benzenes;
secondary amino compound		appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
calcitriol[no description available]medium30D3 vitamins;
hydroxycalciol;
triol		antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
pentafluorobenzoic acid[no description available]medium10perfluorinated compound
cephalosporin c[no description available]medium10cephalosporinfungal metabolite
xylose[no description available]medium10D-xylose
sapropterin[no description available]medium105,6,7,8-tetrahydrobiopterincoenzyme;
cofactor;
diagnostic agent;
human metabolite
phenylthiourea[no description available]medium10thioureasEC 1.14.18.1 (tyrosinase) inhibitor
enkephalin, leucine[no description available]medium80pentapeptide;
peptide zwitterion		analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
beta-endorphin[no description available]medium60
alitretinoin[no description available]medium10retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist
acebutolol[no description available]medium30alpha-D-glucosyl-(1->4)-D-mannopyranose
methylamine[no description available]medium10methylamines;
one-carbon compound;
primary aliphatic amine		mouse metabolite
lysine[no description available]medium30aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
leucine[no description available]medium20amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
zonisamide[no description available]medium101,2-benzoxazoles;
sulfonamide		anticonvulsant;
antioxidant;
central nervous system drug;
protective agent;
T-type calcium channel blocker
1-palmitoyl-2-oleoylphosphatidylcholine[no description available]medium20
phosphatidylcholines[no description available]medium401,2-diacyl-sn-glycero-3-phosphocholine
indoleacetic acid[no description available]medium30indole-3-acetic acids;
monocarboxylic acid		auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
cerium sulfate[no description available]medium10
oxalates[no description available]medium20
succinic acid[no description available]medium20alpha,omega-dicarboxylic acid;
C4-dicarboxylic acid		anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
ethylene carbonate[no description available]medium10carbonate ester
carbonates[no description available]medium20carbon oxoanion
2-bromolysergic acid diethylamide[no description available]medium10
6-chloro-2-(1-piperazinyl)pyrazine[no description available]medium10N-arylpiperazine
lysergic acid diethylamide[no description available]medium30ergoline alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound		dopamine agonist;
hallucinogen;
serotonergic agonist
mianserin[no description available]medium10dibenzoazepineadrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
H1-receptor antagonist;
histamine agonist;
sedative;
serotonergic antagonist
pyrazines[no description available]medium20diazine;
pyrazines		Daphnia magna metabolite
phosphoramidite[no description available]medium10
rhodamine b[no description available]medium10organic chloride salt;
xanthene dye		fluorescent probe;
fluorochrome;
histological dye
rhodamine 6g[no description available]medium10
glucose-1-phosphate[no description available]medium10D-glucopyranose 1-phosphate
2-propanol[no description available]medium20secondary alcohol;
secondary fatty alcohol		protic solvent
isopentyl alcohol[no description available]medium20alkyl alcohol;
primary alcohol;
volatile organic compound		antifungal agent;
Saccharomyces cerevisiae metabolite;
xenobiotic metabolite
phosphorus radioisotopes[no description available]medium40
spermine[no description available]medium40polyazaalkane;
tetramine		antioxidant;
fundamental metabolite;
immunosuppressive agent
3-buten-2-one[no description available]medium10enone;
methyl ketone
acrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acidmetabolite
ucn 1028 c[no description available]medium20
acid phosphatase[no description available]medium40
mozavaptan[no description available]medium10benzamidesaquaretic
1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt[no description available]medium10organosulfur compound;
sulfonic acid derivative
soman[no description available]medium20phosphonic ester
phosphothreonine[no description available]medium10L-threonine derivative;
non-proteinogenic L-alpha-amino acid;
O-phosphoamino acid		Escherichia coli metabolite
sumatriptan[no description available]medium20sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
methysergide[no description available]medium20ergoline alkaloid
knk 437[no description available]medium10
n-(2-chloroethyl)-4-piperidinyl diphenylacetate[no description available]medium10
muscarine[no description available]medium30monosaccharide
technetium tc 99m pentetate[no description available]medium10
methomyl[no description available]medium10aliphatic sulfide;
carbamate ester		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
nematicide;
xenobiotic
urb 597[no description available]medium20biphenyls
dactinomycin[no description available]medium40actinomycinmutagen
eflornithine[no description available]medium10alpha-amino acid;
fluoroamino acid		trypanocidal drug
ethyl methanesulfonate[no description available]medium20methanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
genotoxin;
mutagen;
teratogenic agent
methyl mannoside, (alpha-d)-isomer[no description available]medium10alpha-D-mannoside;
methyl mannoside
phytic acid[no description available]medium10inositol phosphate
inositol 1-phosphate[no description available]medium190
histamine[no description available]medium100aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
sodium tungstate(vi)[no description available]medium10inorganic sodium saltreagent
ecdysterone[no description available]medium1014alpha-hydroxy steroid;
20-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
ecdysteroid;
phytoecdysteroid		animal metabolite;
plant metabolite
swainsonine[no description available]medium10indolizidine alkaloidantineoplastic agent;
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor;
immunological adjuvant;
plant metabolite
hygromycin a[no description available]medium10hydroxycinnamic acidmetabolite
hygromycin b[no description available]medium10
betaine[no description available]medium10amino-acid betaine;
glycine derivative		fundamental metabolite
vitamin k 3[no description available]medium101,4-naphthoquinones;
vitamin K		angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
o-(chloroacetylcarbamoyl)fumagillol[no description available]medium10carbamate ester;
organochlorine compound;
semisynthetic derivative;
sesquiterpenoid;
spiro-epoxide		angiogenesis inhibitor;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
methionine aminopeptidase 2 inhibitor;
retinoic acid receptor alpha antagonist
ckd732[no description available]medium10
pyrene[no description available]medium10ortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate[no description available]medium10purine ribonucleoside triphosphate
fumonisin b1[no description available]medium10diester;
fumonisin;
primary amino compound;
triol		carcinogenic agent;
metabolite
sanglifehrin a[no description available]medium10
thromboxane b2[no description available]medium10thromboxanes Bhuman metabolite;
mouse metabolite
acetylglucosamine[no description available]medium10N-acetyl-D-glucosamineepitope
potassium carbonate[no description available]medium10carbonate salt;
potassium salt		catalyst;
fertilizer;
flame retardant
potassium sulfate[no description available]medium10inorganic potassium salt;
potassium salt
glycolipids[no description available]medium10
linoleic acid[no description available]medium20octadecadienoic acid;
omega-6 fatty acid		algal metabolite;
Daphnia galeata metabolite;
plant metabolite
palmitic acid[no description available]medium10long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
casein kinase ii[no description available]medium20
n,n-carbonyldiimidazole[no description available]medium10
tetrabutylammonium[no description available]medium10quaternary ammonium ion
stilbenes[no description available]medium10stilbene
kinetin[no description available]medium206-aminopurines;
furans		cytokinin;
geroprotector
veratridine[no description available]medium60
lidocaine[no description available]medium60benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
p-aminoazobenzene[no description available]medium10
c.i. solvent yellow 56[no description available]medium10azobenzenes;
substituted aniline;
tertiary amino compound		dye;
mutagen
su 5402[no description available]medium10
8-bromo cyclic adenosine monophosphate[no description available]medium403',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
organobromine compound		antidepressant;
protein kinase agonist
ethacrynic acid[no description available]medium30aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid		EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
2-aminopurine[no description available]medium102-aminopurines;
nucleobase analogue		antimetabolite
pregnanolone[no description available]medium103-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid		human metabolite;
intravenous anaesthetic;
sedative
sr 144528[no description available]medium10bridged compound;
monochlorobenzenes;
pyrazoles;
secondary carboxamide		CB2 receptor antagonist;
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
am-356[no description available]medium10fatty amide
antimony[no description available]medium10metalloid atom;
pnictogen
peptide yy[no description available]medium10
incretins[no description available]medium10
erythrose[no description available]medium10erythroseplant metabolite
1-deoxynojirimycin[no description available]medium102-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid		anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
tin[no description available]medium10carbon group element atom;
elemental tin;
metal atom		micronutrient
lorazepam[no description available]medium11benzodiazepine
oxcarbazepine[no description available]medium11cyclic ketone;
dibenzoazepine		anticonvulsant;
drug allergen
pregabalin[no description available]medium10gamma-amino acidanticonvulsant;
calcium channel blocker
capsaicin[no description available]medium40capsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
sudan iii[no description available]medium10azobenzenes;
bis(azo) compound;
naphthols		carcinogenic agent;
fluorochrome;
histological dye
ammonium bromide[no description available]medium10ammonium salt;
bromide salt		NMR chemical shift reference compound
potassium bromide[no description available]medium20potassium salt
hypochlorous acid[no description available]medium10chlorine oxoacid;
reactive oxygen species		EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite
chloramine-t[no description available]medium10organic sodium saltallergen;
antifouling biocide;
disinfectant
niacin[no description available]medium10pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3		antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
procainamide[no description available]medium10benzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
phentolamine[no description available]medium20imidazoles;
phenols;
substituted aniline;
tertiary amino compound		alpha-adrenergic antagonist;
vasodilator agent
potassium phosphate[no description available]medium10inorganic phosphate salt;
inorganic potassium salt
deoxycholic acid[no description available]medium10bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human blood serum metabolite
acetoxycycloheximide[no description available]medium10
puromycin[no description available]medium20puromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
thenalidine[no description available]medium10dialkylarylamine;
tertiary amino compound
antazoline[no description available]medium10aromatic amine;
imidazolines;
tertiary amino compound		cholinergic antagonist;
H1-receptor antagonist;
xenobiotic
ranitidine[no description available]medium10C-nitro compound;
furans;
organic sulfide;
tertiary amino compound		anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
histidine[no description available]medium10amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
pyridoxal phosphate[no description available]medium10methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate		coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
concanavalin a[no description available]medium60
lypressin[no description available]medium20cyclic peptide
vasopressin, 9-des-gly-nh(2)-lys-[no description available]medium10
barbital[no description available]medium20barbituratesdrug allergen
hexobarbital[no description available]medium10barbiturates
dextromoramide[no description available]medium10morpholines;
N-acylpyrrolidine		opioid analgesic
oxotremorine[no description available]medium50N-alkylpyrrolidine
meperidine[no description available]medium10ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound		antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
kanamycin a[no description available]medium10kanamycinsbacterial metabolite
dibekacin[no description available]medium10kanamycinsantibacterial agent;
protein synthesis inhibitor
5-hydroxytryptophan[no description available]medium50hydroxytryptophanhuman metabolite;
neurotransmitter
deoxyguanosine[no description available]medium10purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
dithionitrobenzoic acid[no description available]medium10nitrobenzoic acid;
organic disulfide		indicator
chondroitin sulfates[no description available]medium10
heparitin sulfate[no description available]medium10
dermatan sulfate[no description available]medium10amino disaccharide;
glycosylgalactose derivative;
iduronic acids;
oligosaccharide sulfate
keratan sulfate[no description available]medium10
dihydroalprenolol[no description available]medium10
p-chloroamphetamine[no description available]medium30
sincalide[no description available]medium170oligopeptide
litorin[no description available]medium20
phenylalanine[no description available]medium20amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
acth (4-10)[no description available]medium10
dsp 4[no description available]medium40
p-aminohippuric acid[no description available]medium20N-acylglycineDaphnia magna metabolite
levamisole[no description available]medium106-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazoleantinematodal drug;
antirheumatic drug;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
immunological adjuvant;
immunomodulator
prochlorperazine[no description available]medium20N-alkylpiperazine;
N-methylpiperazine;
organochlorine compound;
phenothiazines		alpha-adrenergic antagonist;
antiemetic;
cholinergic antagonist;
dopamine receptor D2 antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic
nalorphine[no description available]medium20morphinane alkaloid
spiperone[no description available]medium50aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound		alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist
ketanserin[no description available]medium10aromatic ketone;
organofluorine compound;
piperidines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
flunitrazepam[no description available]medium101,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes		anxiolytic drug;
GABAA receptor agonist;
sedative
trimethobenzamide[no description available]medium20benzamides;
tertiary amino compound		antiemetic
cyclizine[no description available]medium10N-alkylpiperazineantiemetic;
central nervous system depressant;
cholinergic antagonist;
H1-receptor antagonist;
local anaesthetic
procaine[no description available]medium10benzoate ester;
substituted aniline;
tertiary amino compound		central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
chromium[no description available]medium10chromium group element atom;
metal allergen		micronutrient
enkephalin, methionine[no description available]medium20
carbon disulfide[no description available]medium10one-carbon compound;
organosulfur compound
tranylcypromine[no description available]medium302-phenylcyclopropan-1-amine
desoxycorticosterone[no description available]medium1020-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
deamino arginine vasopressin[no description available]medium20heterodetic cyclic peptidediagnostic agent;
renal agent;
vasopressin receptor agonist
dinitrofluorobenzene[no description available]medium10C-nitro compound;
organofluorine compound		agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
triamcinolone acetonide[no description available]medium2011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone		anti-allergic agent;
anti-inflammatory drug
oxazepam[no description available]medium101,4-benzodiazepinone;
organochlorine compound		anxiolytic drug;
environmental contaminant;
xenobiotic
deoxyinosine[no description available]medium10purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
inosine[no description available]medium10inosines;
purines D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
7-methylinosine[no description available]medium10inosines;
organic cation		metabolite
glycerophosphoinositol 4,5-bisphosphate[no description available]medium130
aflatoxin b1[no description available]medium10aflatoxin;
aromatic ether;
aromatic ketone		carcinogenic agent;
human metabolite
picrotoxin[no description available]medium10
inositol 4-phosphate[no description available]medium60inositol phosphate
vitamin b 12[no description available]medium20
spermidine[no description available]medium30polyazaalkane;
triamine		autophagy inducer;
fundamental metabolite;
geroprotector
guanosine 5'-o-(2-thiodiphosphate)[no description available]medium20nucleoside diphosphate analogue
1-hexadecyl-2-acetyl-glycero-3-phosphocholine[no description available]medium302-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
pyrimidinones[no description available]medium30
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid[no description available]medium30non-proteinogenic alpha-amino acid
1,9-dideoxyforskolin[no description available]medium10acetate ester;
labdane diterpenoid;
organic heterotricyclic compound		plant metabolite
cyanides[no description available]medium20pseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor
fm1 43[no description available]medium10organic bromide salt;
pyridinium salt;
quaternary ammonium salt;
tertiary amine		fluorochrome
buserelin[no description available]medium20oligopeptide
iodoacetic acid[no description available]medium10haloacetic acid;
organoiodine compound		alkylating agent
azides[no description available]medium20pseudohalide anionmitochondrial respiratory-chain inhibitor
dinoprost[no description available]medium30monocarboxylic acid;
prostaglandins Falpha		human metabolite;
mouse metabolite
alpha-methyl-4-carboxyphenylglycine[no description available]medium10non-proteinogenic alpha-amino acidmetabotropic glutamate receptor antagonist
tetragastrin[no description available]medium10peptidyl amide;
tetrapeptide		anxiogenic;
human metabolite
adenosine diphosphate ribose[no description available]medium30ADP-sugarEscherichia coli metabolite;
mouse metabolite
1-(5-isoquinolinesulfonyl)-2-methylpiperazine[no description available]medium40isoquinolines;
N-sulfonylpiperazine		EC 2.7.11.13 (protein kinase C) inhibitor
trifluoperazine[no description available]medium10N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines		antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
staurosporine aglycone[no description available]medium10
adenylyl imidodiphosphate[no description available]medium20adenosine 5'-phosphate
oxophenylarsine[no description available]medium10arsine oxidesantineoplastic agent;
apoptosis inducer;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
n-hexadecane[no description available]medium10long-chain alkanenon-polar solvent;
plant metabolite;
volatile oil component
6-cyano-7-nitroquinoxaline-2,3-dione[no description available]medium30quinoxaline derivative
cyclopentane[no description available]medium10cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
3-aminocyclopentane-1-carboxylic acid[no description available]medium10
diphenhydramine[no description available]medium30ether;
tertiary amino compound		anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
sodium perchlorate[no description available]medium10inorganic sodium salt
formaldehyde[no description available]medium20aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
3-o-methylglucose[no description available]medium20D-aldohexose derivative
indolactam v[no description available]medium10indoles
u 73343[no description available]medium10
copper sulfate[no description available]medium60metal sulfateemetic;
fertilizer;
sensitiser
halothane[no description available]medium20haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
phorbol 12,13-dibutyrate[no description available]medium70butyrate ester;
phorbol ester;
tertiary alpha-hydroxy ketone
cycloleucine[no description available]medium20non-proteinogenic alpha-amino acidEC 2.5.1.6 (methionine adenosyltransferase) inhibitor
diprenorphine[no description available]medium20morphinane alkaloid
mr 2034[no description available]medium10
formamide[no description available]medium20carboximidic acid;
formamides;
monocarboxylic acid amide;
one-carbon compound		solvent
tetradecyltrimethylammonium[no description available]medium30
guanidine isothiocyanate[no description available]medium10
proxyphylline[no description available]medium10oxopurine
naltrexone[no description available]medium70cyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound		antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
norbinaltorphimine[no description available]medium10isoquinolines
prazosin[no description available]medium100aromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
melibiose[no description available]medium20glycosylglucose
benzylaminopurine[no description available]medium106-aminopurinescytokinin;
plant metabolite
diminazene aceturate[no description available]medium20N-acetylglycinate saltantiparasitic agent;
trypanocidal drug
diminazene[no description available]medium20carboxamidine;
triazene derivative		antiparasitic agent;
trypanocidal drug
azaguanine[no description available]medium10nucleobase analogue;
triazolopyrimidines		antimetabolite;
antineoplastic agent;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
flupenthixol[no description available]medium20thioxanthenes
cytidine monophosphate[no description available]medium20cytidine 5'-phosphate;
pyrimidine ribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
uric acid[no description available]medium10uric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
7-hydroxy-2-n,n-dipropylaminotetralin[no description available]medium10tetralins
tetraethylammonium[no description available]medium10quaternary ammonium ion
benzoic acid[no description available]medium10benzoic acidsalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
inosine triphosphate[no description available]medium10inosine phosphate;
purine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
ci 988[no description available]medium10
l 365260[no description available]medium20benzodiazepine
devazepide[no description available]medium201,4-benzodiazepinone;
indolecarboxamide		antineoplastic agent;
apoptosis inducer;
cholecystokinin antagonist;
gastrointestinal drug
meglumine[no description available]medium20hexosamine;
secondary amino compound
adamantane[no description available]medium10adamantanes;
polycyclic alkane
a 77636[no description available]medium10adamantanes;
catechols;
isochromenes;
primary amino compound		antiparkinson drug;
dopamine agonist
r 56865[no description available]medium10
snx 230[no description available]medium10
selegiline[no description available]medium20selegiline;
terminal acetylenic compound		geroprotector
1-hexanol[no description available]medium10hexanol;
primary alcohol		alarm pheromone;
antibacterial agent;
fragrance;
plant metabolite
methimazole[no description available]medium101,3-dihydroimidazole-2-thionesantithyroid drug
chlorethylclonidine[no description available]medium20
wb 4101[no description available]medium20aromatic ether;
benzodioxine;
secondary amino compound		alpha-adrenergic antagonist
chiniofon[no description available]medium10
2-(n-heptyl)-4-hydroxyquinoline n-oxide[no description available]medium10monohydroxyquinoline
sodium cyanide[no description available]medium20cyanide salt;
one-carbon compound;
sodium salt		EC 1.15.1.1 (superoxide dismutase) inhibitor
carbon monoxide[no description available]medium10carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
cholic acid[no description available]medium1012alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
bile acid;
C24-steroid;
trihydroxy-5beta-cholanic acid		human metabolite;
mouse metabolite
inositol 4,5-bisphosphate[no description available]medium20myo-inositol bisphosphate
melitten[no description available]medium10
inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester[no description available]medium10
biotin[no description available]medium20biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
trehalose[no description available]medium10trehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
somatostatin, trp(8)-cys(14)-[no description available]medium10
bim 23056[no description available]medium10
bim 23027[no description available]medium10
dehydroascorbic acid[no description available]medium10dehydroascorbic acid;
vitamin C		coenzyme;
mouse metabolite
cytochalasin b[no description available]medium20cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
dantrolene[no description available]medium10hydrazone;
imidazolidine-2,4-dione		muscle relaxant;
neuroprotective agent;
ryanodine receptor antagonist
quil a[no description available]medium10
quillaja saponins[no description available]medium10
sodium glutamate[no description available]medium10monosodium glutamateflavouring agent
inositol 1,4,5-triphosphorothioate[no description available]medium10
guanidine thiocyanate[no description available]medium30
copper gluconate[no description available]medium20organic molecular entity
gluconic acid[no description available]medium10gluconic acidchelator;
Penicillium metabolite
suramin[no description available]medium10naphthalenesulfonic acid;
phenylureas;
secondary carboxamide		angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
senktide[no description available]medium10
neurotensin[no description available]medium20peptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
p-methoxy-n-methylphenethylamine[no description available]medium10aromatic ether;
secondary amino compound		metabolite
aspartame[no description available]medium10carboxylic acid;
dipeptide zwitterion;
dipeptide;
methyl ester		apoptosis inhibitor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
environmental contaminant;
micronutrient;
nutraceutical;
sweetening agent;
xenobiotic
thymidine monophosphate[no description available]medium10thymidine 5'-monophosphatefundamental metabolite
cysteamine[no description available]medium10amine;
thiol		geroprotector;
human metabolite;
mouse metabolite;
radiation protective agent
diphenyliodonium[no description available]medium10
triphenylsulfonium ion[no description available]medium10
ethidium[no description available]medium30phenanthridinesfluorochrome;
intercalator
cholecalciferol[no description available]medium10D3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone		geroprotector;
human metabolite
tromethamine[no description available]medium20primary amino compound;
triol		buffer
citrulline[no description available]medium10amino acid zwitterion;
citrulline		Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
ethionine[no description available]medium10S-ethylhomocysteineantimetabolite;
carcinogenic agent
1,2-dioctanoylglycerol[no description available]medium10
inosinic acid[no description available]medium10inosine phosphate;
purine ribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester[no description available]medium10
amikacin[no description available]medium10alpha-D-glucoside;
amino cyclitol glycoside;
aminoglycoside;
carboxamide		antibacterial drug;
antimicrobial agent;
nephrotoxin
l 690330[no description available]medium201,1-bis(phosphonic acid)
hydroxyl radical[no description available]medium10oxygen hydride;
oxygen radical;
reactive oxygen species
1-(4-bromoacetamidobenzyl)edta[no description available]medium10tetracarboxylic acidchelator
candesartan[no description available]medium10benzimidazolecarboxylic acid;
biphenylyltetrazole		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
urapidil[no description available]medium10piperazines
potassium dichromate[no description available]medium10potassium saltallergen;
oxidising agent;
sensitiser
mercuric chloride[no description available]medium20mercury coordination entitysensitiser
calcium chromate(vi)[no description available]medium10
chromates[no description available]medium10chromium oxoanion;
divalent inorganic anion		oxidising agent
n-(ethoxycarbonylmethyl)-6-methoxyquinolinium[no description available]medium10
fluphenazine[no description available]medium10N-alkylpiperazine;
organofluorine compound;
phenothiazines		anticoronaviral agent;
dopaminergic antagonist;
phenothiazine antipsychotic drug
benztropine[no description available]medium10diarylmethane
nad[no description available]medium10organophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
gastrin-releasing peptide[no description available]medium20
neuromedin b[no description available]medium10
neurokinin b[no description available]medium10polypeptide
web 2086[no description available]medium10organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
fluvoxamine[no description available]medium10(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime		antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
lactulose[no description available]medium10
benomyl[no description available]medium10aromatic amide;
benzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		acaricide;
anthelminthic drug;
antifungal agrochemical;
microtubule-destabilising agent;
tubulin modulator
tentoxin[no description available]medium10lactam
iloprost[no description available]medium10carbobicyclic compound;
monocarboxylic acid;
secondary alcohol		platelet aggregation inhibitor;
vasodilator agent
nordidemnin b[no description available]medium10didemninmetabolite
palladium chloride[no description available]medium10palladium coordination entitycatalyst
beta-alanine[no description available]medium10amino acid zwitterion;
beta-amino acid		agonist;
fundamental metabolite;
human metabolite;
inhibitor;
neurotransmitter
2,2-dimethyl-beta-alanine[no description available]medium10
buspirone[no description available]medium11azaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines		anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
acetoacetic acid[no description available]medium103-oxo fatty acid;
ketone body		metabolite
sulfites[no description available]medium10divalent inorganic anion;
sulfur oxide;
sulfur oxoanion
chlorophyll a[no description available]medium10chlorophyll;
methyl ester		cofactor
adenosine-3',5'-cyclic phosphorothioate[no description available]medium10nucleoside 3',5'-cyclic phosphorothioate
2-methylthio-atp[no description available]medium10
n-n-propylnorapomorphine[no description available]medium20
butorphanol[no description available]medium10morphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
barium chloride[no description available]medium20barium salt;
inorganic chloride		potassium channel blocker
cgp 35348[no description available]medium10
w 7[no description available]medium10
valinomycin[no description available]medium10cyclodepsipeptide;
macrocycle		antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore
cadmium[no description available]medium40cadmium molecular entity;
zinc group element atom
fmrfamide[no description available]medium10
phenylalanyl-leucyl-arginyl phenylalaninamide[no description available]medium10
putrescine[no description available]medium20alkane-alpha,omega-diamineantioxidant;
fundamental metabolite
cysteine[no description available]medium10cysteiniumfundamental metabolite
phosphoric acid, trisodium salt[no description available]medium10sodium phosphate
xanomeline[no description available]medium10tetrahydropyridine;
thiadiazoles		muscarinic agonist;
serotonergic agonist
lu 25-109[no description available]medium10dihydropyridine
n-methylnaloxone[no description available]medium10
aphidicolin[no description available]medium20tetracyclic diterpenoidantimicrobial agent;
antimitotic;
antineoplastic agent;
antiviral drug;
apoptosis inducer;
Aspergillus metabolite;
DNA synthesis inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
fungal metabolite
tellurium[no description available]medium10chalcogen;
metalloid atom
tellurous acid[no description available]medium10tellurium oxoacid
thulium[no description available]medium10f-block element atom;
lanthanoid atom
ergotamine[no description available]medium10peptide ergot alkaloidalpha-adrenergic agonist;
mycotoxin;
non-narcotic analgesic;
oxytocic;
serotonergic agonist;
vasoconstrictor agent
orotic acid[no description available]medium10pyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
chlorhexidine[no description available]medium10biguanides;
monochlorobenzenes		antibacterial agent;
antiinfective agent
bradykinin[no description available]medium60oligopeptidehuman blood serum metabolite;
vasodilator agent
ramipril[no description available]medium10azabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester		bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
icatibant[no description available]medium10
glutaral[no description available]medium10dialdehydecross-linking reagent;
disinfectant;
fixative
bromosuccinimide[no description available]medium10dicarboximide;
organobromine compound;
pyrrolidinone		reagent
thallium[no description available]medium10boron group element atom
thallium chloride[no description available]medium10inorganic chloride;
thallium molecular entity
cesium fluoride[no description available]medium10
alanylalanine[no description available]medium10dipeptide
alanylglycine[no description available]medium10
glycylglycine[no description available]medium10dipeptide zwitterion;
dipeptide		human metabolite
n-glycylalanine[no description available]medium10dipeptidemetabolite
phosphocreatine[no description available]medium10phosphagen;
phosphoamino acid		human metabolite;
mouse metabolite
boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester[no description available]medium10
ferric citrate[no description available]medium10iron chelateanti-anaemic agent;
nutraceutical
losartan potassium[no description available]medium10
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone[no description available]medium10
helium[no description available]medium10monoatomic helium;
noble gas atom;
s-block element atom		food packaging gas
niobium[no description available]medium10vanadium group element atom
neon[no description available]medium10monoatomic neon;
noble gas atom;
p-block element atom
clasto-lactacystin beta-lactone[no description available]medium10
vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)-[no description available]medium30
sodium propionate[no description available]medium20organic sodium saltantifungal drug;
food preservative
amylopectin[no description available]medium10
nortriptyline[no description available]medium11organic tricyclic compound;
secondary amine		adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
beryllium chloride[no description available]medium10beryllium molecular entity;
inorganic chloride		carcinogenic agent;
genotoxin
s-adenosylhomocysteine[no description available]medium10adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide		cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
cosyntropin[no description available]medium10
ruthenium[no description available]medium10iron group element atom;
platinum group metal atom
mocimycin[no description available]medium10C-glycosyl compound
guanylyl imidodiphosphate[no description available]medium40nucleoside triphosphate analogue
diethyl maleate[no description available]medium10ethyl ester;
maleate ester		glutathione depleting agent
16,16-dimethylprostaglandin e2[no description available]medium20cyclopentanones;
monocarboxylic acid;
prostanoid;
secondary allylic alcohol		anti-ulcer drug;
gastrointestinal drug;
radiation protective agent
dimercaprol[no description available]medium10dithiol;
primary alcohol		chelator
sodium salicylate[no description available]medium10organic molecular entity
hydroxycitric acid[no description available]medium10carbonyl compound
aluminum chloride[no description available]medium30aluminium coordination entityLewis acid
sodium nitrate[no description available]medium10inorganic nitrate salt;
inorganic sodium salt		fertilizer;
NMR chemical shift reference compound
neostigmine[no description available]medium20quaternary ammonium ionantidote to curare poisoning;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
methyl sulfate[no description available]medium10alkyl sulfate;
one-carbon compound
n-chlorosuccinimide[no description available]medium10dicarboximide;
pyrrolidinone
triphenylphosphine[no description available]medium10benzenes;
tertiary phosphine		NMR chemical shift reference compound;
reducing agent
chloral hydrate[no description available]medium10aldehyde hydrate;
ethanediol;
organochlorine compound		general anaesthetic;
mouse metabolite;
sedative;
xenobiotic
inositol-1,3,4,5-tetrakisphosphate[no description available]medium50inositol phosphate
isoamyl acetate[no description available]medium10acetate estermetabolite;
Saccharomyces cerevisiae metabolite
methacycline[no description available]medium201,2-diglyceride
buprenorphine[no description available]medium10morphinane alkaloiddelta-opioid receptor antagonist;
kappa-opioid receptor antagonist;
mu-opioid receptor agonist;
opioid analgesic
sufentanil[no description available]medium10anilide;
ether;
piperidines;
thiophenes		anaesthesia adjuvant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
zacopride[no description available]medium10benzamides
ly 53857[no description available]medium10
ergoline[no description available]medium10diamine;
ergoline alkaloid;
indole alkaloid fundamental parent;
indole alkaloid;
organic heterotetracyclic compound
1-propanol[no description available]medium20propan-1-ols;
short-chain primary fatty alcohol		metabolite;
protic solvent
iodosulpride[no description available]medium10
phenoxybenzamine[no description available]medium10aromatic amine
indo-1[no description available]medium10indolesfluorochrome
clorgyline[no description available]medium10aromatic ether;
dichlorobenzene;
terminal acetylenic compound;
tertiary amino compound		antidepressant;
EC 1.4.3.4 (monoamine oxidase) inhibitor
inositol 1,4-bis(phosphate)[no description available]medium60
hemicholinium 3[no description available]medium10
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate[no description available]medium201,1-diunsubstituted alkanesulfonate
inositol 2-monophosphate[no description available]medium10
paraoxon[no description available]medium10aryl dialkyl phosphate;
organophosphate insecticide		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
mouse metabolite
alprazolam[no description available]medium10organochlorine compound;
triazolobenzodiazepine		anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
masoprocol[no description available]medium10nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
fluorescein[no description available]medium102-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorescent dye;
radioopaque medium
glutaric acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		Daphnia magna metabolite;
human metabolite
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline[no description available]medium10naphthalenes;
sulfonic acid derivative
methoxamine[no description available]medium10amphetaminesalpha-adrenergic agonist;
antihypotensive agent
demecolcine[no description available]medium10alkaloid;
secondary amino compound		antineoplastic agent;
microtubule-destabilising agent
6-ketoprostaglandin f1 alpha[no description available]medium10prostaglandins Falphahuman metabolite;
mouse metabolite
lanthanum chloride[no description available]medium10
pipecolic acid[no description available]medium10piperidinemonocarboxylic acid
sarkosyl[no description available]medium10
empigen bb[no description available]medium10
n-butoxyethanol[no description available]medium10glycol ether;
primary alcohol		protic solvent
n,n'-4-phenylenedimaleimide[no description available]medium10
monensin[no description available]medium30cyclic hemiketal;
monocarboxylic acid;
polyether antibiotic;
spiroketal		antifungal agent;
coccidiostat;
ionophore
lithium perchlorate[no description available]medium10
deuterium[no description available]medium20dihydrogen
veratrine[no description available]medium10alkaloid
ribosomal protein l7-l12[no description available]medium10
2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran[no description available]medium10
phenylpropanolamine[no description available]medium10amphetamines;
phenethylamine alkaloid		plant metabolite
4-nitrophenyl beta-cellobioside[no description available]medium10
2,3-diphosphoglycerate[no description available]medium20bisphosphoglyceric acid;
tetronic acid derivative		human metabolite
estradiol dipropionate[no description available]medium10steroid ester
isovaleric acid[no description available]medium10branched-chain saturated fatty acid;
methylbutyric acid;
short-chain fatty acid		mammalian metabolite;
plant metabolite
neurokinin a[no description available]medium10
monobutyryl cyclic amp[no description available]medium103',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
butanamides		protein kinase agonist
dibutyryl cyclic gmp[no description available]medium10
barium[no description available]medium20alkaline earth metal atom;
elemental barium
phosphatidylinositol 4-phosphate[no description available]medium20
potassium cyanide[no description available]medium20cyanide salt;
one-carbon compound;
potassium salt		EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin
thymine[no description available]medium10pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid[no description available]medium10
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid[no description available]medium10stilbenoid
chloramphenicol[no description available]medium10C-nitro compound;
carboxamide;
diol;
organochlorine compound		antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
aminooxyacetic acid[no description available]medium10amino acid;
hydroxylamines;
monocarboxylic acid		anticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
nootropic agent
alpha-(difluoromethyl)arginine[no description available]medium10
digitoxin[no description available]medium20cardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
dimyristoylphosphatidylglycerol[no description available]medium10
t-2 toxin[no description available]medium10
1,4-dioxane[no description available]medium10dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
1-monooleoyl-rac-glycerol[no description available]medium101-acylglycerol 18:1;
monooleoylglycerol		plant metabolite
n-formylmethionine leucyl-phenylalanine[no description available]medium10tripeptide
2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate[no description available]medium10
phenylglyoxal[no description available]medium10phenylacetaldehydes
tyramine[no description available]medium10monoamine molecular messenger;
primary amino compound;
tyramines		EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
camphor, (+-)-isomer[no description available]medium20bornane monoterpenoid;
cyclic monoterpene ketone		plant metabolite
methylnaltrexone[no description available]medium10phenanthrenes
5-methoxytryptamine[no description available]medium20aromatic ether;
primary amino compound;
tryptamines		5-hydroxytryptamine 2A receptor agonist;
5-hydroxytryptamine 2B receptor agonist;
5-hydroxytryptamine 2C receptor agonist;
antioxidant;
cardioprotective agent;
human metabolite;
mouse metabolite;
neuroprotective agent;
radiation protective agent;
serotonergic agonist
diphenylhexatriene[no description available]medium10alkatrienefluorochrome
hydrocortisone acetate[no description available]medium10cortisol ester;
tertiary alpha-hydroxy ketone
piperidine[no description available]medium10azacycloalkane;
piperidines;
saturated organic heteromonocyclic parent;
secondary amine		base;
catalyst;
human metabolite;
non-polar solvent;
plant metabolite;
protic solvent;
reagent
salsolinol[no description available]medium101-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diolhuman urinary metabolite
neuromedin n[no description available]medium10
durapatite[no description available]medium10
vasoactive intestinal peptide[no description available]medium10
nickel chloride[no description available]medium10nickel coordination entitycalcium channel blocker;
hapten
racemetirosine[no description available]medium10
4-chloro-7-nitrobenzofurazan[no description available]medium20benzoxadiazole;
C-nitro compound;
organochlorine compound		EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.6.1.3 (adenosinetriphosphatase) inhibitor;
fluorescent probe;
fluorochrome
gallopamil[no description available]medium10benzenes;
organic amino compound
dihydroxyphenylalanine[no description available]medium10hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative		human metabolite
dynorphins[no description available]medium10
dynorphin (1-8)[no description available]medium10
preproenkephalin[no description available]medium10
n-formylnorleucyl-leucyl-4-phenylalanine[no description available]medium10
k-strophanthin-beta[no description available]medium10cardenolide glycoside;
steroid aldehyde
pantothenic acid[no description available]medium10pantothenic acid;
vitamin B5		antidote to curare poisoning;
geroprotector;
human blood serum metabolite
azimexon[no description available]medium10
ubenimex[no description available]medium10
dicarbine[no description available]medium10
butyroxan[no description available]medium10
proroxan[no description available]medium10
cyproheptadine[no description available]medium10piperidines;
tertiary amine		anti-allergic agent;
antipruritic drug;
gastrointestinal drug;
H1-receptor antagonist;
serotonergic antagonist
dithioerythritol[no description available]medium101,4-dimercaptobutane-2,3-diolreducing agent
hyaluronoglucosaminidase[no description available]medium10
argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-[no description available]medium10
dimethonium[no description available]medium10
amitrole[no description available]medium10aromatic amine;
triazoles		carotenoid biosynthesis inhibitor;
EC 1.11.1.6 (catalase) inhibitor;
herbicide
acetaldehyde[no description available]medium10aldehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
dextrorphan[no description available]medium10morphinane alkaloid
levorphanol[no description available]medium10morphinane alkaloid
cpp 199[no description available]medium10
zimeldine[no description available]medium10styrenes
u 0521[no description available]medium10acetophenones
pargyline[no description available]medium10aromatic amine
trimethyltin chloride[no description available]medium10
disulfoton[no description available]medium10organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
trimethoprim, sulfamethoxazole drug combination[no description available]medium10
sulfamethoxazole[no description available]medium10isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
orabase[no description available]medium10
moxalactam[no description available]medium10cephalosporin;
oxacephem		antibacterial drug
mersalyl[no description available]medium10
carnitine[no description available]medium10amino-acid betainehuman metabolite;
mouse metabolite
2,4-dinitrophenol[no description available]medium10dinitrophenolallergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor
triiodothyronine, reverse[no description available]medium103,3',5'-triiodothyronine;
amino acid zwitterion
bilirubin[no description available]medium10biladienes;
dicarboxylic acid		antioxidant;
human metabolite;
mouse metabolite
sulfobromophthalein[no description available]medium102-benzofurans;
organobromine compound;
organosulfonic acid;
phenols		dye
quin2-acetoxymethyl ester[no description available]medium10
nigericin[no description available]medium10polycyclic etherantibacterial agent;
antimicrobial agent;
bacterial metabolite;
potassium ionophore
carbonyl cyanide m-chlorophenyl hydrazone[no description available]medium10hydrazone;
monochlorobenzenes;
nitrile		antibacterial agent;
geroprotector;
ionophore
quin2[no description available]medium10
digitonin[no description available]medium10
pica[no description available]medium50
humulene[no description available]medium10alpha-humulene
s,n,n'-tripropylthiocarbamate[no description available]medium360tertiary amine
vendex[no description available]medium20organotin acaricide
eye[no description available]medium70
fomesafen[no description available]medium70aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols		agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
fusarium[no description available]medium20
salicylic acid[no description available]medium20monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
iodinated glycerol[no description available]medium10dioxolane
nociceptin[no description available]medium20organic molecular entity;
polypeptide		human metabolite;
rat metabolite
rome[no description available]medium102-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-olEC 2.7.1.91 (sphingosine kinase) inhibitor
isoniazid[no description available]medium40carbohydrazideantitubercular agent;
drug allergen
isomethyleugenol[no description available]medium10isomethyleugenol
propiconazole[no description available]medium10conazole fungicide;
cyclic ketal;
dichlorobenzene;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
valproate[no description available]low00branched-chain saturated fatty acid anionantimanic drug
oxaloacetic acid[no description available]low00C4-dicarboxylic acid;
oxo dicarboxylic acid		geroprotector;
metabolite
n-(3-(aminomethyl)benzyl)acetamidine[no description available]low00aralkylamine;
carboxamidine;
primary amino compound		angiogenesis inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector
cgp 52411[no description available]low00phthalimidesgeroprotector;
tyrosine kinase inhibitor
acetaminophen[no description available]low00acetamides;
phenols		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
ag 1295[no description available]low00quinoxaline derivativegeroprotector
berberine[no description available]low00alkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound		antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
buformin[no description available]low00biguanidesantineoplastic agent;
antiviral agent;
geroprotector;
hypoglycemic agent;
radiosensitizing agent
ethoxyquin[no description available]low00aromatic ether;
quinolines		antifungal agrochemical;
food antioxidant;
genotoxin;
geroprotector;
herbicide;
Hsp90 inhibitor;
neuroprotective agent;
UDP-glucuronosyltransferase activator
carbonyl cyanide p-trifluoromethoxyphenylhydrazone[no description available]low00aromatic ether;
hydrazone;
nitrile;
organofluorine compound		ATP synthase inhibitor;
geroprotector;
ionophore
fasudil[no description available]low00isoquinolines;
N-sulfonyldiazepane		antihypertensive agent;
calcium channel blocker;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
geroprotector;
neuroprotective agent;
nootropic agent;
vasodilator agent
metoprolol[no description available]low00aromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound		antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
resveratrol[no description available]low00polyphenol;
resorcinols;
stilbenol		antioxidant;
geroprotector;
glioma-associated oncogene inhibitor;
phytoalexin
4-phenylbutyric acid, sodium salt[no description available]low00organic sodium saltEC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector;
neuroprotective agent;
orphan drug;
prodrug
trimethadione[no description available]low00oxazolidinoneanticonvulsant;
geroprotector
nad[no description available]low00NADgeroprotector
dimethylnitrosamine[no description available]low00nitrosaminegeroprotector;
mutagen
phenformin[no description available]low00biguanidesantineoplastic agent;
geroprotector;
hypoglycemic agent
lithocholic acid[no description available]low00bile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid		geroprotector;
human metabolite;
mouse metabolite
naphthazarin[no description available]low00hydroxy-1,4-naphthoquinoneacaricide;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
geroprotector;
plant metabolite
4-hydroxyphenylethanol[no description available]low00phenolsanti-arrhythmia drug;
antioxidant;
cardiovascular drug;
fungal metabolite;
geroprotector;
plant metabolite;
protective agent
dibromoacetic acid[no description available]low002-bromocarboxylic acid;
monocarboxylic acid		apoptosis inducer;
geroprotector;
marine metabolite
2-(2'-hydroxyphenyl)benzoxazole[no description available]low001,3-benzoxazoles;
phenols		geroprotector
ethidium bromide[no description available]low00organic bromide saltgeroprotector;
intercalator;
trypanocidal drug
thioflavin t[no description available]low00organic chloride saltfluorochrome;
geroprotector;
histological dye
2-(2-hydroxyphenyl)benzothiazole[no description available]low00benzothiazoles;
phenols		geroprotector
butylated hydroxytoluene[no description available]low00phenolsantioxidant;
ferroptosis inhibitor;
food additive;
geroprotector
bezafibrate[no description available]low00aromatic ether;
monocarboxylic acid amide;
monocarboxylic acid;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
acarbose[no description available]low00tetrasaccharide derivativeEC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
geroprotector;
hypoglycemic agent
simvastatin[no description available]low00delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)		EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
ursolic acid[no description available]low00hydroxy monocarboxylic acid;
pentacyclic triterpenoid		geroprotector;
plant metabolite
epigallocatechin gallate[no description available]low00flavans;
gallate ester;
polyphenol		antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose[no description available]low00gallate ester;
galloyl beta-D-glucose		anti-inflammatory agent;
antineoplastic agent;
geroprotector;
hepatoprotective agent;
plant metabolite;
radiation protective agent;
radical scavenger
alfatradiol[no description available]low0017alpha-hydroxy steroid;
3-hydroxy steroid;
estradiol		estrogen;
geroprotector
amperozide[no description available]low00diarylmethane;
monofluorobenzenes;
N-alkylpiperazine;
secondary carboxamide;
ureas		anxiolytic drug;
dopamine uptake inhibitor;
geroprotector;
second generation antipsychotic;
serotonergic antagonist
2-(1H-benzimidazol-2-yl)aniline[no description available]low00benzimidazoles;
primary arylamine;
substituted aniline		geroprotector
thiazolidine-4-carboxylic acid, (r)-isomer[no description available]low00thiazolidinemonocarboxylic acid;
thioproline		geroprotector;
metabolite
paxilline[no description available]low00diterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol		anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
nitroflurbiprofen[no description available]low00biphenyls;
carboxylic ester;
nitrate ester;
organofluorine compound		cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector;
non-steroidal anti-inflammatory drug;
vasodilator agent
oxoline[no description available]low00aromatic ketone;
tetralins		geroprotector
latrepirdine[no description available]low00methylpyridines;
pyridoindole		geroprotector
glucosamine[no description available]low00D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
carnosine[no description available]low00amino acid zwitterion;
dipeptide		anticonvulsant;
antineoplastic agent;
antioxidant;
Daphnia magna metabolite;
geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent
theanine[no description available]low00amino acid zwitterion;
N(5)-alkyl-L-glutamine		geroprotector;
neuroprotective agent;
plant metabolite
nicotinamide-beta-riboside[no description available]low00N-glycosylnicotinamide;
pyridine nucleoside		geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
kanamycin sulfate[no description available]low00aminoglycoside sulfate saltantibacterial drug;
geroprotector
glaucarubinone[no description available]low00carboxylic ester;
organic heteropentacyclic compound;
quassinoid;
secondary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone;
tetrol		antimalarial;
antineoplastic agent;
geroprotector;
plant metabolite
fumaric acid[no description available]low00butenedioic acidfood acidity regulator;
fundamental metabolite;
geroprotector
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene[no description available]low00C-nitro compound;
sulfonamide;
toluenes		bone density conservation agent;
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor;
geroprotector
sodium butyrate[no description available]low00organic sodium saltEC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
quercetin 3-o-glucopyranoside[no description available]low00beta-D-glucoside;
monosaccharide derivative;
quercetin O-glucoside;
tetrahydroxyflavone		antineoplastic agent;
antioxidant;
antipruritic drug;
bone density conservation agent;
geroprotector;
histamine antagonist;
osteogenesis regulator;
plant metabolite
kaempferol[no description available]low007-hydroxyflavonol;
flavonols;
tetrahydroxyflavone		antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
butein[no description available]low00chalcones;
polyphenol		antineoplastic agent;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
geroprotector;
hypoglycemic agent;
plant metabolite;
radiosensitizing agent;
tyrosine kinase inhibitor
baicalein[no description available]low00trihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
fisetin[no description available]low003'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite
polydatin[no description available]low00beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		anti-arrhythmia drug;
antioxidant;
geroprotector;
hepatoprotective agent;
metabolite;
nephroprotective agent;
potassium channel modulator
chicoric acid[no description available]low00organooxygen compoundgeroprotector;
HIV-1 integrase inhibitor
rosmarinic acid[no description available]low00rosmarinic acidgeroprotector;
plant metabolite
ellagic acid[no description available]low00catechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol		antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
10-hydroxy-2-decenoic acid[no description available]low00alpha,beta-unsaturated monocarboxylic acid;
hydroxy monounsaturated fatty acid;
omega-hydroxy-medium-chain fatty acid;
straight-chain fatty acid		animal metabolite;
geroprotector
methyl 2,5-dihydroxycinnamate[no description available]low00cinnamate ester;
hydroquinones;
methyl ester		EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
geroprotector;
human urinary metabolite;
plant metabolite
enalapril[no description available]low00dicarboxylic acid monoester;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one[no description available]low00coumarinsgeroprotector
everolimus[no description available]low00cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
primary alcohol;
secondary alcohol		anticoronaviral agent;
antineoplastic agent;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
l 744832[no description available]low00benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol		antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
5-(4-phenylbutoxy)psoralen[no description available]low00aromatic ether;
benzenes;
psoralens		geroprotector;
immunosuppressive agent;
potassium channel blocker
3,3-diethyl-2-pyrrolidinone[no description available]low00pyrrolidin-2-onesanticonvulsant;
geroprotector
n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride[no description available]low00hydrochloridegeroprotector;
metabotropic glutamate receptor agonist;
neuroprotective agent
trametinib[no description available]low00acetamides;
aromatic amine;
cyclopropanes;
organofluorine compound;
organoiodine compound;
pyridopyrimidine;
ring assembly		anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
4-(1-((5-((2,6-dimethylphenoxy)methyl)-3-isoxazolyl)carbonyl)-4-piperidinyl)pyridine[no description available]low00aromatic amide;
aromatic ether;
isoxazoles;
N-acylpiperidine;
pyridines		geroprotector;
P450 inhibitor
chromium tripicolinate[no description available]low00chromium coordination entityanti-obesity agent;
geroprotector;
hypoglycemic agent;
nutraceutical
didanosine[no description available]low00purine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor;
geroprotector;
HIV-1 reverse transcriptase inhibitor
lead chloride[no description available]low00inorganic chloride;
lead coordination entity
silver chloride[no description available]low00inorganic chloride;
silver salt
antimony trichloride[no description available]low00antimony molecular entity;
inorganic chloride		apoptosis inducer;
colorimetric reagent;
Lewis acid
zirconium chloride[no description available]low00inorganic chloride;
zirconium coordination entity		catalyst
manganese chloride[no description available]low00hydrate;
inorganic chloride;
manganese coordination entity		MRI contrast agent;
nutraceutical
cobaltous chloride[no description available]low00cobalt salt;
inorganic chloride		allergen;
calcium channel blocker;
sensitiser;
two-colour indicator
mercuric chloride, ammoniated[no description available]low00inorganic chloride;
transition element molecular entity
ytterbium trichloride[no description available]low00inorganic chlorideNMR shift reagent
ConditionIndicatedRelationship StrengthStudiesTrials
2019 Novel Coronavirus Disease0low10
2019 Novel Coronavirus Infection0low10
2019-nCoV Disease0low10
2019-nCoV Infection0low10
Abdominal Aortic Aneurysm0low10
Abdominal Pain0low10
Abnormalities, Autosome0low20
Abnormalities, Chromosomal0low20
Abnormalities, Chromosome0low20
Abnormalities, Congenital, Nervous System0low10
Abnormalities, Drug-Induced0low40
Abnormalities, Multiple0low10
Abnormalities, Nervous System0low10
Abnormality, Heart0low20
Abscess, Hepatic0low10
Absence of Brain, Congenital0low10
Absence Seizure0low630
Absence Seizures0low630
Absence Status0low1000
Academic Disorder, Developmental0low70
Ache0low70
Acidosis0low10
Acidosis, Renal Tubular0low20
Acidosis, Renal Tubular, Type I0low20
Acidosis, Renal Tubular, Type II0low20
Acoustic Neurinoma, Bilateral0low10
Acoustic Schwannomas, Bilateral0low10
Acoustic Trauma0low10
Acquired Nephrogenic Diabetes Insipidus0low140
Actinobacillus Infections0low10
Action Tremor0medium41
Acute Brain Injuries0low90
Acute Confusional Senile Dementia0medium301
Acute Disease0medium92
Acute Kidney Failure0low40
Acute Kidney Injury0low40
Acute Kidney Insufficiency0low40
Acute Liver Injury, Drug-Induced0low40
Acute Lung Injury0low10
Acute Myelogenous Leukemia0low40
Acute Myeloid Leukemia0low40
Acute Myeloid Leukemia with Maturation0low40
Acute Myeloid Leukemia without Maturation0low40
Acute Post-Traumatic Stress Disorder0low10
Acute Promyelocytic Leukemia0low70
Acute Renal Failure0low40
Acute Renal Injury0low40
Acute Renal Insufficiency0low40
Acute-Phase Reaction0low10
Acute-Phase State0low10
ACY2 Deficiency0low10
ADDH0medium41
Adenocarcinoma0low80
Adenocarcinoma of Lung0low10
Adenocarcinoma, Basal Cell0low80
Adenocarcinoma, Granular Cell0low80
Adenocarcinoma, Oxyphilic0low80
Adenocarcinoma, Tubular0low80
Adenoma0low20
Adenoma, Basal Cell0low20
Adenoma, beta-Cell0low10
Adenoma, Follicular0low20
Adenoma, Malignant0low80
Adenoma, Microcystic0low20
Adenoma, Monomorphic0low20
Adenoma, Papillary0low20
Adenoma, Trabecular0low20
Adenomatous Polyposis Coli0low10
Adenomatous Polyposis Coli, Familial0low10
Adenomatous Polyposis of the Colon0low10
ADH-Resistant Diabetes Insipidus0low140
Adipocere0low10
Adjuvant Arthritis0low30
Adrenal Cancer0low70
Adrenal Gland Cancer0low70
Adrenal Gland Neoplasms0low70
Adrenal Neoplasm0low70
Adult Fanconi Syndrome0low10
Adult Learning Disabilities0low70
Adult Learning Disorders0low70
Adult Neuronal Ceroid Lipofuscinosis0low10
Adult Spinal Muscular Atrophy0low10
Adult-Onset Spinal Muscular Atrophy0low10
Adverse Drug Event0medium21
Adverse Drug Reaction0medium21
Affective Disorders0medium101
Affective Disorders, Psychotic0medium32
Affective Psychosis, Bipolar0medium17121
African Sleeping Sickness0low20
African Trypanosomiasis0low20
Age-Related Memory Disorders0low170
Age-Related Osteoporosis0low30
Aggression0medium122
Aging0low460
Agitation, Psychomotor0low20
Agranulocytosis0low30
AIDS-Related Complex0low10
Air Sickness0low30
Airflow Obstruction, Chronic0low10
Airsickness0low30
Airway Hyper-Responsiveness0low10
Akathisia0low20
Akinetic-Rigid Variant of Huntington Disease0low80
Albinism0low10
Albuminuria0low20
Alcohol Abuse0medium41
Alcohol Addiction0medium41
Alcohol Dependence0medium41
Alcohol Drinking0low170
Alcohol Problem0low10
Alcohol Related Neurodevelopmental Disorder0low10
Alcohol Use Disorder0medium41
Alcohol-Related Birth Defects0low10
Alcohol-Related Disorders0low10
Alcoholic Intoxication0low20
Alcoholic Intoxication, Chronic0medium41
Alcoholism0medium41
Algor Mortis0low10
Allergic Encephalomyelitis0low10
Allergic Encephalomyelitis, Experimental0low10
Allergy, Drug0low20
Allodynia0low70
Allodynia, Mechanical0low70
Allodynia, Tactile0low70
Allodynia, Thermal0low70
Allotriophagy0low50
Alloxan Diabetes0low70
Alopecia0medium21
Alopecia Cicatrisata0medium21
Alopecia, Androgenetic0medium21
Alopecia, Male Pattern0medium21
ALS - Amyotrophic Lateral Sclerosis0low60
Alveolar Bone Atrophy0low20
Alveolar Bone Loss0low20
Alveolar Process Atrophy0low20
Alveolar Resorption0low20
Alzheimer Dementia0medium301
Alzheimer Disease0medium301
Alzheimer Disease, Early Onset0medium301
Alzheimer Disease, Late Onset0medium301
Alzheimer Sclerosis0medium301
Alzheimer Syndrome0medium301
Alzheimer Type Senile Dementia0medium301
Alzheimer-Type Dementia (ATD)0medium301
Alzheimer's Disease0medium301
Alzheimer's Disease, Focal Onset0medium301
Alzheimer's Diseases0medium301
Amaurotic Idiocy, Adult Type0low10
Ambiguous Genitalia0low10
Ameloblastoma0low10
Amentia0low20
Aminoacylase 2 Deficiency0low10
AML M30low70
Amnesia0low40
Amnesia-Memory Loss0low40
Amnesia, Dissociative0low40
Amnesia, Global0low40
Amnesia, Hysterical0low40
Amnesia, Tactile0low40
Amnesia, Temporary0low40
Amnestic State0low40
Amphetamine Abuse0low10
Amphetamine Addiction0low10
Amphetamine Dependence0low10
Amphetamine-Related Disorders0low10
Amyloid Deposits0low10
Amyloid Plaques0low10
Amyotrophic Lateral Sclerosis0low60
Amyotrophic Lateral Sclerosis With Dementia0low60
Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 10low60
Amyotrophic Lateral Sclerosis, Guam Form0low60
Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam0low60
Amyotrophy, Neurogenic Scapuloperoneal, New England Type0low10
Anaphylactic Reaction0low10
Anaphylactoid Reaction0low10
Anaphylactoid Shock0low10
Anaphylaxis0low10
Anaplastic Astrocytoma0low40
Androgenetic Alopecia0medium21
Androgenic Alopecia0medium21
Anemia, Aplastic0low10
Anemia, Congenital Hypoplastic, Of Blackfan And Diamond0low10
Anemia, Diamond-Blackfan0low10
Anemia, Diamond-Blackfan Type0low10
Anemia, Fanconi0low10
Anemia, Hypoplastic0low10
Anencephalia0low10
Anencephalus0low10
Anencephaly0low10
Anesthesia0low100
Aneuploid0low10
Aneuploid Cell0low10
Aneuploidy0low10
Aneurysm, Abdominal Aortic0low10
Angiogenesis, Pathologic0low10
Angiogenesis, Pathological0low10
Ankylosing Spondylarthritis0low10
Ankylosing Spondylitis0low10
Ankylosing Spondyloarthritis0low10
ANLL0low40
Anochlesia0low30
Anomalies, Nervous System0low10
Anorexia0low110
Anorexia Nervosa0low10
Anoxemia0low110
Anoxia0low110
Anoxia-Ischemia, Brain0low40
Anoxia-Ischemia, Cerebral0low40
Anoxia, Brain0low10
Anoxia, Cerebral0low10
Anoxic Brain Damage0low10
Anoxic Encephalopathy0low10
Anoxic-Ischemic Encephalopathy0low40
Anterior Cerebral Circulation Infarction0low10
Anterior Circulation Brain Infarction0low10
Anterior Circulation Infarction, Brain0low10
Anterior Circulation Transient Ischemic Attack0low50
Anterior Fascicular Block0low10
Antibody Deficiency Syndrome0low20
Anticipatory Vomiting0low90
Antidiuretic Hormone, Inappropriate Secretion0low10
Anxiety0low100
Anxiety Disorders0low30
Anxiety Neuroses0low30
Anxiety States, Neurotic0low30
Aortic Aneurysm, Abdominal0low10
Aplastic Anaemia0low10
Aplastic Anemia0low10
Apoplexy0low20
Appetite Disorders0low30
Aprosencephaly0low10
Arachnoidal Cerebellar Sarcoma, Circumscribed0low20
ARC0low10
Argentaffinoma0low10
Arrhythmia0low60
Arrhythmias, Cardiac0low60
Arrythmia0low60
Arterial Diseases, Carotid0low30
Arterial Diseases, Common Carotid0low30
Arterial Diseases, External Carotid0low30
Arterial Diseases, Internal Carotid0low30
Arthritis, Adjuvant0low30
Arthritis, Adjuvant-Induced0low30
Arthritis, Collagen-Induced0low30
Arthritis, Degenerative0low80
Arthritis, Experimental0low30
Arthritis, Rheumatoid0low10
Arthroses0low80
Arthrosis0low80
Aseptic Necrosis of Bone0low10
Aseptic Necrosis of Femur Head0low40
ASP Deficiency0low10
ASPA Deficiency0low10
Aspartoacylase Deficiency0low10
Aspergillosis0low10
Aspergillus Infection0low10
Asthma0low20
Asthma, Bronchial0low20
Astrocytoma0low40
Astrocytoma, Grade I0low40
Astrocytoma, Grade II0low40
Astrocytoma, Grade III0low40
Astrocytoma, Grade IV0low60
Astrocytoma, Protoplasmic0low40
Astrocytoma, Subependymal Giant Cell0low40
Astrocytosis0low40
Astroglioma0low40
Astrogliosis0low40
Atheroma0low10
Atheromatous Plaque0low10
Atheromatous Plaques0low10
Atherosclerotic Disease, Carotid0low30
Atherosclerotic Parkinsonism0low10
Atherosclerotic Plaque0low10
Atherosclerotic Plaques0low10
Athetoid Movements0low10
Athetosis0low10
ATLL0low10
Atonic Absence Seizure0low630
Atonic Absence Seizures0low630
Atonic Seizure0low630
Atonic Seizures0low630
Atrial Septal Defect0low10
Atrial Septal Defect Ostium Primum0low10
Atrial Septal Defects0low10
Atrioventricular Nodal Re-Entrant Tachycardia0low10
Atrioventricular Reentrant Tachycardia0low10
Atrophy0low10
Atrophy, Muscle0low30
Attention Deficit and Disruptive Behavior Disorders0low10
Attention Deficit and Disruptive Behavioral Disorders0low10
Attention Deficit Disorder0medium41
Attention Deficit Disorder with Hyperactivity0medium41
Attention Deficit Disorders with Hyperactivity0medium41
Attention Deficit Hyperactivity Disorder0medium41
Attention Deficit Hyperactivity Disorders0medium41
Attention Deficit-Hyperactivity Disorder0medium41
Atypical Cluster Headache0low20
Atypical Endometrial Hyperplasia0low10
Aujeszky Disease0low10
Aujeszky's Disease0low10
Aura0low320
Autoimmune Diabetes0low10
Autoimmune Disease0low20
Autoimmune Diseases0low20
Autoimmune Encephalomyelitis, Experimental0low10
Autoimmune Experimental Encephalomyelitis0low10
Autolysis0low10
Autosomal Dominant Cerebellar Ataxia, Type II0low10
Autosomal Dominant Distal Renal Tubular Acidosis0low20
Autosomal Dominant Juvenile Parkinson Disease0low10
Autosomal Dominant Juvenile Parkinsonism0low10
Autosomal Dominant Parkinsonism0low10
Autosomal Dominant Striatonigral Degeneration0low20
Autosomal Recessive Juvenile Parkinson Disease0low10
Autosomal Recessive Juvenile Parkinsonism0low10
Autosomal Recessive Parkinsonism0low10
Autosome Abnormalities0low20
Avascular Necrosis of Bone0low10
Avascular Necrosis Of Femoral Head, Primary0low40
Avascular Necrosis of Femur Head0low40
Avian Diseases0low10
Awakening Epilepsy0low320
Azorean Ataxia0low20
Azorean Disease0low20
Azorean Disease (Machado-Joseph)0low20
Azorean Disease, Nervous System0low20
Azorean Neurologic Disease0low20
B16 Melanoma0low30
Baldness0medium21
Baldness, Male Pattern0medium21
Basophilic Leukemia, Acute0low10
Batten Disease0low10
Batten-Mayou Disease0low10
Batten-Spielmeyer-Vogt Disease0low10
Bechterew Disease0low10
Bechterew's Disease0low10
Behavior Disorders0medium81
Benign Cerebellar Neoplasms0low10
Benign Neoplasms0low90
Benign Neoplasms, Brain0low90
Benign Psychomotor Epilepsy, Childhood0low260
beta-Cell Tumor0low10
Bilateral Acoustic Neurofibromatosis0low10
Binge-Eating Disorder0low10
Bipolar Disorder0medium17121
Bipolar Mood Disorder0medium17121
Bird Diseases0low10
Birth Weight0low20
Blackfan Diamond Anemia0low10
Blackfan-Diamond Disease0low10
Blackfan-Diamond Syndrome0low10
Bladder Cancer0low20
Bladder Neoplasms0low20
Bladder Tumors0low20
Bleeding0low10
Bleeding Between Periods0low10
Blood Poisoning0low20
Blood Pressure, High0low110
Bloodstream Infection0low20
Body Weight0medium722
Bone Diseases0low10
Bone Fractures0low10
Bone Loss, Age-Related0low30
Bone Loss, Alveolar0low20
Bone Loss, Osteoclastic0low10
Bone Loss, Periodontal0low20
Bone Necrosis0low10
Bone Resorption0low10
Bovine Diseases0low30
Brain Anoxia0low10
Brain Anoxia-Ischemia0low40
Brain Cancer0low90
Brain Damage, Chronic0low30
Brain Diseases0low60
Brain Disorders0low60
Brain Dysfunction, Minimal0medium41
Brain Edema0low20
Brain Emboli0low10
Brain Embolism0low10
Brain Hemorrhage, Cerebral0low40
Brain Hypoxia0low10
Brain Hypoxia-Ischemia0low40
Brain Infarct0low10
Brain Infarction0low10
Brain Infarction, Anterior Circulation0low10
Brain Infarction, Posterior Circulation0low10
Brain Infarction, Venous0low10
Brain Inflammation0low40
Brain Injuries0low90
Brain Injuries, Acute0low90
Brain Injuries, Focal0low90
Brain Injuries, Traumatic0low30
Brain Ischemia0low100
Brain Ischemia-Anoxia0low40
Brain Ischemia-Hypoxia0low40
Brain Lacerations0low90
Brain Metastases0low90
Brain Neoplasm, Primary0low90
Brain Neoplasms0low90
Brain Neoplasms, Benign0low90
Brain Neoplasms, Malignant0low90
Brain Neoplasms, Malignant, Primary0low90
Brain Neoplasms, Primary Malignant0low90
Brain Stem Ischemia, Transient0low50
Brain Stem Transient Ischemic Attack0low50
Brain Swelling0low20
Brain TIA0low50
Brain Tumor, Primary0low90
Brain Tumor, Recurrent0low90
Brain Tumors0low90
Brain Vascular Disorders0low10
Brainstem Ischemia, Transient0low50
Brainstem Transient Ischemic Attack0low50
Breakthrough Bleeding0low10
Breast Cancer0low130
Breast Carcinoma0low130
Breast Neoplasms0low130
Breast Tumors0low130
Broken Bones0low10
Bronchial Asthma0low20
Bruise0low10
Bulbospinal Neuronopathy0low10
Bulimia Nervosa0low10
Bundle Branch Block0low10
Bundle-Branch Block0low10
Burkholderia pseudomallei Infection0low20
Burns0low30
Cachexia0low10
Calcification of Posterior Longitudinal Ligament0low10
Calcification, Pathologic0low10
Calcinosis0low10
Calcinosis, Tumoral0low10
Caliciviridae Infections0low10
Calicivirus Infections0low10
Callous-Unemotional Traits0medium21
Canavan Disease0low10
Canavan Disease, Familial Form0low10
Canavan Disease, Infantile0low10
Canavan Disease, Juvenile0low10
Canavan Disease, Neonatal0low10
Canavan Disease, Sporadic Form0low10
Canavan Disease, Type I0low10
Canavan Disease, Type II0low10
Canavan Disease, Type III0low10
Canavan-van Bogaert-Bertrand Disease0low10
Cancer0low90
Cancer of Bladder0low20
Cancer of Brain0low90
Cancer of Breast0low130
Cancer of Cervix0low20
Cancer of Colon0low130
Cancer of Endometrium0low20
Cancer of Esophagus0low40
Cancer of Gastrointestinal Tract0low10
Cancer of Head0low20
Cancer of Head and Neck0low20
Cancer of Intestines0low10
Cancer of Kidney0low10
Cancer of Larynx0low10
Cancer of Liver0low50
Cancer of Lung0low80
Cancer of Mouth0low30
Cancer of Neck0low20
Cancer of Ovary0low60
Cancer of Pancreas0low30
Cancer of Pituitary0low50
Cancer of Prostate0low50
Cancer of Stomach0low100
Cancer of the Adrenal Gland0low70
Cancer of the Bladder0low20
Cancer of the Brain0low90
Cancer of the Breast0low130
Cancer of the Cervix0low20
Cancer of the Colon0low130
Cancer of the Endometrium0low20
Cancer of the Esophagus0low40
Cancer of the Gastrointestinal Tract0low10
Cancer of the Head0low20
Cancer of the Head and Neck0low20
Cancer of the Intestines0low10
Cancer of the Kidney0low10
Cancer of the Larynx0low10
Cancer of the Liver0low50
Cancer of the Lung0low80
Cancer of the Mouth0low30
Cancer of the Neck0low20
Cancer of the Ovary0low60
Cancer of the Pancreas0low30
Cancer of the Pituitary0low50
Cancer of the Prostate0low50
Cancer of the Stomach0low100
Cancer of the Thyroid0low40
Cancer of the Uterine Cervix0low20
Cancer of the Uterus0low10
Cancer of Thyroid0low40
Cancer of Uterus0low10
Cancer, Hepatocellular0low50
Candida Infection0low10
Candidiasis0low10
Canine Diseases0low10
Car Sickness0low30
Carbohydrate Metabolism, Inborn Error0low10
Carbohydrate Metabolism, Inborn Errors0low10
Carcinogenesis0low10
Carcinoid0low10
Carcinoid Tumor0low10
Carcinoid, Goblet Cell0low10
Carcinoma of Endometrium0low20
Carcinoma, Cribriform0low80
Carcinoma, Ductal, Pancreatic0low10
Carcinoma, Ehrlich Tumor0low20
Carcinoma, Embryonal0low10
Carcinoma, Epidermoid0low50
Carcinoma, Granular Cell0low80
Carcinoma, Hepatocellular0low60
Carcinoma, Medullary0low10
Carcinoma, Non-Small Cell Lung0low30
Carcinoma, Non-Small-Cell Lung0low30
Carcinoma, Pancreatic Ductal0low10
Carcinoma, Papillary0low10
Carcinoma, Planocellular0low50
Carcinoma, Squamous0low50
Carcinoma, Squamous Cell0low50
Carcinoma, Tubular0low80
Cardiac Arrhythmia0low60
Cardiac Arrhythmias0low60
Cardiac Complex, Premature0low10
Cardiac Complexes, Premature0low10
Cardiac Diseases0low40
Cardiac Disorders0low40
Cardiac Dysrhythmia0low60
Cardiac Failure0low10
Cardiac Hypertrophy0low20
Cardiac Output, High0low30
Cardiac Output, Low0low40
Cardiac Remodeling, Ventricular0low20
Cardiomegaly0low20
Cardiomyopathy, Congestive0low10
Cardiomyopathy, Dilated0low10
Cardiomyopathy, Dilated, 1a0low10
Cardiomyopathy, Dilated, Autosomal Recessive0low10
Cardiomyopathy, Dilated, CMD1A0low10
Cardiomyopathy, Dilated, LMNA0low10
Cardiomyopathy, Dilated, With Conduction Defect 10low10
Cardiomyopathy, Dilated, with Conduction Deffect10low10
Cardiomyopathy, Familial Idiopathic0low10
Cardiomyopathy, Idiopathic Dilated0low10
Cardiovascular Diseases0low10
Cardiovascular Stroke0low70
Carditis0low10
Caries, Dental0low10
Carious Dentin0low10
Carious Lesions0low10
Carotid Artery Diseases0low30
Carotid Artery Disorders0low30
Carotid Atherosclerosis0low30
Carotid Atherosclerotic Disease0low30
Carotid Circulation Transient Ischemic Attack0low50
Carsickness0low30
Cartilage Diseases0low10
Cat Diseases0low10
Catalepsy0low30
Cattle Diseases0low30
Cell Transformation, Neoplastic0low40
Cell Transformation, Viral0low20
Central Hypothyroidism0low40
Central Nervous System Disease0low10
Central Nervous System Diseases0low10
Central Nervous System Disorder0low10
Central Nervous System Disorders0low10
Central Nervous System Disorders, Intracranial0low60
Central Nervous System Intracranial Disorders0low60
Central Neurofibromatosis0low10
Centrala nervsystemets sjukdomar@sv0low10
Cerea Flexibilitas0low30
Cerebellar Cancer0low10
Cerebellar Degeneration with Slow Eye Movements0low10
Cerebellar Neoplasms0low10
Cerebellar Neoplasms, Benign0low10
Cerebellar Neoplasms, Malignant0low10
Cerebellar Neoplasms, Primary0low10
Cerebellar Tumors0low10
Cerebelloparenchymal Disorder I0low10
Cerebral Anoxia0low10
Cerebral Anoxia-Ischemia0low40
Cerebral Astrocytoma0low40
Cerebral Edema0low20
Cerebral Edema, Cytotoxic0low20
Cerebral Edema, Vasogenic0low20
Cerebral Emboli0low10
Cerebral Embolism0low10
Cerebral Hemorrhage0low40
Cerebral Hypoxia0low10
Cerebral Hypoxia-Ischemia0low40
Cerebral Infarction, Middle Cerebral Artery0low40
Cerebral Ischemia0low100
Cerebral Ischemia-Anoxia0low40
Cerebral Ischemia-Hypoxia0low40
Cerebral Ischemia, Transient0low50
Cerebral Parenchymal Hemorrhage0low40
Cerebral Pseudosclerosis0low20
Cerebral Stroke0low20
Cerebrovascular Accident0low20
Cerebrovascular Accident, Acute0low20
Cerebrovascular Apoplexy0low20
Cerebrovascular Diseases0low10
Cerebrovascular Disorders0low10
Cerebrovascular Insufficiency0low10
Cerebrovascular Occlusion0low10
Cerebrovascular Stroke0low20
Ceroid Lipofuscinosis, Neuronal 3, Juvenile0low10
Ceroid Lipofuscinosis, Neuronal 40low10
Ceroid Lipofuscinosis, Neuronal, 30low10
Ceroid Lipofuscinosis, Neuronal, 4A, Autosomal Recessive0low10
Ceroid Lipofuscinosis, Neuronal, 4B, Autosomal Dominant0low10
Ceroid Lipofuscinosis, Neuronal, Parry Type0low10
Ceroid Storage Disease0low10
Ceroid-Lipofuscinosis, Neuronal0low10
Cervical Cancer0low20
Cervical Neoplasms0low20
Cervix Cancer0low20
Cervix Neoplasms0low20
Charcot Disease0low60
Chemical and Drug Induced Liver Injury0low40
Chemical Dependence0low50
Chemically-Induced Liver Toxicity0low40
Chemo-Fog0low10
Chemobrain0low10
Chemotherapy-Induced Cognitive Dysfunction0low10
Chemotherapy-Induced Cognitive Impairment0low10
Chemotherapy-Induced Cognitive Impairments0low10
Chemotherapy-Related Cognitive Dysfunction0low10
Chemotherapy-Related Cognitive Impairment0low10
Chest Pain0low10
Childhood Benign Psychomotor Epilepsy0low260
Childhood Cerebral Astrocytoma0low40
Cholera Infantum0low40
Chondromalacia0low10
Chorea0low10
Chorea Disorders0low10
Chorea Syndromes0low10
Chorea, Benign Hereditary0low10
Chorea, Chronic Progressive0low10
Chorea, Chronic Progressive Hereditary (Huntington)0low80
Chorea, Rheumatic0low10
Chorea, Senile0low10
Chorea, Sydenham0low10
Choreatic Disorders0low10
Choreatic Syndromes0low10
Choreic Movement0low10
Choreiform Movement0low10
Choroby OUN@pl0low10
Chromosomal Aberrations0low20
Chromosomal Triplication0low10
Chromosome 6-Linked Autosomal Recessive Parkinsonism0low10
Chromosome Aberrations0low20
Chromosome Abnormalities0low20
Chromosome Deletion0low10
Chromosome-Defective Micronuclei0low10
Chronic Airflow Obstruction0low10
Chronic Cluster Headache0low20
Chronic Congenital Agenerative Anemia0low10
Chronic Disease0low120
Chronic Encephalopathy0low30
Chronic Illness0low120
Chronic Lung Injury0low10
Chronic Lymphocytic Thyroiditis0low10
Chronic Obstructive Airway Disease0low10
Chronic Obstructive Lung Disease0low10
Chronic Obstructive Pulmonary Disease0low10
Chronic Obstructive Pulmonary Diseases0low10
Chronic Post-Traumatic Stress Disorder0low10
Chronic Progressive Epilepsia Partialis Continua0low10
Chronic Progressive Hereditary Chorea (Huntington)0low80
Chronically Ill0low120
Chylopericardium0low10
Cicatrix0low10
Cicatrization0low10
Ciliary Dyskinesia, Primary, 10low10
Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus0low10
Ciliary Neuralgia0low20
Cirrhosis0low30
Cirrhosis, Liver0low20
CJD (Creutzfeldt-Jakob Disease)0low10
Classic Distal Renal Tubular Acidosis0low20
Claustrophobia0low10
Cleft Palate0low10
Cleft Palate, Isolated0low10
Clinically Isolated CNS Demyelinating Syndrome0low10
Clinically Isolated Syndrome, CNS Demyelinating0low10
CLN3-Related Neuronal Ceroid-Lipofuscinosis0low10
CLN4A0low10
CLN4B0low10
Clonic Seizure0low630
Clonic Seizures0low630
Clubfeet0low10
Clubfeet, Congenital0low10
Clubfoot0low10
Clubfoot, Congenital0low10
Cluster Headache0low20
Cluster Headache Syndrome0low20
CNS Disease0low10
CNS Diseases0low10
CNS Disorders, Intracranial0low60
COAD0low10
Coarse Tremor0medium41
Cocaine Abuse0low30
Cocaine Addiction0low30
Cocaine Dependence0low30
Cocaine-Related Disorders0low30
Cognition Disorders0medium141
Cognitive Decline0low60
Cognitive Dysfunction0low60
Cognitive Impairments0low60
Colicky Pain0low10
Colitis0low50
Collagen Arthritis0low30
Colon Cancer0low130
Colon Neoplasms0low130
Colonic Cancer0low130
Colonic Neoplasms0low130
Colorectal Cancer0low90
Colorectal Carcinoma0low90
Colorectal Neoplasms0low90
Colorectal Tumors0low90
Coma, Hyperglycemic Hyperosmolar Nonketotic0low10
Common Carotid Artery Diseases0low30
Complex Endometrial Hyperplasia0low10
Complex Partial Seizure0low630
Complex Partial Seizures0low630
Complex Partial Status Epilepticus0low1000
Complication, Postoperative0low30
Complications, Pregnancy0low10
Conduct Disorder0medium21
Congenital Abnormalities, Nervous System0low10
Congenital Absence of Brain0low10
Congenital Anomalies, Nervous System0low10
Congenital Erythroid Hypoplastic Anemia0low10
Congenital Heart Defect0low20
Congenital Heart Defects0low20
Congenital Heart Disease0low20
Congenital Hypoplastic Anemia of Blackfan and Diamond0low10
Congenital Limb Deformities0low20
Congenital Malformations, Nervous System0low10
Congenital Myasthenia0low10
Congenital Myasthenia Gravis0low10
Congenital Myasthenic Syndrome0low10
Congenital Myasthenic Syndromes0low10
Congenital Myasthenic Syndromes, Postsynaptic0low10
Congenital Myasthenic Syndromes, Presynaptic0low10
Congenital Nephrogenic Diabetes Insipidus0low140
Congenital Pure Red Cell Anemia0low10
Congenital Pure Red Cell Aplasia0low10
Congenital Slow-Channel Myasthenic Syndrome0low10
Congenital Slow-Channel Myasthenic Syndromes0low10
Congenital Talipes Equinovarus0low10
Congenital Zika Syndrome0low10
Congenital Zika Virus Infection0low10
Congestive Cardiomyopathy0low10
Congestive Heart Failure0low10
Conjugate Nystagmus0low10
Contact Dermatitis0low10
Continuous Tremor0medium41
Contracture0low10
Contusions0low10
Convergence Nystagmus0low10
Convulsion0low630
Convulsion, Non-Epileptic0low630
Convulsions0low630
Convulsive Seizure0low630
Convulsive Seizures0low630
COPD0low10
Copper Storage Disease0low20
Corneal Diseases0low10
Corneal Dystrophies0low20
Corneal Dystrophies, Hereditary0low20
Coronavirus Disease 20190low10
Coronavirus Disease-190low10
Coronavirus Infections0low20
COVID-190low10
COVID-19 Pandemic0low10
COVID-19 Pandemics0low10
COVID-19 Virus Disease0low10
COVID-19 Virus Infection0low10
COVID190low10
Coxsackie Virus Infections0low10
Coxsackievirus Infections0low10
Cranial Nerve II Injuries0low20
Cranioschisis0low10
Crescendo Transient Ischemic Attacks0low50
Creutzfeldt Jacob Disease0low10
Creutzfeldt-Jakob Disease0low10
Creutzfeldt-Jakob Disease, Familial0low10
Creutzfeldt-Jakob Disease, New Variant0low10
Creutzfeldt-Jakob Disease, Variant0low10
Creutzfeldt-Jakob Syndrome0low10
Cruor0low10
CVA (Cerebrovascular Accident)0low20
Cyclothymia0medium11
Cyclothymic Disorder0medium11
Cyclothymic Personality0medium11
Cystadenocarcinoma, Serous0low10
Cytogenetic Aberrations0low20
Cytogenetic Abnormalities0low20
Cytomegalovirus0low30
Cytotoxic Brain Edema0low20
Cytotoxic Cerebral Edema0low20
Darkness Tremor0medium41
De Toni-Debre-Fanconi Syndrome0low10
Deafness, Transitory0low10
Decay, Dental0low10
Decerebrate Posturing0low30
Decerebrate State0low30
Decorticate Rigidity0low30
Decorticate State0low30
Defects, Congenital Heart0low20
Deficiency Disease, Aspartoacylase0low10
Deficiency Syndrome, Immunologic0low20
Deficiency Syndromes, Antibody0low20
Deficiency Syndromes, Immunologic0low20
Deficiency, Glucosephosphatase0low20
Deficiency, Oxygen0low110
Deficiency, Thiamine0low10
Degenerative Disc Disease0low20
Degenerative Diseases, Central Nervous System0low110
Degenerative Diseases, Nervous System0low110
Degenerative Diseases, Neurologic0low110
Degenerative Diseases, Spinal Cord0low110
Degenerative Intervertebral Discs0low20
Degenerative Intervertebral Disks0low20
Degenerative Neurologic Diseases0low110
Degenerative Neurologic Disorders0low110
Deglutition Disorders0low10
Delayed Effects, Prenatal Exposure0low100
Delayed Hypersensitivity0low20
Delayed Onset Post-Traumatic Stress Disorder0low10
Dementia0low20
Dementia Praecox0medium143
Dementia With Amyotrophic Lateral Sclerosis0low60
Dementia, Alzheimer Type0medium301
Dementia, Presenile0medium301
Dementia, Primary Senile Degenerative0medium301
Dementia, Senile0medium301
Dementias, Transmissible0low20
Demyelinating Diseases0low10
Demyelinating Disorders0low10
Demyelination0low10
Dental Caries0low10
Dental Decay0low10
Dental White Spot0low10
Dental White Spots0low10
Depression0low270
Depression, Bipolar0medium17121
Depression, Endogenous0medium202
Depression, Involutional0medium43
Depression, Neurotic0medium202
Depression, Reactive, Psychotic0medium32
Depression, Unipolar0medium202
Depressive Disorder0medium202
Depressive Disorder, Major0medium43
Depressive Syndrome0medium202
Dermatitis Medicamentosa0low10
Dermatitis Venenata0low10
Dermatitis, Adverse Drug Reaction0low10
Dermatitis, Contact0low10
Developmental Academic Disability0low70
Developmental Academic Disorder0low70
Developmental Coordination Disorder0low10
Developmental Disabilities of Scholastic Skills0low70
Developmental Disorders of Scholastic Skills0low70
Developmental Psychomotor Disorders0low10
Dextrocardia, Bronchiectasis, and Sinusitis0low10
Di Guglielmo Disease0low40
Di Guglielmo's Disease0low40
Diabetes Insipidus0low60
Diabetes Insipidus Renalis0low140
Diabetes Insipidus, Nephrogenic0low140
Diabetes Insipidus, Nephrogenic, Autosomal0low140
Diabetes Insipidus, Nephrogenic, Type 10low140
Diabetes Insipidus, Nephrogenic, Type I0low140
Diabetes Insipidus, Nephrogenic, Type II0low140
Diabetes Insipidus, Nephrogenic, X-Linked0low140
Diabetes Mellitus, Adult-Onset0low40
Diabetes Mellitus, Brittle0low10
Diabetes Mellitus, Experimental0low70
Diabetes Mellitus, Insulin-Dependent0low10
Diabetes Mellitus, Insulin-Dependent, 10low10
Diabetes Mellitus, Juvenile-Onset0low10
Diabetes Mellitus, Ketosis-Prone0low10
Diabetes Mellitus, Ketosis-Resistant0low40
Diabetes Mellitus, Maturity-Onset0low40
Diabetes Mellitus, Non Insulin Dependent0low40
Diabetes Mellitus, Non-Insulin-Dependent0low40
Diabetes Mellitus, Noninsulin Dependent0low40
Diabetes Mellitus, Noninsulin-Dependent0low40
Diabetes Mellitus, Slow-Onset0low40
Diabetes Mellitus, Stable0low40
Diabetes Mellitus, Sudden-Onset0low10
Diabetes Mellitus, Type 10low10
Diabetes Mellitus, Type 20low40
Diabetes Mellitus, Type I0low10
Diabetes Mellitus, Type II0low40
Diabetes, Autoimmune0low10
Diabetic Glomerulosclerosis0low30
Diabetic Kidney Disease0low30
Diabetic Nephropathies0low30
Diabetic Nephropathy0low30
Diagnosis, Psychiatric0medium81
Diamond-Blackfan Anemia0low10
Diathesis0low60
Dilated Cardiomyopathy0low10
Disbacteriosis0low10
Disbiosis0low10
Disc Degeneration0low20
Disc Degradation0low20
Disease0low40
Disease Exacerbation0medium142
Disease Models, Animal0low2600
Disease Progression0medium142
Disease Resistance0low10
Disease Susceptibility0low60
Diseases in Twins0low10
Diseases, Metabolic0medium31
Disk Degeneration0low20
Disk Degradation0low20
Disomy, Uniparental0low10
Disorders of Sex Development0low10
Disorders of Sexual Development0low10
Disruptive Behavior Disorder0low10
Disruptive Behavioral Disorder0low10
Disruptive, Impulse Control, and Conduct Disorders0low20
Dissociated Nystagmus0low10
Distal Renal Tubular Acidosis0low20
Distal Spinal Muscular Atrophy0low10
Distorted Hearing0low10
Doenu00E7as do Sistema Nervoso Central@pt0low10
Dog Diseases0low10
Dominantly-Inherited Spinocerebellar Ataxias0low10
Drug Abuse0low50
Drug Addiction0low50
Drug Allergy0low20
Drug Dependence0low50
Drug Eruptions0low10
Drug Habituation0low50
Drug Hypersensitivity0low20
Drug Overdose0low30
Drug Refractory Epilepsy0low10
Drug Resistant Epilepsy0low10
Drug Side Effects0medium21
Drug Toxicity0medium21
Drug Use Disorders0low50
Drug Withdrawal Symptoms0low100
Drug-Induced Abnormalities0low40
Drug-Induced Acute Liver Injury0low40
Drug-Induced Liver Disease0low40
Drug-Induced Liver Injury0low40
Drug-Related Side Effects and Adverse Reactions0medium21
Drunkenness0low20
Duct-Cell Carcinoma of the Pancreas0low10
Duct-Cell Carcinoma, Pancreas0low10
Ductal Carcinoma of the Pancreas0low10
Duodenal Reflux0low10
Duodeno-Gastric Reflux0low10
Duodenogastric Reflux0low10
Dys-symbiosis0low10
Dysacusis0low10
Dysbacteriosis0low10
Dysbiosis0low10
Dysembryoma0low10
Dysfunctional Uterine Bleeding0low10
Dysgeusia0low40
Dyskinesia Syndromes0low20
Dyskinesia, Drug-Induced0low30
Dyskinesia, Medication-Induced0low30
Dyskinesias, Paroxysmal0low10
Dysphagia0low10
Ear Diseases0low10
Early Onset Alzheimer Disease0medium301
Eating and Feeding Disorders0low30
Eating Disorders0low30
Ectopic Heartbeats0low10
Ectopic Ossification0low10
Eczema, Contact0low10
Edema-Proteinuria-Hypertension Gestosis0low20
Edema, Pulmonary0low20
Edemas, Pulmonary0low20
Ehrlich Ascites Tumor0low20
EHS Tumor0low10
Electrolytes0low160
Embolic Infarction, Middle Cerebral Artery0low40
Embolism, Brain0low10
Embolism, Intracranial0low10
Embolus, Middle Cerebral Artery0low40
Emergencies0low10
Emesis0low220
Emphysema0low10
Encephalitis0low40
Encephalitis, Rasmussen0low40
Encephalomyelitis, Allergic0low10
Encephalomyelitis, Autoimmune, Experimental0low10
Encephalomyelitis, Experimental Autoimmune0low10
Encephalon Diseases0low60
Encephalopathies, Spongiform, Transmissible0low20
Encephalopathy0low60
Encephalopathy, Anoxic-Ischemic0low40
Encephalopathy, Chronic0low30
Encephalopathy, Hypoxic0low10
Encephalopathy, Hypoxic-Ischemic0low40
Encephalopathy, Ischemic0low100
Encephalopathy, Toxic0low80
Encephalopathy, Traumatic0low30
Endometrial Cancer0low20
Endometrial Carcinoma0low20
Endometrial Hyperplasia0low10
Endometrial Neoplasms0low20
Endometrium Cancer0low20
Endotoxemia0low10
Endotoxin Shock0low10
Enfermedades del Sistema Nervioso Central@es0low10
Enlarged Heart0low20
Enterovirus Infections0low10
EPH Complex0low20
EPH Gestosis0low20
EPH Toxemias0low20
Epidermal Cyst0low10
Epidermoid Cyst0low10
Epilepsia Partialis Continua0low10
Epilepsia Partialis Continua, Chronic Progressive0low10
Epilepsy0low320
Epilepsy, Benign Psychomotor, Childhood0low260
Epilepsy, Cryptogenic0low320
Epilepsy, Drug Refractory0low10
Epilepsy, Drug Resistant0low10
Epilepsy, Intractable0low10
Epilepsy, Lateral Temporal0low260
Epilepsy, Temporal Lobe0low260
Epilepsy, Uncinate0low260
Epileptic Seizure0low630
Epileptic Seizures0low630
Episodic Cluster Headache0low20
Equine Diseases0low20
Equinovarus0low10
ER-Negative PR-Negative HER2-Negative Breast Cancer0low20
ER-Negative PR-Negative HER2-Negative Breast Neoplasms0low20
Erectile Dysfunction0low10
Erythremic Myelosis0low40
Erythroblastic Leukemia, Acute0low40
Erythrogenesis Imperfecta0low10
Erythroleukemia0low40
Esophageal Cancer0low40
Esophageal Dysphagia0low10
Esophageal Neoplasms0low40
Esophageal Squamous Cell Carcinoma0low10
Esophagus Cancer0low40
Esophagus Neoplasm0low40
Etat Marbre0low20
Ethanol Abuse0medium41
Excitement, Psychomotor0low20
Experimental Allergic Encephalomyelitis0low10
Experimental Autoimmune Encephalomyelitis0low10
Experimental Diabetes Mellitus0low70
Experimental Hepatoma0low40
Experimental Hepatomas0low40
Experimental Leukemia0low30
Experimental Leukemias0low30
Experimental Liver Neoplasms0low40
Experimental Mammary Neoplasms0low20
Experimental Melanoma0low30
Experimental Melanomas0low30
Experimental Neoplasms0low50
Experimental Parkinson Disease0low10
Experimental Parkinsonism0low10
Experimental Parkinsonism, MPTP-Induced0low10
Experimental Pneumococcal Meningitis0low10
Experimental Sarcoma0low10
Experimental Sarcomas0low10
External Carotid Artery Diseases0low30
Extrasystole0low10
Extrasystoles0low10
Extravascular Hemolysis0low10
Eye Abnormalities0low20
Eye Cancer, Retinoblastoma0low10
FAE (Fetal Alcohol Effects)0low10
Familial Acoustic Neuromas0low10
Familial Adenomatous Polyposis0low10
Familial Adenomatous Polyposis Coli0low10
Familial Adenomatous Polyposis of the Colon0low10
Familial Alzheimer Disease (FAD)0medium301
Familial Creutzfeldt-Jakob Disease0low10
Familial Dementia0low20
Familial Form of Canavan Disease0low10
Familial Intestinal Polyposis0low10
Familial Juvenile Parkinsonism0low10
Familial Multiple Polyposi0low10
Familial Multiple Polyposis0low10
Familial Multiple Polyposis Syndrome0low10
Familial Parkinson Disease, Autosomal Recessive0low10
Familial Polyposis Coli0low10
Familial Polyposis of the Colon0low10
Familial Polyposis Syndrome0low10
Familial Retinoblastoma0low10
Fanconi Anemia0low10
Fanconi Bickel Syndrome0low10
Fanconi Hypoplastic Anemia0low10
Fanconi Pancytopenia0low10
Fanconi Panmyelopathy0low10
Fanconi Renotubular Syndrome0low10
Fanconi Syndrome0low10
Fanconi Syndrome with Intestinal Malabsorption and Galactose Intolerance0low10
Fanconi Syndrome without Cystinosis0low10
Fanconi-Bickel Syndrome0low10
Fanconi's Anemia0low10
Fascicular Block0low10
FASD0low10
Fasting Hypoglycemia0low30
Fatigable Positional Nystagmus0low10
Fatigue0low20
Fatty Liver0low10
Fatty Streak, Arterial0low10
Feeding and Eating Disorders0low30
Feeding Disorders0low30
Feline Diseases0low10
Female Pattern Baldness0medium21
Femoral Fractures0low10
Femoral Head, Avascular Necrosis Of0low40
Femur Head Necrosis0low40
Fetal Alcohol Spectrum Disorder0low10
Fetal Alcohol Spectrum Disorders0low10
Fetal Alcohol Syndrome0low10
Fetal Resorption0low10
Fever0low10
Fever, Zika0low10
Fibrillary Astrocytoma0low40
Fibroatheroma0low10
Fibroatheromatous Plaques0low10
Fibrosarcoma0low20
Fibrosis0low30
Fibrosis, Liver0low20
Fine Tremor0medium41
Flaccid Quadriplegia0low10
Flaccid Tetraplegia0low10
Flexibility, Waxy0low30
Focal Brain Injuries0low90
Focal Onset Alzheimer's Disease0medium301
Foot and Mouth Disease0low10
Foot-and-Mouth Disease0low10
Fra(X) Syndrome0low30
Fractures, Bone0low10
Fragile X Mental Retardation Syndrome0low30
Fragile X Syndrome0low30
Fragile X-F Mental Retardation Syndrome0low30
Francisella tularensis Infection0low10
FRAXA Syndrome0low30
FRAXE Syndrome0low30
Functional Gastrointestinal Disorders0low40
Gagging0low10
Gambling0low10
Gambling, Pathologic0low10
Gambling, Pathological0low10
Gastric Cancer0low100
Gastric Cancer, Familial Diffuse0low100
Gastric Diseases0low10
Gastric Neoplasms0low100
Gastric Ulcer0low20
Gastritis0low20
Gastroduodenal Ulcer0low10
Gastrointestinal Cancer0low10
Gastrointestinal Diseases0low40
Gastrointestinal Disorders0low40
Gastrointestinal Disorders, Functional0low40
Gastrointestinal Hemorrhage0low20
Gastrointestinal Neoplasms0low10
Gehrig's Disease0low60
Gemistocytic Astrocytoma0low40
Generalized Absence Seizure0low630
Generalized Absence Seizures0low630
Generalized Convulsive Status Epilepticus0low1000
Generalized Tonic-Clonic Seizures0low630
Genetic Predisposition0low60
Genetic Predisposition to Disease0low60
Genetic Susceptibility0low60
Genital Ambiguity0low10
Genome Instability0low10
Genome Stability0low10
Genomic Instability0low10
Genomic Stability0low10
Genotoxicant-Induced Micronuclei0low10
Geophagia0low50
Germinoblastoma0low40
Gestosis, EPH0low20
Giant Cell Glioblastoma0low60
Gierke Disease0low20
Gierke's Disease0low20
Glaucoma0low20
Glenoid Labral Tears0low10
Glial Cell Tumors0low130
Glial Scar0low40
Glioblastoma0low60
Glioblastoma Multiforme0low60
Glioblastoma, Retinal0low10
Glioma0low130
Glioma, Astrocytic0low40
Glioma, Retinal0low10
Gliosis0low40
Glomerulonephritis, Lupus0low10
Glomerulosclerosis, Diabetic0low30
Glucose-6-Phosphatase Deficiency0low20
Glucosephosphatase Deficiency0low20
Glycine Encephalopathy0low10
Glycogen Storage Disease 1 (GSD I)0low20
Glycogen Storage Disease Type I0low20
Glycogen Storage Disease XI0low10
Glycogenosis 10low20
Glycogenosis, Fanconi Type0low10
Glycosuria0low10
Goiter0low10
Gout0low10
Grand Mal Status Epilepticus0low1000
Granular Dystrophy, Corneal0low20
Granulocytic Leukemia0low30
Granulocytopenia0low30
Groenouw's Dystrophies0low20
Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction0low10
Guam Disease0low60
Guam Form of Amyotrophic Lateral Sclerosis0low60
Haemolysis0low10
Hair Loss0medium21
Hammond Disease0low10
Hammond's Disease0low10
Harding Passey Melanoma0low30
Hashimoto Disease0low10
Hashimoto Struma0low10
Hashimoto Thyroiditis0low10
Hashimoto's Disease0low10
Hashimoto's Struma0low10
Hashimoto's Syndrome0low10
Head and Neck Cancer0low20
Head and Neck Neoplasm0low20
Head and Neck Neoplasms0low20
Head Cancer0low20
Head Neoplasm0low20
Head Neoplasms0low20
Head, Neck Neoplasms0low20
Headache, Cluster0low20
Hearing Disorders0low10
Hearing Impairment0low10
Hearing Loss0low10
Hearing Loss, Noise-Induced0low10
Hearing Loss, Transitory0low10
Heart Abnormalities0low20
Heart Attack0low70
Heart Decompensation0low10
Heart Defect, Congenital0low20
Heart Defects, Congenital0low20
Heart Disease, Ischemic0low20
Heart Diseases0low40
Heart Disorders0low40
Heart Enlargement0low20
Heart Failure0low10
Heart Failure, Congestive0low10
Heart Failure, Left-Sided0low10
Heart Failure, Right-Sided0low10
Heart Hypertrophy0low20
Heart Septal Defects, Atrial0low10
Heart, Malformation Of0low20
Hematochezia0low20
Hematoma0low10
Hemicranial Anencephaly0low10
Hemolysis0low10
Hemopericardium0low10
Hemorrhage0low10
Hemorrhage, Cerebral0low40
Hemorrhage, Cerebrum0low40
Hemorrhage, Gastrointestinal0low20
Hepatic Cancer0low50
Hepatic Cirrhosis0low20
Hepatic Form of Wilson Disease0low20
Hepatic Glycogenosis with Amino Aciduria and Glucosuria0low10
Hepatic Glycogenosis with Fanconi Nephropathy0low10
Hepatic Neoplasms0low50
Hepatitis0low10
Hepatitis C0low10
Hepatitis, Drug-Induced0low40
Hepatitis, Toxic0low40
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted0low10
Hepato-Neurologic Wilson Disease0low20
Hepatocellular Cancer0low50
Hepatocellular Carcinoma0low60
Hepatocerebral Degeneration0low20
Hepatolenticular Degeneration0low20
Hepatolenticular Degeneration Syndrome0low20
Hepatoma0low60
Hepatoma, Experimental0low40
Hepatoma, Morris0low40
Hepatoma, Novikoff0low40
Hepatomas, Experimental0low40
Hepatorenal Glycogen Storage Disease0low20
Hepatorenal Glycogenosis with Renal Fanconi Syndrome0low10
Hereditary Chorea0low10
Hereditary Motor Neuronopathy0low10
Hereditary Polyposis Coli0low10
Hereditary Progressive Chorea Without Dementia0low10
Hereditary Retinoblastoma0low10
Hermaphroditism0low10
Heterotopic Ossification0low10
High Cardiac Output0low30
Histamine Cephalgia0low20
HIV Coinfection0low20
HIV Infections0low20
Horizontal Nystagmus0low10
Hormone-Dependent Neoplasms0low10
Horse Diseases0low20
Horton Syndrome0low20
Horton's Syndrome0low20
HTLV I Associated T Cell Leukemia Lymphoma0low10
HTLV-Associated Leukemia-Lymphoma0low10
HTLV-I-Associated T-Cell Leukemia-Lymphoma0low10
HTLV-III Infections0low20
HTLV-III-LAV Infections0low20
Human Mammary Carcinoma0low130
Human T Lymphotropic Virus Associated Leukemia Lymphoma0low10
Human T Lymphotropic Virus-Associated Leukemia-Lymphoma0low10
Human T-Cell Leukemia-Lymphoma0low10
Human Transmissible Spongiform Encephalopathies, Inherited0low20
Huntington Chorea0low80
Huntington Chronic Progressive Hereditary Chorea0low80
Huntington Disease0low80
Huntington Disease, Akinetic-Rigid Variant0low80
Huntington Disease, Juvenile0low80
Huntington Disease, Juvenile-Onset0low80
Huntington Disease, Late Onset0low80
Huntington's Chorea0low80
Huntington's Disease0low80
Hyperactivity, Motor0low70
Hyperalgesia0low70
Hyperalgesia, Mechanical0low70
Hyperalgesia, Primary0low70
Hyperalgesia, Secondary0low70
Hyperalgesia, Tactile0low70
Hyperalgesia, Thermal0low70
Hyperalgesic Sensations0low70
Hyperalgia0low70
Hyperalgia, Mechanical0low70
Hyperalgia, Primary0low70
Hyperalgia, Secondary0low70
Hyperammonemia0low10
Hypercalcemia0low10
Hyperglycemia0low10
Hyperglycemia, Postprandial0low10
Hyperglycemic Hyperosmolar Nonketotic Coma0low10
Hyperglycinemia, Nonketotic0low10
Hyperglycinemia, Nonketotic, Type I0low10
Hyperglycinemia, Nonketotic, Type II0low10
Hyperglycinemia, Nonketotic, Type III0low10
Hyperkinesia0low70
Hyperkinesia, Generalized0low70
Hyperkinesis0low70
Hyperkinetic Movements0low70
Hyperkinetic Syndrome0medium41
Hyperosmolar Hyperglycemic Nonketotic Coma0low10
Hyperosmolar Hyperglycemic State0low10
Hyperosmolar Hyperglycemic Syndrome0low10
Hyperosmolar Nonketotic Coma0low10
Hyperparathyroidism0low20
Hyperphagia0low10
Hyperplasia0low10
Hypersensitivity, Contact0low10
Hypersensitivity, Delayed0low20
Hypersensitivity, Drug0low20
Hypersensitivity, Respiratory0low10
Hypersensitivity, Tuberculin-Type0low20
Hypersensitivity, Type IV0low20
Hypertension0low110
Hypertension-Edema-Proteinuria Gestosis0low20
Hyperthyroid0low20
Hyperthyroidism0low20
Hypertrophy0low70
Hypertrophy, Left Ventricular0low20
Hypoacusis0low10
Hypoglycemia0low30
Hypomania0low40
Hypomanic Episode0low40
Hyponatremia0low50
Hypoplastic Congenital Anemia0low10
Hypothermia0low50
Hypothermia, Accidental0low50
Hypothyroidism0low40
Hypovolemia0low10
Hypovolemic0low10
Hypoxemia0low110
Hypoxia0low110
Hypoxia-Ischemia, Brain0low40
Hypoxia-Ischemia, Cerebral0low40
Hypoxia, Brain0low10
Hypoxia, Cerebral0low10
Hypoxic Brain Damage0low10
Hypoxic Encephalopathy0low10
Hypoxic-Ischemic Encephalopathy0low40
IDDM0low10
Idiopathic De Toni-Debre-Fanconi Syndrome0low10
Idiopathic Parkinson Disease0low40
Idiopathic Parkinson's Disease0low40
Idiopathic Ventricular Tachycardia0low10
Immunologic Deficiency Syndrome0low20
Immunologic Deficiency Syndromes0low20
Immunological Deficiency Syndromes0low20
Impotence0low10
Impotence, Arteriogenic0low10
Impotence, Vasculogenic0low10
Impotence, Venogenic0low10
Impulse Control Disorders0low20
Impulse-Control Disorders0low20
Inadequate Sleep0low50
Inappropriate ADH Syndrome0low10
Inappropriate Vasopressin Secretion Syndrome0low10
Inclusion Body Myopathy, Sporadic0low10
Inclusion Body Myositis0low10
Inclusion Body Myositis, Sporadic0low10
Incomplete Anencephaly0low10
Infantile Canavan Disease0low10
Infantile Neuronal Ceroid Lipofuscinosis0low10
Infarction, Anterior Cerebral Circulation0low10
Infarction, Anterior Circulation, Brain0low10
Infarction, Brain, Anterior Circulation0low10
Infarction, Brain, Posterior Circulation0low10
Infarction, Middle Cerebral Artery0low40
Infarction, Posterior Circulation, Brain0low10
Infection0low20
Infection and Infestation0low20
Infections0low20
Infections and Infestations0low20
Infections, Actinobacillus0low10
Infections, Caliciviridae0low10
Infections, Calicivirus0low10
Infections, Coronavirus0low20
Infections, Coxsackie Virus0low10
Infections, Coxsackievirus0low10
Infections, Enterovirus0low10
Infections, Klebsiella0low10
Infections, Meningococcal0low10
Infections, Parvoviridae0low10
Infections, Parvovirus0low10
Infections, Plasmodium0low10
Infections, Pseudomonas0low10
Infections, Reoviridae0low10
Infections, Respiratory0low10
Infections, Respiratory Tract0low10
Infections, Respirovirus0low20
Infections, Staphylococcal0low10
Infections, Upper Respiratory0low10
Infections, Upper Respiratory Tract0low10
Infectious Skin Diseases0low10
Inflammation0low190
Inflammation, Brain0low40
Inherited Erythroblastopenia0low10
Inherited Human Transmissible Spongiform Encephalopathies0low20
Injuries, Acute Brain0low90
Injuries, Brain0low90
Injuries, Spinal Cord0low100
Injuries, Tendon0low10
Injury, Brain, Traumatic0low30
Injury, Ischemia-Reperfusion0low120
Injury, Myocardial Reperfusion0low30
Injury, Reperfusion0low120
Innate Inflammatory Response0low190
Insufficient Sleep0low50
Insufficient Sleep Syndrome0low50
Insulin Resistance0low20
Insulin Sensitivity0low20
Insulin-Dependent Diabetes Mellitus 10low10
Insulinoma0low10
Insuloma0low10
Intention Tremor0medium41
Intermenstrual Bleeding0low10
Intermittent Explosive Disorder0low20
Intermittent Tremor0medium41
Internal Carotid Artery Diseases0low30
Intersex Conditions0low10
Intersexuality0low10
Intervertebral Disc Degeneration0low20
Intervertebral Disk Degeneration0low20
Intestinal Cancer0low10
Intestinal Neoplasms0low10
Intestines Cancer0low10
Intestines Neoplasms0low10
Intoxication, Alcoholic0low20
Intracapillary Glomerulosclerosis0low30
Intracerebral Hemorrhage0low40
Intracranial Astrocytoma0low40
Intracranial Central Nervous System Disorders0low60
Intracranial CNS Disorders0low60
Intracranial Edema0low20
Intracranial Embolism0low10
Intracranial Neoplasms0low90
Intracranial Vascular Disorders0low10
Intractable Epilepsy0low10
Intraocular Pressure0low20
Intravascular Hemolysis0low10
Invasiveness, Neoplasm0low140
Involuntary Quiver0medium41
Ischemia0low40
Ischemia-Anoxia, Brain0low40
Ischemia-Anoxia, Cerebral0low40
Ischemia-Hypoxia, Brain0low40
Ischemia-Hypoxia, Cerebral0low40
Ischemia-Reperfusion Injury0low120
Ischemia, Cerebral0low100
Ischemia, Myocardial0low20
Ischemic Attack, Transient0low50
Ischemic Encephalopathy0low100
Ischemic Heart Disease0low20
Ischemic Necrosis Of Femoral Head0low40
Ischemic-Hypoxic Encephalopathy0low40
Itching0low10
Jacksonian Seizure0low630
Jakob-Creutzfeldt Disease0low10
Jakob-Creutzfeldt Syndrome0low10
Jansky-Bielschowsky Disease0low10
Jerk Nystagmus0low10
Joseph Azorean Disease0low20
Joseph Disease0low20
Juvenile Batten Disease0low10
Juvenile Canavan Disease0low10
Juvenile Cerebroretinal Degeneration0low10
Juvenile Huntington Disease0low80
Juvenile Neuronal Ceroid Lipofuscinosis0low10
Juvenile Parkinson Disease0low10
Juvenile Parkinson Disease, Autosomal Dominant0low10
Juvenile Parkinson Disease, Autosomal Recessive0low10
Juvenile Parkinsonism, Autosomal Dominant0low10
Juvenile Parkinsonism, Autosomal Recessive0low10
Juvenile Pilocytic Astrocytoma0low40
Juvenile-Onset Diabetes0low10
Juvenile-Onset Huntington Disease0low80
Kahler Disease0low50
Kartagener Syndrome0low10
Kartagener Triad0low10
Kartagener's Syndrome0low10
Kartagener's Triad0low10
Keratitis0low10
Keskushermoston sairaudet@fi0low10
Kidney Cancer0low10
Kidney Diseases0low40
Kidney Failure, Acute0low40
Kidney Insufficiency, Acute0low40
Kidney Neoplasms0low10
Kidney, Polycystic0low10
Kienbock Disease0low10
Kienbock's Disease0low10
Kienboeck Disease0low10
Kienboeck's Disease0low10
Kimmelstiel-Wilson Disease0low30
Kimmelstiel-Wilson Syndrome0low30
Kinnier-Wilson Disease0low20
Klebsiella Infections0low10
Kleptomania0low20
Kojevnikov's Epilepsy0low10
Kojewnikov's Epilepsy0low10
Kojewnikow Syndrome0low10
Kojewnikow's Syndrome0low10
Kozhevnikov Syndrome0low10
Kozhevnikov's Syndrome0low10
Kozhevnikow Syndrome, Progressive Variant0low10
Kuf's Disease0low10
Kufs Disease0low10
Kufs Disease Autosomal Recessive0low10
Kufs Disease, Autosomal Dominant0low10
Kufs Disease, Autosomal Recessive0low10
Kufs Type Neuronal Ceroid Lipofuscinosis0low10
Laryngeal Cancer0low10
Laryngeal Neoplasms0low10
Larynx Cancer0low10
Larynx Neoplasms0low10
Lassitude0low20
Late Effects, Prenatal Exposure0low100
Late Onset Alzheimer Disease0medium301
Late-Infantile Neuronal Ceroid Lipofuscinosis0low10
Late-Onset Huntington Disease0low80
Learning Disabilities0low70
Learning Disorders0low70
Learning Disorders, Adult0low70
Learning Disturbance0low70
Left Bundle-Branch Block0low10
Left Middle Cerebral Artery Infarction0low40
Left Ventricle Remodeling0low20
Left Ventricular Hypertrophy0low20
Left Ventricular Remodeling0low20
Left-Sided Heart Failure0low10
Leucocythaemia0low50
Leucocythemia0low50
Leukemia0low50
Leukemia Lymphoma, Adult T Cell0low10
Leukemia Lymphoma, T Cell, Acute, HTLV I Associated0low10
Leukemia Model, Animal0low30
Leukemia-Lymphoma, Adult T-Cell0low10
Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated0low10
Leukemia, Acute Myelogenous0low40
Leukemia, Acute Myeloid0low40
Leukemia, Acute Promyelocytic0low70
Leukemia, Adult T-Cell0low10
Leukemia, Basophilic, Acute0low10
Leukemia, Erythroblastic, Acute0low40
Leukemia, Experimental0low30
Leukemia, Granulocytic0low30
Leukemia, Lymphocytic0low10
Leukemia, Lymphoid0low10
Leukemia, Monocytic, Chronic0low30
Leukemia, Myeloblastic, Acute0low40
Leukemia, Myelocytic0low30
Leukemia, Myelocytic, Acute0low40
Leukemia, Myelogenous0low30
Leukemia, Myelogenous, Acute0low40
Leukemia, Myeloid0low30
Leukemia, Myeloid, Acute0low40
Leukemia, Myeloid, Acute, M10low40
Leukemia, Myeloid, Acute, M20low40
Leukemia, Myeloid, Acute, M30low70
Leukemia, Myeloid, Acute, M40low30
Leukemia, Myeloid, Acute, M60low40
Leukemia, Myeloid, Naegeli-Type0low30
Leukemia, Myelomonocytic, Acute0low30
Leukemia, Nonlymphoblastic, Acute0low40
Leukemia, Nonlymphocytic, Acute0low40
Leukemia, Progranulocytic0low70
Leukemia, Promyelocytic, Acute0low70
Leukemias, Experimental0low30
Leukocytosis0low10
Leukodystrophy, Spongiform0low10
Lewy Body Parkinson Disease0low40
Lewy Body Parkinson's Disease0low40
Libman-Sacks Disease0low30
Lignac-Fanconi Syndrome0low10
Limb Deformities, Congenital0low20
Limb-Girdle Muscular Dystrophies0low10
Limb-Girdle Muscular Dystrophy0low10
Limb-Girdle Syndrome0low10
Lipofuscin Storage Disease0low10
Lipofuscinosis, Neuronal Ceroid0low10
Liver Abscess0low10
Liver Cancer0low50
Liver Cancer, Adult0low60
Liver Cell Carcinoma0low60
Liver Cell Carcinoma, Adult0low60
Liver Cirrhosis0low20
Liver Diseases0low10
Liver Dysfunction0low10
Liver Fibrosis0low20
Liver Injury, Drug-Induced0low40
Liver Injury, Drug-Induced, Acute0low40
Liver Neoplasms0low50
Liver Neoplasms, Experimental0low40
Liver Steatosis0low10
Livor Mortis0low10
Long Sleeper Syndrome0low10
Lou Gehrig Disease0low60
Lou Gehrig's Disease0low60
Lou-Gehrigs Disease0low60
Low Cardiac Output0low40
Low Cardiac Output Syndrome0low40
Luder-Sheldon Syndrome0low10
Lung Adenocarcinoma0low10
Lung Cancer0low80
Lung Injuries0low10
Lung Injury0low10
Lung Injury, Acute0low10
Lung Neoplasms0low80
Lupus Erythematosus Disseminatus0low30
Lupus Erythematosus, Systemic0low30
Lupus Glomerulonephritis0low10
Lupus Nephritis0low10
Lymphadenopathy Syndrome0low10
Lymphocytic Leukemia0low10
Lymphoid Leukemia0low10
Lymphoma0low40
Lymphoma, Malignant0low40
M3 ANLL0low70
Machado-Joseph Azorean Disease0low20
Machado-Joseph Disease0low20
Machado-Joseph Disease Type I0low20
Machado-Joseph Disease Type II0low20
Machado-Joseph Disease Type III0low20
Machado-Joseph Disease Type IV0low20
Macular Dystrophy, Corneal0low20
Maculopapular Drug Eruption0low10
Maculopapular Exanthem0low10
Major Depressive Disorder0medium43
Maladie du systu00E8me nerveux central@fr0low10
Malaria0low10
Malaria, Falciparum0low10
Malattie del sistema nervoso centrale@it0low10
Male Impotence0low10
Male Pattern Baldness0medium21
Male Sexual Impotence0low10
Malformations, Nervous System, Congenital0low10
Malignancy0low90
Malignant Cerebellar Neoplasms0low10
Malignant Glioma0low130
Malignant Melanoma0low40
Malignant Neoplasm of Breast0low130
Malignant Neoplasms0low90
Malignant Neoplasms, Brain0low90
Malignant Primary Brain Neoplasms0low90
Malignant Primary Brain Tumors0low90
Malignant Tumor of Breast0low130
Malignant Tumor of Urinary Bladder0low20
Mammary Cancer0low130
Mammary Carcinoma, Human0low130
Mammary Neoplasm, Human0low130
Mammary Neoplasms, Experimental0low20
Mammary Neoplasms, Human0low130
Mandibular Diseases0low10
Manganese Poisoning0low10
Mania0low40
Manic Depression0medium17121
Manic Disorder0medium17121
Manic Episode0low40
Manic State0low40
Manic-Depressive Psychosis0medium17121
Mar (X) Syndrome0low30
Marginal Ulcer0low10
Marie-Struempell Disease0low10
Marker X Syndrome0low30
Marsh Fever0low10
Martin-Bell Syndrome0low30
Massive Tremor0medium41
Maturity-Onset Diabetes0low40
Maturity-Onset Diabetes Mellitus0low40
MCA Infarct0low40
MCA Infarction0low40
Mechanical Allodynia0low70
Mechanical Hyperalgesia0low70
Medication Resistant Epilepsy0low10
Medication-Induced Dyskinesia0low30
Medulloblastoma0low20
Medulloblastoma, Adult0low20
Medulloblastoma, Childhood0low20
Medulloblastoma, Desmoplastic0low20
Medullomyoblastoma0low20
Melancholia0medium202
Melancholia, Involutional0medium43
Melanocytic Medulloblastoma0low20
Melanoma0low40
Melanoma, B160low30
Melanoma, Cloudman S910low30
Melanoma, Experimental0low30
Melanoma, Harding-Passey0low30
Melanomas, Experimental0low30
Melioidosis0low20
Memory Deficits0low170
Memory Disorder, Semantic0low170
Memory Disorder, Spatial0low170
Memory Disorders0low170
Memory Disorders, Age-Related0low170
Memory Loss0low170
Meningitis, Pneumococcal0low10
Meningitis, Pneumococcal, Experimental0low10
Meningitis, Pneumococcal, Penicillin-Resistant0low10
Meningitis, Pneumococcal, Recurrent0low10
Meningitis, Streptococcus pneumoniae0low10
Meningococcal Disease0low10
Meningococcal Infections0low10
Mental Deterioration0low60
Mental Disorders0medium81
Mental Disorders, Severe0medium81
Mental Illness0medium81
Mental Retardation, X-Linked, Associated With Fragile Site Fraxe0low30
Mental Retardation, X-Linked, Associated With Marxq280low30
Menzel Type OPCA0low10
MERS (Middle East Respiratory Syndrome)0low20
Metabolic Acidosis0low10
Metabolic Diseases0medium31
Metastase0low30
Metastases, Neoplasm0low30
Metastasis0low30
Metastasis, Neoplasm0low30
Metrorrhagia0low10
Microcalcification0low10
Microcalcinosis0low10
Micronuclei, Chromosome-Defective0low10
Micronuclei, Genotoxicant-Induced0low10
Micronucleus, Chromosome-Defective0low10
Middle Cerebral Artery Circulation Infarction0low40
Middle Cerebral Artery Embolic Infarction0low40
Middle Cerebral Artery Embolus0low40
Middle Cerebral Artery Infarction0low40
Middle Cerebral Artery Occlusion0low40
Middle Cerebral Artery Stroke0low40
Middle Cerebral Artery Syndrome0low40
Middle Cerebral Artery Thrombosis0low40
Middle Cerebral Artery Thrombotic Infarction0low40
Middle East Respiratory Syndrome0low20
Mild Cognitive Impairment0low60
Mild Neurocognitive Disorder0low60
Milk-Alkali Syndrome0low10
Minimal Brain Dysfunction0medium41
Mixed Glioma0low130
MODY0low40
Moniliasis0low10
Monkey Diseases0low10
Monocytic Leukemia, Chronic0low30
Monosomy, Partial0low10
Mood Disorders0medium101
Mood Disorders, Psychotic0medium32
Moral Injury0low10
Morbilliform Drug Reaction0low10
Morbilliform Exanthem0low10
Morphine Abuse0low60
Morphine Addiction0low60
Morphine Dependence0low60
Motion Sickness0low30
Motor Neuron Disease, Amyotrophic Lateral Sclerosis0low60
Motor Skills Disorders0low10
Mouth Cancer0low30
Mouth Neoplasms0low30
Movement Disorder Syndromes0low20
Movement Disorders0low20
MPTP Neurotoxicity Syndrome0low10
MPTP Poisoning0low10
MPTP-Induced Degeneration of the Striatum0low10
MPTP-Induced Experimental Parkinsonism0low10
MPTP-Induced Parkinsonism0low10
MS (Multiple Sclerosis)0low20
Mucopolysaccharidoses0low10
Mucopolysaccharidosis0low10
Mucositis, Oral0low10
Multidirectional Nystagmus0low10
Multiple Abnormalities0low10
Multiple Myeloma0low50
Multiple Sclerosis0low20
Multiple Sclerosis, Acute Fulminating0low20
Muscle Contraction0low170
Muscle Disorders0low10
Muscle Relaxation0low50
Muscle Weakness0low10
Muscular Atrophy0low30
Muscular Atrophy, Adult Spinal0low10
Muscular Atrophy, Spinal0low10
Muscular Diseases0low10
Muscular Dystrophies, Limb-Girdle0low10
Muscular Dystrophy, Limb-Girdle0low10
Muscular Dystrophy, Oculopharyngeal0low10
Muscular Weakness0low10
Myasthenia Gravis, Congenital0low10
Myasthenic Syndrome, Congenital, Slow-Channel0low10
Myasthenic Syndromes, Congenital0low10
Myasthenic Syndromes, Congenital, Slow Channel0low10
Myeloblastic Leukemia, Acute0low40
Myelocytic Leukemia0low30
Myelocytic Leukemia, Acute0low40
Myelogenous Leukemia0low30
Myelogenous Leukemia, Acute0low40
Myeloid Leukemia0low30
Myeloid Leukemia, Acute0low40
Myeloid Leukemia, Acute, M10low40
Myeloid Leukemia, Acute, M20low40
Myeloid Leukemia, Acute, M30low70
Myeloid Leukemia, Acute, M40low30
Myeloid Leukemia, Acute, M60low40
Myeloid Leukemia, Naegeli-Type0low30
Myeloma-Multiple0low50
Myeloma, Multiple0low50
Myeloma, Plasma-Cell0low50
Myelomatosis0low50
Myelomonocytic Leukemia, Acute0low30
Myelopathic Muscular Atrophy0low10
Myelopathic Muscular Atrophy, Progressive0low10
Myelopathy, Traumatic0low100
Myh-Associated Polyposis0low10
Myocardial Failure0low10
Myocardial Infarct0low70
Myocardial Infarction0low70
Myocardial Ischemia0low20
Myocardial Ischemic Reperfusion Injury0low30
Myocardial Remodeling, Ventricular0low20
Myocardial Reperfusion Injury0low30
Myocarditis0low10
Myoclonic Seizure0low630
Myoclonic Seizures0low630
Myopathic Conditions0low10
Myopathic Limb-Girdle Syndrome0low10
Myopathies0low10
Myopathy, Inclusion Body, Sporadic0low10
Myositis, Inclusion Body0low10
Myositis, Inclusion Body, Sporadic0low10
Nagana0low20
Nausea0low580
Neck Cancer0low20
Neck Neoplasm0low20
Neck Neoplasms0low20
Necrosis0low110
Necrosis, Aseptic, of Bone0low10
Necrosis, Aseptic, of Femur Head0low40
Necrosis, Avascular, of Bone0low10
Necrosis, Avascular, of Femur Head0low40
nemoci centru00E1lnu00EDho nervovu00E9ho systu00E9mu@cs0low10
Neointima0low10
Neointima Formation0low10
Neonatal Canavan Disease0low10
Neonatal De Toni-Debre-Fanconi Syndrome0low10
Neoplasia0low90
Neoplasm0low90
Neoplasm Invasion0low140
Neoplasm Invasiveness0low140
Neoplasm Metastases0low30
Neoplasm Metastasis0low30
Neoplasms0low90
Neoplasms, Adrenal Gland0low70
Neoplasms, Benign0low90
Neoplasms, Bladder0low20
Neoplasms, Brain0low90
Neoplasms, Brain, Benign0low90
Neoplasms, Brain, Malignant0low90
Neoplasms, Brain, Primary0low90
Neoplasms, Breast0low130
Neoplasms, Cerebellar0low10
Neoplasms, Cerebellar, Benign0low10
Neoplasms, Cerebellar, Malignant0low10
Neoplasms, Cerebellar, Primary0low10
Neoplasms, Cervical0low20
Neoplasms, Cervix0low20
Neoplasms, Colonic0low130
Neoplasms, Colorectal0low90
Neoplasms, Endometrial0low20
Neoplasms, Esophageal0low40
Neoplasms, Experimental0low50
Neoplasms, Experimental Liver0low40
Neoplasms, Experimental Mammary0low20
Neoplasms, Gastric0low100
Neoplasms, Gastrointestinal0low10
Neoplasms, Head0low20
Neoplasms, Head and Neck0low20
Neoplasms, Hepatic0low50
Neoplasms, Hormone-Dependent0low10
Neoplasms, Intestinal0low10
Neoplasms, Intracranial0low90
Neoplasms, Kidney0low10
Neoplasms, Laryngeal0low10
Neoplasms, Liver0low50
Neoplasms, Lung0low80
Neoplasms, Mouth0low30
Neoplasms, Neck0low20
Neoplasms, Oral0low30
Neoplasms, Ovarian0low60
Neoplasms, Pancreatic0low30
Neoplasms, Prostate0low50
Neoplasms, Prostatic0low50
Neoplasms, Pulmonary0low80
Neoplasms, Stomach0low100
Neoplasms, Thyroid0low40
Neoplasms, Upper Aerodigestive Tract0low20
Neoplasms, Uterine0low10
Neoplasms, Uterus0low10
Neoplastic Cell Transformation0low40
Neoplastic Transformation, Cell0low40
Neovascularization, Optic Disc0low10
Neovascularization, Pathologic0low10
Neovascularization, Pathological0low10
Neovascularization, Retinal0low10
Nephritis, Lupus0low10
Nephrogenic Diabetes Insipidus0low140
Nephrogenic Diabetes Insipidus, Type I0low140
Nephrogenic Diabetes Insipidus, Type II0low140
Nerve Degeneration0low190
Nerve Pain0low30
Nerve Root Avulsion0low10
Nerve Root Compression0low10
Nerve Root Disorder0low10
Nerve Root Inflammation0low10
Nervous System Abnormalities0low10
Nervous System Anomalies0low10
Nervous System Azorean Disease0low20
Nervous System Congenital Abnormalities0low10
Nervous System Congenital Malformations0low10
Nervous System Degenerative Diseases0low110
Nervous System Diseases0low30
Nervous System Diseases, Manganese-Induced0low10
Nervous System Disorders0low30
Nervous System Malformations0low10
Nervous System Malformations, Congenital0low10
Nervous System Poisoning0low80
Nervous System Poisoning, Manganese0low10
Neuralgia0low30
Neuralgia, Atypical0low30
Neuralgia, Iliohypogastric Nerve0low30
Neuralgia, Ilioinguinal0low30
Neuralgia, Perineal0low30
Neuralgia, Stump0low30
Neuralgia, Supraorbital0low30
Neuralgia, Vidian0low30
Neuralgic Migraine0low20
Neurilemmoma0low10
Neurilemoma0low10
Neurinoma0low10
Neuritic Plaques0low10
Neuroblastoma0low250
Neuroblastoma, Retinal0low10
Neurodegenerative Diseases0low110
Neurodegenerative Disorders0low110
Neurodynia0low30
Neuroendocrine Tumors0medium11
Neurofibromatosis 20low10
Neurofibromatosis II0low10
Neurofibromatosis Type 20low10
Neurofibromatosis Type II0low10
Neurofibromatosis, Acoustic, Bilateral0low10
Neurofibromatosis, Central NF20low10
Neurofibromatosis, central type0low10
Neurofibromatosis, Central, NF 20low10
Neurofibromatosis, Central, NF20low10
Neurofibromatosis, Type 20low10
Neurofibromatosis, Type II0low10
Neurogenic Muscular Atrophy0low30
Neurohepatic Degeneration0low20
Neuroleptic Malignant Syndrome0low40
Neuroleptic-Induced Neuroleptic Malignant Syndrome0low40
Neuroleptic-Malignant Syndrome, Neuroleptic Induced0low40
Neurologic Degenerative Conditions0low110
Neurologic Degenerative Diseases0low110
Neurologic Diseases, Degenerative0low110
Neurologic Disorders0low30
Neurological Disorders0low30
Neuroma, Acoustic, Bilateral0low10
Neuron Degeneration0low190
Neuronal Ceroid Lipofuscinosis0low10
Neuronal Ceroid Lipofuscinosis Juvenile Type0low10
Neuronal Ceroid Lipofuscinosis, Adult0low10
Neuronal Ceroid Lipofuscinosis, Adult Type0low10
Neuronal Ceroid Lipofuscinosis, Infantile0low10
Neuronal Ceroid Lipofuscinosis, Juvenile0low10
Neuronal Ceroid Lipofuscinosis, Late Infantile0low10
Neuronal Ceroid Lipofuscinosis, Late-Infantile0low10
Neuronal Ceroid-Lipofuscinoses0low10
Neuronal Ceroid-Lipofuscinosis0low10
Neuropathic Pain0low30
Neuroses, Anxiety0low30
Neuroses, Phobic0low10
Neuroses, Post-Traumatic0low10
Neuroses, Posttraumatic0low10
Neurosis, Depressive0medium202
Neurotoxic Disorders0low80
Neurotoxicity Syndrome, Manganese0low10
Neurotoxicity Syndrome, MPTP0low10
Neurotoxicity Syndromes0low80
Neurotoxin Diseases0low80
Neurotoxin Disorders0low80
Neurotrophic Muscular Atrophy0low30
Neutropenia0low50
New Variant Creutzfeldt-Jakob Disease0low10
Newcastle Disease0low10
NF2 (Neurofibromatosis 2)0low10
NIDDM0low40
Nigrospinodentatal Degeneration0low20
NMS (Neuroleptic Malignant Syndrome)0low40
Nodular Glomerulosclerosis0low30
Non-Convulsive Status Epilepticus0low1000
Non-Epileptic Seizure0low630
Non-Epileptic Seizures0low630
Non-Fatigable Positional Nystagmus0low10
Non-ketotic Hyperglycinemia0low10
Non-Small Cell Lung Cancer0low30
Non-Small Cell Lung Carcinoma0low30
Non-Small-Cell Lung Carcinoma0low30
Nonepileptic Seizure0low630
Nonepileptic Seizures0low630
Noninsulin-Dependent Diabetes Mellitus0low40
Nonketotic Hyperglycemic Coma0low10
Nonketotic Hyperglycinemia0low10
Nonketotic Hyperglycinemia, Type I0low10
Nonketotic Hyperglycinemia, Type II0low10
Nonketotic Hyperglycinemia, Type III0low10
Nonketotic Hyperosmolar Coma0low10
Nonlymphoblastic Leukemia, Acute0low40
Nonlymphocytic Leukemia, Acute0low40
Nonsmall Cell Lung Cancer0low30
Nonsustained Ventricular Tachycardia0low10
Norovirus Infections0low10
Nystagmus, Pathologic0low10
Obesity0low130
Occlusion, Middle Cerebral Artery0low40
Oculopharyngeal Dystrophy0low10
Oculopharyngeal Muscular Dystrophy0low10
Oculopharyngeal Spinal Muscular Atrophy0low10
Oligoastrocytoma, Mixed0low40
Olivopontocerebellar Atrophy 20low10
Olivopontocerebellar Atrophy I0low10
Olivopontocerebellar Atrophy II0low10
Olivopontocerebellar Atrophy III0low10
Olivopontocerebellar Atrophy IV0low10
Olivopontocerebellar Atrophy, Holguin Type0low10
Oncogenesis0low10
OPCA with Macular Degeneration and External Ophthalmoplegia0low10
OPCA with Retinal Degeneration0low10
Oppositional Defiant Disorder0low10
Optic Disc Neovascularization0low10
Optic Disk Neovascularization0low10
Optic Nerve Avulsion0low20
Optic Nerve Contusion0low20
Optic Nerve Injuries0low20
Optic Nerve Transection0low20
Optic Nerve Trauma0low20
Optic Neuropathy, Traumatic0low20
Oral Cancer0low30
Oral Mucositis0low10
Oral Neoplasms0low30
Orbital Diseases0low10
Organic Mental Disorders, Substance-Induced0low50
Oromucositis0low10
Oropharyngeal Dysphagia0low10
Ossification of Posterior Longitudinal Ligament0low10
Ossification, Ectopic0low10
Ossification, Heterotopic0low10
Ossification, Pathologic0low10
Ossification, Pathological0low10
Osteoarthritis0low80
Osteoarthritis of Knee0low10
Osteoarthritis of the Knee0low10
Osteoarthritis, Knee0low10
Osteoarthrosis0low80
Osteoarthrosis Deformans0low80
Osteoclastic Bone Loss0low10
Osteolysis0low10
Osteonecrosis0low10
Osteoporosis0low30
Osteoporosis, Age-Related0low30
Osteoporosis, Involutional0low30
Osteoporosis, Post-Traumatic0low30
Osteoporosis, Senile0low30
Ostium Secundum Atrial Septal Defect0low10
Otologic Diseases0low10
Otological Diseases0low10
Ovarian Cancer0low60
Ovarian Neoplasms0low60
Ovary Cancer0low60
Ovary Neoplasms0low60
Overeating0low10
Overinclusion0medium141
Ovine Diseases0medium41
Oxygen Deficiency0low110
Pain0low70
Pain, Burning0low70
Pain, Crushing0low70
Pain, Migratory0low70
Pain, Radiating0low70
Pain, Splitting0low70
Palmoplantaris Pustulosis0low20
Palsy0low10
Paludism0low10
Pancreas Cancer0low30
Pancreas Neoplasms0low30
Pancreatic Cancer0low30
Pancreatic Duct Cell Carcinoma0low10
Pancreatic Ductal Carcinoma0low10
Pancreatic Neoplasms0low30
Paracousis0low10
Paracusis0low10
Paraganglioma0low10
Paraganglioma, Gangliocytic0low10
Paragangliomas 10low10
Paragangliomas, Familial, 10low10
Paragangliomata0low10
Parageusia0low40
Paralysis0low10
Paralysis Agitans0low40
Paralysis, Spinal, Quadriplegic0low10
Paraphrenia, Involutional0medium43
Parasitemia0low20
Parenterally-Transmitted Non-A, Non-B Hepatitis0low10
Parkinson Disease0low40
Parkinson Disease 20low10
Parkinson Disease 2, Autosomal Recessive Juvenile0low10
Parkinson Disease Autosomal Recessive, Early Onset0low10
Parkinson Disease, Autosomal Dominant. Juvenile0low10
Parkinson Disease, Experimental0low10
Parkinson Disease, Familial, Autosomal Recessive0low10
Parkinson Disease, Idiopathic0low40
Parkinson Disease, Juvenile0low10
Parkinson Disease, Juvenile, Autosomal Dominant0low10
Parkinson Disease, Juvenile, Autosomal Recessive0low10
Parkinson Disease, Secondary0low10
Parkinson Disease, Secondary Vascular0low10
Parkinson Disease, Symptomatic0low10
Parkinson's Disease0low40
Parkinson's Disease, Idiopathic0low40
Parkinson's Disease, Lewy Body0low40
Parkinsonian Diseases0low10
Parkinsonian Disorders0low10
Parkinsonian Syndrome0low10
Parkinsonian Syndromes0low10
Parkinsonism0low10
Parkinsonism, Early Onset, with Diurnal Fluctuation0low10
Parkinsonism, Early-Onset, With Diurnal Fluctuation0low10
Parkinsonism, Experimental0low10
Parkinsonism, Juvenile0low10
Parkinsonism, Juvenile, Autosomal Dominant0low10
Parkinsonism, Juvenile, Autosomal Recessive0low10
Parkinsonism, Secondary0low10
Parkinsonism, Symptomatic0low10
Paroxysmal Dyskinesias0low10
Paroxysmal Nerve Pain0low30
Paroxysmal Supraventricular Tachycardia0low10
Partial Anencephaly0low10
Partial Fetal Alcohol Syndrome0low10
Partial Monosomy0low10
Partial Seizure0low630
Partial Seizures0low630
Partial Trisomy0low10
Parvoviridae Infections0low10
Parvovirus Infections0low10
Passive Tremor0medium41
Pathologic Angiogenesis0low10
Pathologic Calcification0low10
Pathologic Neovascularization0low10
Pathologic Ossification0low10
Pathological Gambling0low10
Pattern Baldness0medium21
Pendular Nystagmus0low10
Peptic Ulcer0low10
Periapical Periodontitis0low10
Pericardial Effusion0low10
Pericementitis0low20
Periodic Alternating Nystagmus0low10
Periodontal Bone Loss0low20
Periodontal Resorption0low20
Periodontitis0low20
Periodontitis, Acute Nonsuppurative0low10
Periodontitis, Apical0low10
Peripheral Nerve Diseases0low20
Peripheral Nerve Injuries0low10
Peripheral Nerve Injury0low10
Peripheral Nervous System Disease0low20
Peripheral Nervous System Diseases0low20
Peripheral Nervous System Disorders0low20
Peripheral Neuropathies0low20
Permanent Nystagmus0low10
Persistent Ostium Primum0low10
Persistent Tremor0medium41
Petit Mal Convulsion0low630
Petit Mal Status0low1000
Pharyngeal Reflex0low10
Pheochromocytoma0low80
Pheochromocytoma, Extra-Adrenal0low80
Phobia, School0low10
Phobias0low10
Phobic Disorders0low10
Phobic Neuroses0low10
Pica0low50
Pie Torcido0low10
Pilar Cyst0low10
Pill Rolling Tremor0medium41
Pilocytic Astrocytoma0low40
Pituitary Adenoma0low50
Pituitary Cancer0low50
Pituitary Carcinoma0low50
Pituitary Neoplasms0low50
Pituitary Tumors0low50
Plant Poisoning0low70
Plaque, Amyloid0low10
Plaque, Atherosclerotic0low10
Plaques, Amyloid0low10
Plasma Cell Myeloma0low50
Plasma Cell Tumor0low10
Plasmacytoma0low10
Plasmocytoma0low10
Plasmodium falciparum Malaria0low10
Plasmodium Infections0low10
Plegia0low10
Pleocytosis0low10
Pneumonia, Viral0low10
PNS (Peripheral Nervous System) Diseases0low20
PNS Diseases0low20
Poisoning0low40
Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine0low10
Poisoning, Blood0low20
Poisoning, Manganese0low10
Poisoning, Nervous System0low80
Poisoning, Plant0low70
Polycystic Kidney0low10
Polycystic Kidney Disease0low10
Polycystic Kidney Diseases0low10
Polycystic Kidneys0low10
Polycystic Renal Disease0low10
Polynesian Bronchiectasis0low10
Polyphagia0low10
Polyploid0low10
Polyploid Cell0low10
Polyploidy0low10
Polyposis Coli0low10
Polyposis Coli, Familial0low10
Polyposis Syndrome, Familial0low10
Polyposis, Adenomatous Intestinal0low10
Polyuria0low120
Post Traumatic Stress Disorder0low10
Post-Traumatic Myelopathy0low100
Post-Traumatic Stress Disorders0low10
Postabsorptive Hypoglycemia0low30
Posterior Circulation Brain Infarction0low10
Posterior Circulation Infarction, Brain0low10
Posterior Circulation Transient Ischemic Attack0low50
Posterior Fascicular Block0low10
Posterior Longitudinal Ligament Calcification0low10
Posterior Longitudinal Ligament Ossification0low10
Postmortem Changes0low10
Postoperative Complications0low30
Postprandial Hyperglycemia0low10
Postprandial Hypoglycemia0low30
Postsynaptic Congenital Myasthenic Syndrome0low10
Postsynaptic Congenital Myasthenic Syndromes0low10
Posttraumatic Stress Disorders0low10
Poultry Diseases0low20
Pre-Eclampsia0low20
Precordial Catch0low10
Precordial Catch Syndrome0low10
Predisposition, Genetic0low60
Preeclampsia0low20
Preeclampsia Eclampsia 10low20
Pregnancy0low460
Pregnancy Complications0low10
Pregnancy Toxemias0low20
Premature Beats0low10
Premature Cardiac Complex0low10
Premature Cardiac Complexes0low10
Prenatal Exposure Delayed Effects0low100
Prescription Drug Abuse0low50
Presenile Alzheimer Dementia0medium301
Presynaptic Congenital Myasthenic Syndrome0low10
Presynaptic Congenital Myasthenic Syndromes0low10
Primary Brain Neoplasms0low90
Primary Hyperthyroidism0low20
Primary Hypothyroidism0low40
Primary Malignant Brain Neoplasms0low90
Primary Malignant Brain Tumors0low90
Primary Neoplasms, Cerebellum0low10
Primary Parkinsonism0low40
Primary Senile Degenerative Dementia0medium301
Primary Toni-Debre-Fanconi Syndrome0low10
Prion Disease0low20
Prion Diseases0low20
Prion Protein Diseases0low20
Prion-Associated Disorders0low20
Prion-Induced Disorder0low20
Prion-Induced Disorders0low20
Progranulocytic Leukemia0low70
Progressive Chorea, Chronic Hereditary (Huntington)0low80
Progressive Chorea, Hereditary, Chronic (Huntington)0low80
Progressive Lenticular Degeneration0low20
Progressive Muscular Atrophy0low10
Progressive Muscular Dystrophy, Oculopharyngeal Type0low10
Progressive Myelopathic Muscular Atrophy0low10
Progressive Proximal Myelopathic Muscular Atrophy0low10
Progressive Variant of Kozhevnikow Syndrome0low10
Promyelocytic Leukemia, Acute0low70
Prostate Cancer0low50
Prostate Neoplasms0low50
Prostatic Cancer0low50
Prostatic Neoplasms0low50
Prosthesis Durability0low10
Prosthesis Failure0low10
Prosthesis Loosening0low10
Prosthesis Migration0low10
Prosthesis Survival0low10
Protein Aggregation, Pathological0low10
Protein Folding Diseases0low10
Protein Folding Disorders0low10
Protein Misfolding Diseases0low10
Protein Misfolding Disorders0low10
Proteinuria0low10
Proteinuria-Edema-Hypertension Gestosis0low20
Proteostasis Deficiencies0low10
Proteostasis Dysfunctions0low10
Proximal Myelopathic Muscular Atrophy, Progressive0low10
Proximal Renal Tubular Acidosis0low20
Proximal Renal Tubular Dysfunction0low10
Pruritis0low10
Pruritus0low10
Pseudo-Phlorizin Diabetes0low10
Pseudohermaphroditism0low10
Pseudomonas aeruginosa Infection0low10
Pseudomonas Infections0low10
Pseudopelade0medium21
Pseudorabies0low10
Pseudosclerosis0low20
Psoriasis0low20
Psychiatric Diagnosis0medium81
Psychiatric Diseases0medium81
Psychiatric Disorders0medium81
Psychiatric Illness0medium81
Psychomotor Agitation0low20
Psychomotor Disorders0low10
Psychomotor Disorders, Developmental0low10
Psychomotor Hyperactivity0low20
Psychomotor Impairment0low10
Psychomotor Restlessness0low20
Psychoses0medium74
Psychoses, Affective0medium32
Psychoses, Manic-Depressive0medium17121
Psychosis0medium74
Psychosis, Brief Reactive0medium74
Psychosis, Involutional0medium43
Psychosis, Manic-Depressive0medium17121
Psychotic Affective Disorders0medium32
Psychotic Disorders0medium74
Psychotic Mood Disorders0medium32
PT-NANBH0low10
PTSD0low10
Pulmonary Cancer0low80
Pulmonary Disease, Chronic Obstructive0low10
Pulmonary Edema0low20
Pulmonary Edemas0low20
Pulmonary Injury0low10
Pulmonary Neoplasms0low80
Pure Hereditary Red Cell Aplasia0low10
Pustular Psoriasis of Palms and Soles0low20
Pustulosis of Palms and Soles0low20
Pustulosis Palmaris et Plantaris0low20
Pyaemia0low20
Pyemia0low20
Pyohemia0low20
Pyrexia0low10
Quadriparesis0low10
Quadriplegia0low10
Radiculitis0low10
Radiculopathy0low10
Radiculopathy, Cervical0low10
Ramsay Hunt Paralysis Syndrome0low10
Rasmussen Encephalitis0low40
Rasmussen Syndrome0low40
Rasmussen's Syndrome0low40
Reaction, Acute-Phase0low10
Reactive Hypoglycemia0low30
Rebound Nystagmus0low10
Recrudescence0medium93
Recurrence0medium93
Red Cell Aplasia, Pure, Hereditary0low10
Reflex, Pharyngeal0low10
Refractory Epilepsy0low10
Relapse0medium93
REM Sleep Deprivation0low50
Remittent Fever0low10
Renal Cancer0low10
Renal Failure, Acute0low40
Renal Fanconi Syndrome0low10
Renal Insufficiency, Acute0low40
Renal Neoplasms0low10
Renal Tubular Acidosis0low20
Renal Tubular Acidosis 10low20
Renal Tubular Acidosis I0low20
Renal Tubular Acidosis II0low20
Renal Tubular Acidosis, Distal, Autosomal Dominant0low20
Renal Tubular Acidosis, Proximal0low20
Renal Tubular Acidosis, Proximal, with Ocular Abnormalities0low20
Renal Tubular Acidosis, Type I0low20
Renal Tubular Acidosis, Type II0low20
Reoviridae Infections0low10
Reovirus Infections0low10
Reperfusion Damage0low120
Reperfusion Injury0low120
Reperfusion Injury, Myocardial0low30
Resistance, Disease0low10
Respiratory Hypersensitivity0low10
Respiratory Infections0low10
Respiratory Tract Infections0low10
Respirovirus Infections0low20
Response, Acute-Phase0low10
Rest Tremor0medium41
Resting Tremor0medium41
Restlessness0low20
Retention Disorders, Cognitive0low170
Reticulolymphosarcoma0low40
Reticulum Cell-Like Sarcoma, Yoshida0low10
Retinal Degeneration0low20
Retinal Diseases0low10
Retinal Neovascularization0low10
Retinoblastoma0low10
Retraction Nystagmus0low10
Rhabdomyosarcoma0low10
Rheumatic Chorea0low10
Rheumatoid Arthritis0low10
Rheumatoid Spondylitis0low10
Right Bundle-Branch Block0low10
Right Middle Cerebral Artery Infarction0low40
Right-Sided Heart Failure0low10
Rigidity, Decerebrate0low30
Rigidity, Decorticate0low30
Rodent Diseases0low10
Root Resorption0low10
Rotary Nystagmus0low10
Rotational Nystagmus0low10
Rotator Cuff Injuries0low10
Rotator Cuff Tears0low10
Rotator Cuff Tendinitis0low10
Rotator Cuff Tendinosis0low10
RTA, Classic Type0low20
RTA, Distal Type, Autosomal Dominant0low20
RTA, Gradient Type0low20
RTA, Proximal Type0low20
Santavuori-Haltia Disease0low10
Sarcoma, Cerebellar, Circumscribed Arachnoidal0low20
Sarcoma, Engelbreth-Holm-Swarm0low10
Sarcoma, Experimental0low10
Sarcoma, Germinoblastic0low40
Sarcoma, Jensen0low10
Sarcoma, Yoshida0low10
Sarcomas, Experimental0low10
SARS Coronavirus 2 Infection0low10
SARS-CoV-2 Infection0low10
Saturnine Tremor0medium41
SCA10low10
Scapuloperoneal Form of Spinal Muscular Atrophy0low10
Scapuloperoneal Spinal Muscular Atrophy0low10
Scar0low10
Scarring0low10
Scars0low10
Schizoaffective Disorder0medium74
Schizophrenia0medium143
Schizophrenic Disorders0medium143
Schizophreniform Disorders0medium74
Scholastic Skills Development Disorders0low70
Schut-Haymaker Type OPCA0low10
Schwannoma0low10
Schwannoma, Acoustic, Bilateral0low10
Schwannomatosis, Plexiform0low10
Schwartz-Bartter Syndrome0low10
Sclerosis0low10
Sclerosis, Disseminated0low20
Sea Fan Neovascularization0low10
Sea Sickness0low30
Seasickness0low30
Sebaceous Cyst0low10
Second Cranial Nerve Injuries0low20
Second Cranial Nerve Trauma0low20
Secondary Hypothyroidism0low40
Secondary Parkinsonism0low10
Secondary Vascular Parkinson Disease0low10
See-Saw Nystagmus0low10
Seizure0low630
Seizure Disorder0low320
Seizures0low630
Seizures, Auditory0low630
Seizures, Clonic0low630
Seizures, Convulsive0low630
Seizures, Epileptic0low630
Seizures, Focal0low630
Seizures, Generalized0low630
Seizures, Gustatory0low630
Seizures, Motor0low630
Seizures, Olfactory0low630
Seizures, Sensory0low630
Seizures, Somatosensory0low630
Seizures, Tonic0low630
Seizures, Tonic-Clonic0low630
Seizures, Vertiginous0low630
Seizures, Vestibular0low630
Seizures, Visual0low630
Semantic Memory Disorder0low170
Senile Chorea0low10
Senile Dementia, Acute Confusional0medium301
Senile Dementia, Alzheimer Type0medium301
Senile Osteoporosis0low30
Senile Paranoid Dementia0low20
Senile Plaques0low10
Senile Tremor0medium41
Sensitivity and Specificity0low120
Sensitivity, Contact0low10
Sepsis0low20
Septic Shock0low10
Septicemia0low20
Serotonin Syndrome0low30
Severe Sepsis0low20
Sex Development Disorders0low10
Sex Differentiation Disorders0low10
Sex Disorders0medium11
Sexual Development Disorders0low10
Sexual Differentiation Disorders0low10
Sexual Disorders, Physiological0medium11
Sexual Dysfunction, Physiological0medium11
Sexual Dysfunctions, Physiological0medium11
Sheep Diseases0medium41
Shock, Anaphylactic0low10
Shock, Endotoxic0low10
Shock, Septic0low10
Shock, Toxic0low10
Short Sleep Phenotype0low10
Short Sleeper Syndrome0low10
SIADH0low10
Siamese Twins0low10
Side Effects of Drugs0medium21
Siewert Syndrome0low10
Simple Endometrial Hyperplasia0low10
Simple Partial Status Epilepticus0low1000
Single Seizure0low630
Situs Inversus0low10
Situs Inversus Viscerum0low10
Skin Diseases, Infectious0low10
Sleep Debt0low50
Sleep Deprivation0low50
Sleep Disorders0low10
Sleep Fragmentation0low50
Sleep Insufficiency0low50
Sleep Wake Disorders0low10
Sleep-Related Neurogenic Tachypnea0low10
Slow-Channel Congenital Myasthenic Syndrome0low10
Slow-Channel Congenital Myasthenic Syndromes0low10
Spastic Quadriplegia0low10
Spastic Tetraplegia0low10
Spatial Memory Disorder0low170
Spielmeyer-Sjogren Disease0low10
Spielmeyer-Vogt Disease0low10
Spinal Amyotrophy0low10
Spinal Cord Contusion0low100
Spinal Cord Injuries0low100
Spinal Cord Laceration0low100
Spinal Cord Transection0low100
Spinal Cord Trauma0low100
Spinal Muscular Atrophy0low10
Spinal Muscular Atrophy, Distal0low10
Spinal Muscular Atrophy, Oculopharyngeal0low10
Spinal Muscular Atrophy, Scapuloperoneal0low10
Spinal Muscular Atrophy, Scapuloperoneal Form0low10
Spinocerebellar Ataxia 10low10
Spinocerebellar Ataxia 20low10
Spinocerebellar Ataxia 30low20
Spinocerebellar Ataxia 40low10
Spinocerebellar Ataxia 50low10
Spinocerebellar Ataxia 60low10
Spinocerebellar Ataxia 70low10
Spinocerebellar Ataxia Type 10low10
Spinocerebellar Ataxia Type 20low10
Spinocerebellar Ataxia Type 30low20
Spinocerebellar Ataxia Type 40low10
Spinocerebellar Ataxia Type 50low10
Spinocerebellar Ataxia Type 60low10
Spinocerebellar Ataxia Type 70low10
Spinocerebellar Ataxia with Slow Eye Movements0low10
Spinocerebellar Ataxia-10low10
Spinocerebellar Ataxia-20low10
Spinocerebellar Ataxia-30low20
Spinocerebellar Ataxia-40low10
Spinocerebellar Ataxia-50low10
Spinocerebellar Ataxia-60low10
Spinocerebellar Ataxia-70low10
Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy0low10
Spinocerebellar Ataxia, Cuban Type0low10
Spinocerebellar Ataxias0low10
Spinocerebellar Ataxias, Dominantly-Inherited0low10
Spinocerebellar Atrophies0low10
Spinocerebellar Atrophy 20low10
Spinocerebellar Atrophy I0low10
Spinocerebellar Atrophy II0low10
Spinocerebellar Atrophy III0low20
Spinocerebellar Atrophy Type 30low20
Spinocerebellar Degeneration with Slow Eye Movements0low10
Spiral Fractures0low10
Spondylarthritis Ankylopoietica0low10
Spondylitis Ankylopoietica0low10
Spondylitis, Ankylosing0low10
Spondyloarthritis Ankylopoietica0low10
Spongiform Encephalopathies, Transmissible0low20
Spongiform Encephalopathy, Subacute0low10
Spongy Degeneration Of Central Nervous System0low10
Spongy Degeneration of Infancy0low10
Spongy Degeneration of the Brain0low10
Spongy Degeneration of the Central Nervous System0low10
Spongy Degeneration of White Matter In Infancy0low10
Spongy Disease of Central Nervous System0low10
Spongy Disease of White Matter0low10
Spontaneous Ocular Nystagmus0low10
Sporadic Form of Canavan Disease0low10
Sporadic Inclusion Body Myositis0low10
Sporadic Retinoblastoma0low10
Spotting0low10
Squamous Cell Carcinoma0low50
SREDIu0160NJI u017DIVu010CANI SUSTAV, BOLESTI@hr0low10
St. Vitus's Dance0low10
Staphylococcal Infections0low10
Staphylococcus aureus Infection0low10
Starvation0low10
Static Tremor0medium41
Status Epilepticus0low1000
Status Epilepticus, Complex Partial0low1000
Status Epilepticus, Electrographic0low1000
Status Epilepticus, Generalized0low1000
Status Epilepticus, Generalized Convulsive0low1000
Status Epilepticus, Grand Mal0low1000
Status Epilepticus, Non-Convulsive0low1000
Status Epilepticus, Simple Partial0low1000
Status Epilepticus, Subclinical0low1000
Status Marmoratus0low20
Steatohepatitis0low10
Steatosis of Liver0low10
Stomach Cancer0low100
Stomach Diseases0low10
Stomach Neoplasms0low100
Stomach Ulcer0low20
Stomatitis0low10
Streptozocin Diabetes0low70
Streptozotocin Diabetes0low70
Stress Disorder, Post Traumatic0low10
Stress Disorders, Post-Traumatic0low10
Stress Disorders, Posttraumatic0low10
Striatonigral Degeneration, Autosomal Dominant0low20
Stroke0low20
Stroke, Acute0low20
Stroke, Middle Cerebral Artery0low40
Stromal Dystrophies, Corneal0low20
Subependymal Giant Cell Astrocytoma0low40
Substance Abuse0low50
Substance Addiction0low50
Substance Dependence0low50
Substance Use0low50
Substance Use Disorders0low50
Substance Withdrawal Syndrome0low100
Substance-Related Disorders0low50
Subwakefullness Syndrome0low10
Suffering, Physical0low70
Suicidal Ideation0low20
Susceptibility, Disease0low60
Susceptibility, Genetic0low60
Swallowing Disorders0low10
Swine Diseases0low50
Sydenham Chorea0low10
Sydenham's Chorea0low10
Sykdommer i sentralnervesystemet@no0low10
Symptomatic Nystagmus0low10
Symptomatic Parkinson Disease0low10
Syndrome of Inappropriate ADH (SIADH) Secretion0low10
Systemic Lupus Erythematosus0low30
T Cell Leukemia Lymphoma, HTLV I Associated0low10
T Cell Leukemia, Adult0low10
T-Cell Leukemia-Lymphoma, Adult0low10
T-Cell Leukemia-Lymphoma, HTLV-I-Associated0low10
T-Cell Leukemia, Adult0low10
T-Lymphotropic Virus Type III Infections, Human0low20
Tachyarrhythmia0low10
Tachycardia0low10
Tachycardia, Ventricular0low10
Tactile Allodynia0low70
Talipes Equinovarus0low10
Taste Disorder, Anterior Tongue0low10
Taste Disorder, Posterior Tongue0low10
Taste Disorder, Primary0low10
Taste Disorder, Primary, Bitter0low10
Taste Disorder, Primary, Salt0low10
Taste Disorder, Primary, Sweet0low10
Taste Disorder, Secondary0low10
Taste Disorder, Secondary, Bitter0low10
Taste Disorder, Secondary, Salt0low10
Taste Disorder, Secondary, Sweet0low10
Taste Disorders0low10
Taste Dysfunction0low10
Taste, Altered0low40
Taste, Distorted0low40
Taste, Metallic0low10
Tauopathies0low70
Tauopathy0low70
TBI (Traumatic Brain Injury)0low30
TBIs (Traumatic Brain Injuries)0low30
Temporary Nystagmus0low10
Tendon Injuries0low10
Teratocarcinoma0low30
Teratoid Tumor0low10
Teratoma0low10
Teratoma, Benign0low10
Teratoma, Cystic0low10
Teratoma, Immature0low10
Teratoma, Malignant0low10
Teratoma, Mature0low10
Tetraplegia0low10
Texidor's Twinge0low10
Thermal Allodynia0low70
Thesaurismosis0medium31
Thiamine Deficiency0low10
Thrombosis, Middle Cerebral Artery0low40
Thrombotic Infarction, Middle Cerebral Artery0low40
Thyroid Adenoma0low40
Thyroid Cancer0low40
Thyroid Carcinoma0low40
Thyroid Diseases0low30
Thyroid Neoplasms0low40
Thyroid-Stimulating Hormone Deficiency0low40
Thyroiditis0low10
Thyrotoxicosis0low10
TIA (Transient Ischemic Attack)0low50
Todd Paralysis0low10
Todd's Paralysis0low10
Toni-Debre-Fanconi Syndrome0low10
Tonic Clonic Seizure0low630
Tonic Seizure0low630
Tonic Seizures0low630
Tonic-Clonic Seizure0low630
Tonic-Clonic Seizures0low630
Torsion Fractures0low10
Toxemia Of Pregnancy0low20
Toxemias, Pregnancy0low20
Toxic Encephalitis0low80
Toxic Hepatitis0low40
Toxic Shock0low10
Toxic Shock Syndrome0low10
Toxicity, Drug0medium21
Transformation, Neoplastic Cell0low40
Transformation, Viral Cell0low20
Transient Ischemic Attack0low50
Transient Ischemic Attack, Anterior Circulation0low50
Transient Ischemic Attack, Brain Stem0low50
Transient Ischemic Attack, Brainstem0low50
Transient Ischemic Attack, Carotid Circulation0low50
Transient Ischemic Attack, Posterior Circulation0low50
Transient Ischemic Attack, Vertebrobasilar Circulation0low50
Transient Ischemic Attacks, Crescendo0low50
Transitory Hearing Loss0low10
Transmissible Dementias0low20
Transmissible Spongiform Encephalopathies0low20
Trauma, Brain0low30
Trauma, Second Cranial Nerve0low20
Traumatic Brain Injury0low30
Traumatic Encephalopathy0low30
Tremor0medium41
Tremor, Limb0medium41
Tremor, Muscle0medium41
Tremor, Neonatal0medium41
Tremor, Nerve0medium41
Tremor, Perioral0medium41
Tremor, Semirhythmic0medium41
Trigeminal Autonomic Cephalalgias0low10
Triple Negative Breast Cancer0low20
Triple Negative Breast Neoplasms0low20
Triple-Negative Breast Cancer0low20
Triple-Negative Breast Neoplasm0low20
Trisomy0low10
Trypanosomiasis, African0low20
TSH Deficiency0low40
Tuberculin-Type Hypersensitivity0low20
Tularemia0low10
Tumorigenesis0low10
Tumorigenic Transformation0low40
Tumors0low90
Tumors, Breast0low130
Twins, Conjoined0low10
Twins, Siamese0low10
Type 1 Diabetes0low10
Type 1 Diabetes Mellitus0low10
Type 1 Spinocerebellar Ataxia0low10
Type 2 Diabetes0low40
Type 2 Diabetes Mellitus0low40
Type 2 Spinocerebellar Ataxia0low10
Type 3 Spinocerebellar Ataxia0low20
Type 4 Spinocerebellar Ataxia0low10
Type 5 Spinocerebellar Ataxia0low10
Type 6 Spinocerebellar Ataxia0low10
Type 7 Spinocerebellar Ataxia0low10
Type I Canavan Disease0low10
Type I Machado-Joseph Disease0low20
Type I Nonketotic Hyperglycinemia0low10
Type I Renal Tubular Acidosis0low20
Type II Canavan Disease0low10
Type II Machado-Joseph Disease0low20
Type II Nonketotic Hyperglycinemia0low10
Type II Renal Tubular Acidosis0low20
Type III Canavan Disease0low10
Type III Machado-Joseph Disease0low20
Type III Nonketotic Hyperglycinemia0low10
Type IV Hypersensitivity0low20
Type IV Machado-Joseph Disease0low20
u041Du0415u0420u0412u041Du041Eu0419 u0421u0418u0421u0422u0415u041Cu042B u0426u0415u041Du0422u0420u0410u041Bu042Cu041Du041Eu0419 u0411u041Eu041Bu0415u0417u041Du0418@ru0low10
u4E2Du67A2u795Eu7D4Cu7CFBu75BEu60A3@ja0low10
UADT Neoplasm0low20
UADT Neoplasms0low20
Unidirectional Nystagmus0low10
Uniparental Disomy0low10
Uniparental Heterodisomy0low10
Uniparental Isodisomy0low10
Unipolar Depression0medium202
Upper Aerodigestive Tract Neoplasm0low20
Upper Aerodigestive Tract Neoplasms0low20
Upper Respiratory Infections0low10
Upper Respiratory Tract Infection0low10
Upper Respiratory Tract Infections0low10
Urinary Bladder Cancer0low20
Urinary Bladder Neoplasms0low20
Uterine Cancer0low10
Uterine Cervical Cancer0low20
Uterine Cervical Neoplasms0low20
Uterine Neoplasms0low10
Uterus Cancer0low10
Uterus Neoplasms0low10
Uveitis0low10
V-CJD (Variant-Creutzfeldt-Jakob Disease)0low10
Van Bogaert-Bertrand Syndrome0low10
Variant Creutzfeldt-Jakob Disease0low10
Vascular Accident, Brain0low20
Vascular Calcification0low10
Vascular Calcinosis0low10
Vascular Diseases0low10
Vascular Diseases, Intracranial0low10
Vasogenic Brain Edema0low20
Vasogenic Cerebral Edema0low20
Vasopressin-Resistant Diabetes Insipidus0low140
Venous Infarction, Brain0low10
Venous Leakage, Penile0low10
Ventricle Remodeling0low20
Ventricular Hypertrophy, Left0low20
Ventricular Remodeling0low20
Ventricular Tachyarrhythmias0low10
Ventricular Tachycardia0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low50
Vertical Nystagmus0low10
Viral Cell Transformation0low20
Visceral Steatosis0low10
Vogt Spielmeyer Disease0low10
Vogt-Spielmeyer Disease0low10
Vomiting0low220
Vomiting, Anticipatory0low90
Von Bogaert-Bertrand Disease0low10
von Gierke Disease0low20
von Gierke's Disease0low20
Wadia Swami Syndrome0low10
Wadia-Swami Syndrome0low10
Weight Gain0low40
Weight Loss0low30
Weight Reduction0low30
Westphal-Strumpell Syndrome0low20
Wet Lung0low20
White Spot, Dental0low10
White Spots, Dental0low10
Wilson Disease0low20
Wilson Disease, Hepatic Form0low20
Wilson's Disease0low20
Withdrawal Symptoms0low100
X-Linked Mental Retardation and Macroorchidism0low30
Zentralnervensystemkrankheiten@de0low10
Ziekte, centraalzenuwstelsel-@nl0low10
Zika Fever0low10
Zika Virus Disease0low10
Zika Virus Infection0low10
ZikV Infection0low10

Research Highlights

Safety/Toxicity (52)

ArticleYear
Cytotoxicity of Exogenous Acetoacetate in Lithium Salt Form Is Mediated by Lithium and Not Acetoacetate.
Anticancer research, Volume: 40, Issue: 7		2020
Enhancing autophagy by down-regulating GSK-3β alleviates cisplatin-induced ototoxicity in vivo and in vitro.
Toxicology letters, Oct-01, Volume: 313		2019
Lithium Toxicity in Older Adults: a Systematic Review of Case Reports.
Clinical drug investigation, Volume: 38, Issue: 3		2018
Lithium attenuates lead induced toxicity on mouse non-adherent bone marrow cells.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), Volume: 36		2016
Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
PloS one, Volume: 11, Issue: 4		2016
Toxic Effects of Lithium Chloride during Early Neonatal Period of Rat Development.
Bulletin of experimental biology and medicine, Volume: 160, Issue: 4		2016
BPA-toxicity via superoxide anion overload and a deficit in β-catenin signaling in human bone mesenchymal stem cells.
Environmental toxicology, Volume: 32, Issue: 1		2017
Lithium protects against methamphetamine-induced neurotoxicity in PC12 cells via Akt/GSK3β/mTOR pathway.
Biochemical and biophysical research communications, Sep-25, Volume: 465, Issue: 3		2015
Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein.
Biochimica et biophysica acta, Volume: 1853, Issue: 10 Pt A		2015
Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats.
Neuroscience, Feb-26, Volume: 287		2015
Lithium prevents acrolein-induced neurotoxicity in HT22 mouse hippocampal cells.
Neurochemical research, Volume: 39, Issue: 4		2014
Temporal association as a prerequisite factor of valsartan-induced lithium toxicity.
Bipolar disorders, Volume: 16, Issue: 6		2014
Nitrergic, glutamatergic and gabaergic systems in lithium toxicity.
The Journal of toxicological sciences, Volume: 37, Issue: 5		2012
Role of autophagy inhibitors and inducers in modulating the toxicity of trimethyltin in neuronal cell cultures.
Journal of neural transmission (Vienna, Austria : 1996), Volume: 119, Issue: 11		2012
Lithium attenuates bupivacaine-induced neurotoxicity in vitro through phosphatidylinositol-3-kinase/threonine-serine protein kinase B- and extracellular signal-regulated kinase-dependent mechanisms.
Neuroscience, Mar-29, Volume: 206		2012
Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Journal of neuroscience research, Volume: 89, Issue: 3		2011
Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators.
Biochemical and biophysical research communications, Jan-14, Volume: 404, Issue: 2		2011
Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y.
Journal of neuro-oncology, Volume: 100, Issue: 3		2010
Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides.
Journal of neurochemistry, Volume: 112, Issue: 2		2010
Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study.
Clinical toxicology (Philadelphia, Pa.), Volume: 48, Issue: 1		2010
Severe toxicity and cyclooxygenase (COX)-2 mRNA increase by lithium in the neonatal mouse kidney.
The Journal of toxicological sciences, Volume: 34, Issue: 5		2009
Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Hearing research, Volume: 257, Issue: 1-2		2009
Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.
CNS drugs, Volume: 23, Issue: 5		2009
Cytotoxicity and mitotic alterations induced by non-genotoxic lithium salts in CHO cells in vitro.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 23, Issue: 3		2009
Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary cultures.
Brain research, May-01, Volume: 1268		2009
Safe taste memory consolidation is disrupted by a protein synthesis inhibitor in the nucleus accumbens shell.
Neurobiology of learning and memory, Volume: 92, Issue: 1		2009
Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing.
Toxicology, Jul-30, Volume: 249, Issue: 2-3		2008
Astroglia growth retardation and increased microglia proliferation by lithium and ornithine decarboxylase inhibitor in rat cerebellar cultures: Cytotoxicity by combined lithium and polyamine inhibition.
Journal of neuroscience research, Feb-15, Volume: 85, Issue: 3		2007
Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 30, Issue: 6		2005
Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo.
Brain research, Nov-05, Volume: 1026, Issue: 1		2004
p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity.
The Journal of neuroscience : the official journal of the Society for Neuroscience, Aug-13, Volume: 23, Issue: 19		2003
Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.
Neuropharmacology, Volume: 43, Issue: 7		2002
Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.
The Journal of biological chemistry, Sep-13, Volume: 277, Issue: 37		2002
Pharmacokinetics and toxic effects of lithium chloride after intravenous adminstration in conscious horses.
American journal of veterinary research, Volume: 62, Issue: 9		2001
Effects of chronic lithium on ototoxicity induced by gentamicin and amikacin in guinea-pigs.
Pharmacology & toxicology, Volume: 83, Issue: 5		1998
Prevention of lithium nephrotoxicity in a novel one-hour model in rats.
Psychopharmacology, Volume: 138, Issue: 1		1998
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx.
Proceedings of the National Academy of Sciences of the United States of America, Mar-03, Volume: 95, Issue: 5		1998
The yeast HAL2 nucleotidase is an in vivo target of salt toxicity.
The Journal of biological chemistry, Nov-15, Volume: 271, Issue: 46		1996
Enhancement of tumor necrosis factor cytotoxicity by lithium chloride is associated with increased inositol phosphate accumulation.
Journal of immunology (Baltimore, Md. : 1950), Jul-01, Volume: 151, Issue: 1		1993
Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
Cytokine, Volume: 7, Issue: 5		1995
Strain dependent rate of Li+ elimination associated with toxic effects of lethal doses of lithium chloride in mice.
Pharmacology, biochemistry, and behavior, Volume: 19, Issue: 2		1983
Effect of alkali metals on chlorpromazine toxicity in the mouse.
Brain research bulletin, Volume: 11, Issue: 2		1983
Genetic basis for lithium toxicity and its relationship with tissue distribution: a diallel cross analysis of six strains of mice.
Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie, Volume: 25, Issue: 2		1983
Effect of age and route of administration on LD50 of lithium chloride in the rat.
Acta pharmacologica et toxicologica, Volume: 47, Issue: 5		1980
Role of dopamine in manganese neurotoxicity.
Brain research, Nov-15, Volume: 473, Issue: 2		1988
Lack of effectiveness of forskolin or inositol as antidote in lithium toxicity. Short note.
Journal of neural transmission, Volume: 72, Issue: 2		1988
Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America, Volume: 86, Issue: 23		1989
Food aversion learning: ability of lambs to distinguish safe from harmful foods.
Journal of animal science, Volume: 67, Issue: 7		1989
TNF-mediated IL6 gene expression and cytotoxicity are co-inducible in TNF-resistant L929 cells.
FEBS letters, May-18, Volume: 302, Issue: 3		1992
Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride.
Journal of internal medicine, Volume: 231, Issue: 3		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (48)

ArticleYear
Chloroquine attenuates lithium-induced NDI and proliferation of renal collecting duct cells.
American journal of physiology. Renal physiology, 05-01, Volume: 318, Issue: 5		2020
Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression.
Progress in neuro-psychopharmacology & biological psychiatry, Dec-03, Volume: 63		2015
Effects of lithium and aripiprazole on brain stimulation reward and neuroplasticity markers in the limbic forebrain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, Volume: 24, Issue: 4		2014
Uptake of lithium into rat brain after acute and chronic administration.
Neuroscience letters, Jul-11, Volume: 521, Issue: 1		2012
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.
Neuropharmacology, Volume: 62, Issue: 1		2012
Glycogen synthase kinase 3β in the nucleus accumbens core is critical for methamphetamine-induced behavioral sensitization.
Journal of neurochemistry, Volume: 118, Issue: 1		2011
Memantine reduces mania-like symptoms in animal models.
Psychiatry research, Aug-15, Volume: 188, Issue: 3		2011
A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test.
Behavioural brain research, Jun-08, Volume: 200, Issue: 1		2009
Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.
Neuropharmacology, Volume: 56, Issue: 2		2009
Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
European journal of pharmacology, Nov-12, Volume: 597, Issue: 1-3		2008
Effect of lithium on swim stress-induced antinociception in naive mice and mice with subchronic administration of morphine or swim stress in formalin test.
Archives of Iranian medicine, Volume: 11, Issue: 2		2008
Protective effects of chronic lithium treatment against spatial memory retention deficits induced by the protein kinase AII inhibitor H-89 in rats.
Pharmacology, Volume: 80, Issue: 2-3		2007
The effect of lithium chloride on morphine-induced tolerance and dependence in isolated guinea pig ileum.
European journal of pharmacology, Sep-18, Volume: 545, Issue: 2-3		2006
Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Volume: 22, Issue: 1		2007
Lithium inhibits the modulatory effects of morphine on susceptibility to pentylenetetrazole-induced clonic seizure in mice: involvement of a nitric oxide pathway.
Brain research, Dec-10, Volume: 1029, Issue: 1		2004
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
Neuropharmacology, Volume: 43, Issue: 7		2002
Lithium chloride at a therapeutic concentration reduces Ca2+ response in protein kinase C down-regulated human astrocytoma cells.
European journal of pharmacology, May-03, Volume: 442, Issue: 1-2		2002
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain.
Psychopharmacology, Volume: 158, Issue: 1		2001
Chronic lithium chloride injection increases glucocorticoid receptor but not mineralocorticoid receptor mRNA expression in rat brain.
Neuroscience research, Volume: 38, Issue: 3		2000
Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
Brain research, Feb-07, Volume: 855, Issue: 1		2000
Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo.
Journal of neurochemistry, Volume: 73, Issue: 6		1999
The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats.
Brain research, May-01, Volume: 826, Issue: 2		1999
Lithium stimulates gene expression through the AP-1 transcription factor pathway.
Brain research. Molecular brain research, Jul-15, Volume: 58, Issue: 1-2		1998
Lithium modulation of phosphoinositide signaling system in rat cortex: selective effect on phorbol ester binding.
Journal of neurochemistry, Volume: 61, Issue: 5		1993
Effect of chronic lithium chloride on membrane adenosine triphosphatases in certain postural muscles of rats.
European journal of pharmacology, Jun-23, Volume: 259, Issue: 1		1994
Chronic administration of lithium chloride increases immunodetectable glial fibrillary acidic protein in the rat hippocampus.
Journal of neurochemistry, Volume: 63, Issue: 4		1994
Decreased number of benzodiazepine receptors in frontal cortex of rat brain following long-term lithium treatment.
Journal of neurochemistry, Volume: 41, Issue: 1		1983
Effect of lithium upon desipramine enhanced shock-elicited fighting in rats.
Pharmacology, biochemistry, and behavior, Volume: 17, Issue: 2		1982
Effect of serotonin depletion induced by p-chloroamphetamine on changes in rats' activity levels-produced by lithium.
Neuropsychobiology, Volume: 8, Issue: 3		1982
[Effect of chronic administration of lithium chloride on the development of dopamine receptor sensitivity during morphine withdrawal in rats].
Biulleten' eksperimental'noi biologii i meditsiny, Volume: 92, Issue: 11		1981
Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat.
Journal of neurochemistry, Volume: 36, Issue: 6		1981
Using profiles of saccharin and water drinking to detect and discriminate actions of drugs and toxicants.
Pharmacology, biochemistry, and behavior, Volume: 13, Issue: 4		1980
Chronic administration of lithium modulates tryptophan transport by changing the properties of the synaptosomal plasma membrane.
Life sciences, Aug-03, Volume: 41, Issue: 5		1987
Comparing oral lithium carbonate and intraperitoneal lithium chloride chronic administrations on rats' activity levels.
Neuropsychobiology, Volume: 16, Issue: 2-3		1986
Lithium effects on adjunctive alcohol consumption. II: Effects of adding concurrent shock.
Pharmacology, biochemistry, and behavior, Volume: 25, Issue: 6		1986
Lithium effects on adjunctive alcohol consumption. I: Comparison with adjunctive water consumption.
Pharmacology, biochemistry, and behavior, Volume: 25, Issue: 6		1986
Effects of lithium and rubidium on shock-induced changes in open-field activity.
Psychopharmacology, Volume: 88, Issue: 2		1986
Lithium effects on position learning with exploratory and aversive goal-box conditions.
Pharmacology, biochemistry, and behavior, Volume: 22, Issue: 5		1985
Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats.
Brain research, Volume: 427, Issue: 2		1988
Lithium: evidence for reduction in circulating testosterone levels in mice following chronic administration.
Life sciences, Volume: 43, Issue: 19		1988
Change of synaptic membrane lipid composition and fluidity by chronic administration of lithium.
Biochimica et biophysica acta, Apr-22, Volume: 939, Issue: 3		1988
Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid.
Experimental neurology, Volume: 98, Issue: 3		1987
[Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
Biulleten' eksperimental'noi biologii i meditsiny, Volume: 108, Issue: 8		1989
Determination of monoamines in rat brain regions after chronic administration of lithium.
Neurochemical research, Volume: 14, Issue: 9		1989
Long-term lithium treatment does not suppress hibernation in European hamsters.
Neuropsychobiology, Volume: 23, Issue: 1		1990
Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats.
The American journal of physiology, Volume: 261, Issue: 3 Pt 2		1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (17)

ArticleYear
Pharmacokinetics of intravenous lithium chloride and assessment of agreement between two methods of lithium concentration measurement in the horse.
Equine veterinary journal, Volume: 50, Issue: 4		2018
Decreased right hippocampal volumes and neuroprogression markers in adolescents with bipolar disorder.
Neuropsychobiology, Volume: 71, Issue: 3		2015
Optimizations of packed sorbent and inlet temperature for large volume-direct aqueous injection-gas chromatography to determine high boiling volatile organic compounds in water.
Journal of chromatography. A, Aug-22, Volume: 1356		2014
Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment.
Bipolar disorders, Volume: 14, Issue: 3		2012
Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 35, Issue: 8		2010
Thalamic volumes in patients with bipolar disorder.
European archives of psychiatry and clinical neuroscience, Volume: 260, Issue: 8		2010
Status epilepticus in 12-day-old rats leads to temporal lobe neurodegeneration and volume reduction: a histologic and MRI study.
Epilepsia, Volume: 47, Issue: 3		2006
Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging.
Magnetic resonance imaging, Volume: 23, Issue: 8		2005
Increased gray matter volume in lithium-treated bipolar disorder patients.
Neuroscience letters, Aug-30, Volume: 329, Issue: 2		2002
Pharmacokinetics and toxic effects of lithium chloride after intravenous adminstration in conscious horses.
American journal of veterinary research, Volume: 62, Issue: 9		2001
Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat.
Naunyn-Schmiedeberg's archives of pharmacology, Volume: 363, Issue: 3		2001
Effects of lithium on the pharmacokinetics of valproate in rats.
The Journal of pharmacy and pharmacology, Volume: 52, Issue: 3		2000
A comparison between endogenous and exogenous lithium clearance in the anaesthetized rat.
Acta physiologica Scandinavica, Volume: 151, Issue: 2		1994
The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug.
Neuropharmacology, Volume: 25, Issue: 11		1986
Pharmacokinetics of lithium in the dog.
Journal of veterinary pharmacology and therapeutics, Volume: 9, Issue: 1		1986
Inter-organ relation between salivary gland and kidney in lithium excretion. II. Salivary, renal and systemic clearances of lithium under continuous stimulation of salivation in water loaded dogs.
Journal of pharmacobio-dynamics, Volume: 12, Issue: 9		1989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (3)

ArticleYear
Effect of acetazolamide on lithium reabsorption and lithium-induced GSK3β phosphorylation in rat kidney.
Die Pharmazie, 10-01, Volume: 74, Issue: 10		2019
A comparison between endogenous and exogenous lithium clearance in the anaesthetized rat.
Acta physiologica Scandinavica, Volume: 151, Issue: 2		1994
Pharmacokinetics of lithium in the dog.
Journal of veterinary pharmacology and therapeutics, Volume: 9, Issue: 1		1986
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (86)

ArticleYear
Effect of lithium chloride on d-galactose induced organs injury: Possible antioxidative role.
Pakistan journal of pharmaceutical sciences, Volume: 33, Issue: 4(Suppleme		2020
Neuroprotective Effect of Intravitreal Single-Dose Lithium Chloride after Optic Nerve Injury in Rats.
Current eye research, Volume: 46, Issue: 4		2021
Potent Inhibition of Biphasic Tubular Reabsorption of Lithium by Acetazolamide and Foscarnet in Rats.
Physiological research, 08-31, Volume: 69, Issue: 4		2020
Aryl hydrocarbon receptor is indispensable for β-naphthoflavone-induced novel food avoidance and may be involved in LiCl-triggered conditioned taste aversion in rats.
Physiology & behavior, 05-15, Volume: 204		2019
Lithium Clinics in Berlin and Dresden: a 50-Year Experience.
Pharmacopsychiatry, Volume: 51, Issue: 5		2018
Status epilepticus: Role for etiology in determining response to benzodiazepines.
Annals of neurology, Volume: 83, Issue: 4		2018
[Acute lithium poisoning: epidemiology, clinical characteristics, and treatment].
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Volume: 29, Issue: 1		2017
Six2 Is a Coordinator of LiCl-Induced Cell Proliferation and Apoptosis.
International journal of molecular sciences, Sep-08, Volume: 17, Issue: 9		2016
A sub-threshold dose of pilocarpine increases glutamine synthetase in reactive astrocytes and enhances the progression of amygdaloid-kindling epilepsy in rats.
Neuroreport, Mar-02, Volume: 27, Issue: 4		2016
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
Journal of medicinal chemistry, Nov-25, Volume: 58, Issue: 22		2015
Effect of daily lithium chloride administration on bone mass and strength in growing broiler chickens.
Poultry science, Volume: 94, Issue: 2		2015
Kinetics of lithium as a lithium chloride dose suitable for conditioned taste aversion in lactating goats and dry sheep.
Journal of animal science, Volume: 93, Issue: 2		2015
Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 40, Issue: 2		2015
Temporal association as a prerequisite factor of valsartan-induced lithium toxicity.
Bipolar disorders, Volume: 16, Issue: 6		2014
Conditioned taste aversion as instrumental punishment.
Journal of experimental psychology. Animal behavior processes, Volume: 39, Issue: 3		2013
The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144)
Bipolar disorders, Volume: 15, Issue: 1		2013
Quantification of sewer leakage by a continuous tracer method.
Water science and technology : a journal of the International Association on Water Pollution Research, Volume: 64, Issue: 1		2011
The lithiumeter: a measured approach.
Bipolar disorders, Volume: 13, Issue: 3		2011
Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
Tropical biomedicine, Volume: 27, Issue: 3		2010
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors.
The oncologist, Volume: 16, Issue: 4		2011
A comparison between taste avoidance and conditioned disgust reactions induced by ethanol and lithium chloride in preweanling rats.
Developmental psychobiology, Volume: 52, Issue: 6		2010
Effects of methamphetamine on sexual performance and compulsive sex behavior in male rats.
Psychopharmacology, Volume: 212, Issue: 1		2010
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas.
Surgery, Volume: 141, Issue: 2		2007
Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging.
Magnetic resonance imaging, Volume: 23, Issue: 8		2005
Outcome of status epilepticus in immature rats varies according to the paraldehyde treatment.
Epilepsia, Volume: 46 Suppl 5		2005
Dose response effects of lithium chloride on conditioned place aversions and locomotor activity in rats.
European journal of pharmacology, May-16, Volume: 515, Issue: 1-3		2005
Lamotrigine use in geriatric patients with bipolar depression.
Canadian journal of psychiatry. Revue canadienne de psychiatrie, Volume: 47, Issue: 8		2002
How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.
Journal of clinical psychopharmacology, Volume: 22, Issue: 4		2002
LiCl attenuates M(1)AChR-mediated intrathecal pilocarpine-induced reciprocal hindlimb scratching in mice.
Pharmacology, Volume: 65, Issue: 4		2002
Conditioning taste aversions to locoweed (Oxytropis sericea) in horses.
Journal of animal science, Volume: 80, Issue: 1		2002
Postnatal anoxia from CO2 for one minute produces sex-specific changes in contextual fear conditioning in adult rats.
Perceptual and motor skills, Volume: 93, Issue: 3		2001
The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
British journal of pharmacology, Volume: 133, Issue: 8		2001
Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.
Journal of clinical psychopharmacology, Volume: 21, Issue: 2		2001
Multiple cellular processes affected by the absence of the Rpb4 subunit of RNA polymerase II contribute to the deficiency in the stress response of the yeast rpb4(delta) mutant.
Molecular & general genetics : MGG, Volume: 264, Issue: 6		2001
Excitation evoked by FMRFamide and FLRFamide in the heart of Buccinum undatum and evidence for inositol 1,4,5-trisphosphate as an RF-tetrapeptide second messenger.
Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, Volume: 170, Issue: 5-6		2000
Nordidemnin potently inhibits inositol uptake in cultured astrocytes and dose-dependently augments lithium's proconvulsant effect in vivo.
Journal of neuroscience research, Apr-01, Volume: 60, Issue: 1		2000
The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats.
Brain research, May-01, Volume: 826, Issue: 2		1999
Lithium-induced alterations in the testis of the male roseringed parakeet (Psittacula krameri) : evidence for significant structural changes and disruption in the spermatogenetic activity.
Endocrine research, Volume: 25, Issue: 1		1999
The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.
Journal of the American Society of Nephrology : JASN, Volume: 10 Suppl 11		1999
Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice.
Journal of toxicology. Clinical toxicology, Volume: 36, Issue: 4		1998
Conditioned taste aversion and c-fos expression in the rat brainstem after administration of various USs.
Neuroreport, Jul-07, Volume: 8, Issue: 9-10		1997
Renal side-effects of long-term lithium treatment.
Journal of affective disorders, Volume: 43, Issue: 1		1997
LiCl-induced malformations of the eyes and the rostral CNS in Xenopus laevis.
Journal fur Hirnforschung, Volume: 38, Issue: 1		1997
Blockade of lithium chloride-induced conditioned place aversion as a test for antiemetic agents: comparison of metoclopramide with combined extracts of Zingiber officinale and Ginkgo biloba.
Pharmacology, biochemistry, and behavior, Volume: 52, Issue: 2		1995
Salt tolerance and methionine biosynthesis in Saccharomyces cerevisiae involve a putative phosphatase gene.
The EMBO journal, Volume: 12, Issue: 8		1993
Influence of cattle age, lithium chloride dose level, and food type in the retention of food aversions.
Journal of animal science, Volume: 71, Issue: 2		1993
Cellular mechanisms mediating the stimulation of ovine endometrial secretion of prostaglandin F2 alpha in response to oxytocin: role of phospholipase C and diacylglycerol.
The Journal of endocrinology, Volume: 141, Issue: 3		1994
Cognition-activating properties of 3-(Aryloxy)pyridines.
Journal of medicinal chemistry, Volume: 24, Issue: 3		1981
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
Journal of medicinal chemistry, Volume: 27, Issue: 5		1984
Relationship between inositol polyphosphate production and the increase of cytosolic free Ca2+ induced by vasopressin in isolated hepatocytes.
The Journal of biological chemistry, May-10, Volume: 259, Issue: 9		1984
Growth effect of lithium on mouse mammary epithelial cells in serum-free collagen gel culture.
Journal of cellular physiology, Volume: 117, Issue: 3		1983
Use of pharmacological challenges to disclose neurobehavioral deficits.
Federation proceedings, Volume: 42, Issue: 15		1983
Lithium-induced changes in the plasma and pituitary levels of luteinizing hormone, follicle stimulating hormone and prolactin in rats.
Life sciences, Oct-17, Volume: 33, Issue: 16		1983
Chlorpromazine and lithium interaction: a biochemical and histological study.
Brain research bulletin, Volume: 11, Issue: 2		1983
Effect of alkali metals on chlorpromazine toxicity in the mouse.
Brain research bulletin, Volume: 11, Issue: 2		1983
Behavioral, metabolic and histological aspects of lithium and ethanol interaction.
Drug and chemical toxicology, Volume: 6, Issue: 4		1983
Lithium chloride-induced taste aversion in C57BL/6J and DBA/2J mice.
The Journal of general psychology, Volume: 106, Issue: 2d Half		1982
The effect of lithium chloride on renal structure and sodium-potassium-adenosine triphosphatase activity in dogs.
Veterinary pathology, Volume: 19, Issue: 1		1982
[Morphofunctional changes in the thyroid glands of rats following lithium chloride administration].
Biulleten' eksperimental'noi biologii i meditsiny, Volume: 91, Issue: 6		1981
[Mechanisms of the central action of lithium].
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), Volume: 81, Issue: 4		1981
Norepinephrine and thyroid-stimulating hormone induce inositol phosphate accumulation in FRTL-5 cells.
Endocrinology, Volume: 119, Issue: 5		1986
Control by cations of opioid binding in guinea pig brain membranes.
Proceedings of the National Academy of Sciences of the United States of America, Volume: 83, Issue: 16		1986
Sham feeding, flavor associations and diet self-selection as indicators of feeding satiety or aversive effects of peptide hormones.
Brain research bulletin, Volume: 14, Issue: 6		1985
Patterns of increased and decreased ingestive behavior after injections of lithium chloride and 2-deoxy-D-glucose.
Physiology & behavior, Volume: 43, Issue: 6		1988
Site-dependent effects of ions on mu-, delta- and kappa-opioid binding in suspensions of guinea-pig brain membranes.
NIDA research monograph, Volume: 75		1986
Effects of anterior basolateral amygdala lesions on taste aversions produced by high and low oral doses of LiCl and lactose in the rat.
Behavioural brain research, Volume: 25, Issue: 2		1987
Lithium chloride SCN injection alters the circadian rhythm of food intake.
Chronobiology international, Volume: 6, Issue: 2		1989
Conditioned taste aversion to injected flavor: differential effect of anesthesia on the formation of the gustatory trace and on its association with poisoning in rats.
Neuroscience letters, Apr-10, Volume: 98, Issue: 3		1989
Lithium suppresses ovariectomy-induced surges in plasma gonadotropins in rats.
Life sciences, Volume: 44, Issue: 19		1989
In vitro effect of lithium on carbamazepine-induced inhibition of murine and human bone marrow-derived granulocyte-macrophage, erythroid, and megakaryocyte progenitor stem cells.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), Volume: 190, Issue: 1		1989
Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex.
Journal of neurochemistry, Volume: 52, Issue: 2		1989
Plasma lithium as a marker of lithium chloride in wild Norway rats (R. norvegicus).
Physiology & behavior, Volume: 47, Issue: 5		1990
Characterization of a dose-response curve for nicotine-induced conditioned taste aversion in rats: relationship to elevation of plasma beta-endorphin concentration.
Behavioral and neural biology, Volume: 53, Issue: 3		1990
Influence of repeated administration of lithium on urinary excretion of prostaglandins in rats.
Japanese journal of pharmacology, Volume: 57, Issue: 4		1991
Influence of chronic lithium treatment on urinary amount of furosemide in rats.
Japanese journal of pharmacology, Volume: 56, Issue: 4		1991
Induction of neurite outgrowth of PC12 cells by an inhibitor of vacuolar H(+)-ATPase, bafilomycin A1.
FEBS letters, Dec-02, Volume: 294, Issue: 1-2		1991
Cholinergic rebound after chlorpromazine exacerbates lithium muscarinic-induced limbic seizures in rats: implications for psychiatric treatment.
Psychological reports, Volume: 69, Issue: 1		1991
Opioid efficacy is linked to the LiCl-sensitive, inositol-1,4,5-trisphosphate-restorable pathway.
European journal of pharmacology, Jul-07, Volume: 217, Issue: 2-3		1992
Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells.
The Biochemical journal, Aug-01, Volume: 285 ( Pt 3)		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (8)

ArticleYear
Neuroprotective effects of vitamin D alone or in combination with lamotrigine against lithium-pilocarpine model of status epilepticus in rats.
Naunyn-Schmiedeberg's archives of pharmacology, Volume: 390, Issue: 10		2017
[Therapeutic effect of lithium chloride combined with cyclosporine A on mouse model with aplastic anemia].
Zhongguo shi yan xue ye xue za zhi, Volume: 20, Issue: 3		2012
[Lithium chloride combined with human umbilical cord blood mesenchymal stem cell transplantation for treatment of spinal cord injury in rats].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University, Volume: 30, Issue: 11		2010
Antiepileptic drugs combined with high-frequency electrical stimulation in the ventral hippocampus modify pilocarpine-induced status epilepticus in rats.
Epilepsia, Volume: 51, Issue: 3		2010
Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats.
Journal of hypertension, Volume: 23, Issue: 12		2005
Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
Journal of clinical psychopharmacology, Volume: 23, Issue: 3		2003
Methodological issues in drug-drug conditioning in rats: nonassociative factors in heart rate and avfail.
Behavioral neuroscience, Volume: 105, Issue: 6		1991
Drug-drug heart rate conditioning in rats: effective USs when pentobarbital is the CS.
Pharmacology, biochemistry, and behavior, Volume: 42, Issue: 4		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (1)

ArticleYear
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
PLoS genetics, Volume: 13, Issue: 3		2017
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]